,Drug Name,Drug Class,LigandType,ModeOfAction,DrugAliases,TargetCategory,Gene,EntryName,Uniprot,Class,Target class,Subfamily,Target_novelty,INDEX,Trial name,Indication(s),Phase,PhaseDate,ClinicalStatus,Status,Approval,Note
0,tolterodine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,
1,PTH analog,small molecule,Peptide,agonist,768974,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,10,"768974, parathyroid hormone analog",Anti-osteoporotic,2,2011,discontinued,in trial,-,
2,alb-127158(a),small molecule,Peptide,antagonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,100,alb-127158(a),Anti-obesity,1,2011,discontinued,in trial,-,UK
3,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1009,intranasal apomorphine,sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2006,completed,in trial,-,
4,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1009,intranasal apomorphine,sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2006,completed,in trial,-,
5,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1009,intranasal apomorphine,sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2006,completed,in trial,-,
6,albiglutide,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,101,"albiglutide, gsk716155,syncria",Antidiabetic,4,,-,approved,2014,
7,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1013,"intranasal morphine,rylomine",Analgesics,2,2008,completed,in trial,-,
8,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1013,"intranasal morphine,rylomine",Analgesics,2,2008,completed,in trial,-,
9,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1013,"intranasal morphine,rylomine",Analgesics,2,2008,completed,in trial,-,
10,salbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,102,"albuterol,ventolin",Bronchodilator,4,,-,approved,1981,
11,ipratropium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1021,"ipratropium bromide + albuterol sulfate,duoneb",chronic obstructive pulmonary disease (COPD),4,,-,approved,1986,
12,ipratropium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1021,"ipratropium bromide + albuterol sulfate,duoneb",chronic obstructive pulmonary disease (COPD),4,,-,approved,1986,
13,salbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1021,"ipratropium bromide + albuterol sulfate,duoneb",chronic obstructive pulmonary disease (COPD),4,,-,approved,1981,
14,irbesartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1023,"irbesartan,avapro, irbetan",Antihypertensive,4,,-,approved,1997,
15,isis 325568,antisense oligo,Peptide,antagonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1030,isis 325568,Antidiabetic,1,2007,discontinued,in trial,-,
16,istradefylline,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1043,"istradefylline, kw-6002",Antiparkinson,3,2005,completed,in trial,-,Not approved by fda -denied in 2008
17,exenatide,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1046,itca 650,Antidiabetic,3,2017,not open yet,in trial,-,
18,iti-007,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1048,"iti-007, iti-722",schizophrenia,3,2016,recruiting,in trial,-,
19,iti-007,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1048,"iti-007, iti-722",schizophrenia,3,2016,recruiting,in trial,-,
20,itopride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1049,"itopride,itax",motilitant,3,2012,completed,in trial,-,Not approved yet by FDA
21,jnj-37822681,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1054,jnj-37822681,schizophrenia,2,2013,completed,in trial,-,
22,jvs-100,dna plasmid,Protein,agonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1056,jvs-100,cardioprotectant,2,2015,recruiting,in trial,-,
23,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1057,jzp-7,restless legs syndrome,1,2008,discontinued,in trial,-,
24,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1057,jzp-7,restless legs syndrome,1,2008,discontinued,in trial,-,
25,alfuzosin,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,107,"alfuzosin,uroxatral",benign prostatic hyperplasia,4,,-,approved,2003,
26,alfuzosin,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,107,"alfuzosin,uroxatral",benign prostatic hyperplasia,4,,-,approved,2003,
27,alfuzosin,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,107,"alfuzosin,uroxatral",benign prostatic hyperplasia,4,,-,approved,2003,
28,ketotifen,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1074,"ketotifen fumarate,zaditen, zaditor",Anti-Allergic,4,,-,approved,1999,
29,kn38-7271,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1076,"kn38-7271, BAY 7271, BAY-387271",neuroprotectant,2,2005,discontinued,in trial,-,No development reported
30,kn38-7271,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1076,"kn38-7271, BAY 7271, BAY-387271",neuroprotectant,2,2005,discontinued,in trial,-,No development reported
31,kos-2187,small molecule,Peptide,agonist,,primary,MLNR,mtlr_human,O43193,Class A (Rhodopsin),GPCR;Rhodopsin,Motilin receptors,not established,1078,kos-2187,gastrointestinal motility disorders,1,2006,discontinued,in trial,-,
32,kp201,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1079,kp201 (prodrug of hydrocodone),Analgesics,2,2015,completed,in trial,-,Difficult to get good clinical trial info for
33,kp201,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1079,kp201 (prodrug of hydrocodone),Analgesics,2,2015,completed,in trial,-,Difficult to get good clinical trial info for
34,kp201,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1079,kp201 (prodrug of hydrocodone),Analgesics,2,2015,completed,in trial,-,Difficult to get good clinical trial info for
35,kuc-7483,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1082,"kuc-7483, Ritobegron",overactive bladder,3,2009,completed,in trial,-,"Article from 2012 suggests may be worth more research, but also possibly discontinued"
36,lanreotide,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1088,"lanreotide ,somatuline autogel, somatuline depot",acromegaly,4,,-,approved,2007,
37,lanreotide,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1089,"lanreotide,somatuline autogel, somatuline depot",acromegaly,4,,-,approved,2007,
38,las-100977,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1092,las-100977,Bronchodilator,2,2011,completed,in trial,-,
39,lasmiditan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1093,"lasmiditan, col-144, ly-573144",Anti-migraine,3,2015,ongoing,in trial,-,
40,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1095,"latanoprost + timolol,xalcom, xalacom",Antiglaucomic,4,,-,approved,1996,
41,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1095,"latanoprost + timolol,xalcom, xalacom",Antiglaucomic,4,,-,approved,1981,
42,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1095,"latanoprost + timolol,xalcom, xalacom",Antiglaucomic,4,,-,approved,1981,
43,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1096,"latanoprost, (sustained release, punctal plug delivery system)",Antiglaucomic,4,,-,approved,1996,
44,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1097,"latanoprost,xalatan fixed flow device",Antiglaucomic,4,,-,approved,1996,
45,sonidegib,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,1101,lde225,Antineoplastic,4,,-,approved,2015,
46,lesogaberan,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,1108,"lesogaberan, azd-3355",gastrointestinal reflux disease,2,2016,ongoing,in trial,-,Had been discontinued since 2009 - new trial in 2016
47,lesogaberan,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,1108,"lesogaberan, azd-3355",gastrointestinal reflux disease,2,2016,ongoing,in trial,-,Had been discontinued since 2009 - new trial in 2016
48,ambrisentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1111,letairis,Antihypertensive,4,,-,approved,2007,
49,ambrisentan,small molecule,Peptide,antagonist,,secondary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1111,letairis,Antihypertensive,4,,-,approved,2007,
50,leuprolide,peptide,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1113,leuprolide,Antineoplastic ; endometriosis,4,,-,approved,1985,
51,leuprolide,peptide,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1114,"leuprolide acetate, tap-144 sr",Antineoplastic ; endometriosis,4,,-,approved,1985,
52,leuprolide,peptide,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1115,leupromaxx,Antineoplastic ; endometriosis,4,,-,approved,1985,
53,salbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1116,levalbuterol,Bronchodilator,4,,-,approved,1981,
54,levocetirizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1118,"levocetirizine dihydrochloride,xusal, xyzal",Anti-Allergic,4,,-,approved,2007,Actually approved in 2007 but not considered a NME because enantiomer of cetirizine  I think
55,levodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,
56,levodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,
57,levodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,
58,levodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,
59,levodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,
60,salbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1146,"lipo-102, salmeterol xinafoate + fluticasone propionate",symptomatic exophthalmos associated with thyroid-related eye disease,4,,-,approved,1981,
61,alks 33,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,115,"alks 29, Baclofen+samidorphan",alcohol dependance; Anti-depressant,1,2008,discontinued,in trial,-,
62,alks 33,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,115,"alks 29, Baclofen+samidorphan",alcohol dependance; Anti-depressant,1,2008,discontinued,in trial,-,
63,alks 33,small molecule,Peptide,antagonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,115,"alks 29, Baclofen+samidorphan",alcohol dependance; Anti-depressant,1,2008,discontinued,in trial,-,
64,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,115,"alks 29, Baclofen/samidorphan",alcohol dependance,1,2008,discontinued,in trial,-,
65,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,115,"alks 29, Baclofen/samidorphan",alcohol dependance,1,2008,discontinued,in trial,-,
66,liraglutide,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1154,liraglutide,Antidiabetic,4,,-,approved,2009,
67,lixivaptan,small molecule,Peptide,antagonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1157,lixivaptan,hyponatremia,3,2010,completed,in trial,-,"Some information from 2012 but does not appear to labeled discontinued, just postponed"
68,lofexidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1159,"lofexidine,britlofex",opiate withdrawal,4,,-,approved,2006,
69,lofexidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1159,"lofexidine,britlofex",opiate withdrawal,4,,-,approved,2006,
70,lofexidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1159,"lofexidine,britlofex",opiate withdrawal,4,,-,approved,2006,
71,alks 33,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,116,"alks 33, samidorphan",alcohol dependance; Anti-depressant,2,2009,completed,in trial,-,
72,alks 33,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,116,"alks 33, samidorphan",alcohol dependance; Anti-depressant,2,2009,completed,in trial,-,
73,alks 33,small molecule,Peptide,antagonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,116,"alks 33, samidorphan",alcohol dependance; Anti-depressant,2,2009,completed,in trial,-,
74,loratadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1163,"loratadine + montelukast sodium,claritin + singulair",Anti-Asthmatic,4,,-,approved,1993,
75,montelukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,1163,"loratadine + montelukast sodium,claritin + singulair",Anti-Asthmatic,3,2012,completed,in trial,-,FDA rejected combination form
76,lorcaserin,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1164,lorcaserin,Anti-obesity,4,,-,approved,2012,
77,methamphetamine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1167,low dose intravenous methamphetamine,neuroprotectant,4,,-,approved,1943,
78,methamphetamine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1167,low dose intravenous methamphetamine,neuroprotectant,4,,-,approved,1943,
79,methamphetamine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1167,low dose intravenous methamphetamine,neuroprotectant,4,,-,approved,1943,
80,methamphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,1167,low dose intravenous methamphetamine,neuroprotectant,4,,-,approved,1943,
81,alks 37,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,117,alks 37,motilitant,2,2011,discontinued,in trial,-,
82,alks 37,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,117,alks 37,motilitant,2,2011,discontinued,in trial,-,
83,alks 37,small molecule,Peptide,antagonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,117,alks 37,motilitant,2,2011,discontinued,in trial,-,
84,lu 02-750,unknown,Aminergic ,unknown,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,
85,lu 02-750,unknown,Aminergic ,unknown,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,
86,lu 02-750,unknown,Aminergic ,unknown,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,
87,lu 02-750,unknown,Aminergic ,unknown,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,
88,lu 02-750,unknown,Aminergic ,unknown,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,
89,vortioxetine,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1171,lu aa21004,Anti-depressant,4,,-,approved,2013,
90,vortioxetine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1171,lu aa21004,Anti-depressant,4,,-,approved,2013,
91,vortioxetine,small molecule,Aminergic ,agonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1171,lu aa21004,Anti-depressant,4,,-,approved,2013,
92,tedatioxetine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1173,lu aa24530,Anti-depressant,2,2009,discontinued,in trial,-,discontinued for strategic reasons
93,tedatioxetine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1173,lu aa24530,Anti-depressant,2,2009,discontinued,in trial,-,discontinued for strategic reasons
94,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,completed,in trial,-,
95,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,completed,in trial,-,
96,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,completed,in trial,-,
97,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,completed,in trial,-,
98,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,completed,in trial,-,
99,zicronapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1176,lu-31130,schizophrenia,3,2011,completed,in trial,-,No development reported
100,lu-ae58054,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1177,"lu-ae58054 , ly-483518, sgs518",schizophrenia,3,2014,ongoing,in trial,-,
101,alks 33,small molecule,Peptide,antagonist,alks5461,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 33, alks 5461, Buprenorphine+samidorphan",alcohol dependance; Anti-depressant,3,2014,completed,in trial,-,
102,alks 33,small molecule,Peptide,antagonist,alks5461,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 33, alks 5461, Buprenorphine+samidorphan",alcohol dependance; Anti-depressant,3,2014,completed,in trial,-,
103,alks 33,small molecule,Peptide,antagonist,alks5461,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 33, alks 5461, Buprenorphine+samidorphan",alcohol dependance; Anti-depressant,3,2014,completed,in trial,-,
104,buprenorphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 5461, Buprenorphine/samidorphan",Anti-depressant; Analgesics; opioid addiction,3,2017,completed,in trial,-,
105,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 5461, Buprenorphine/samidorphan",Anti-depressant; Analgesics; opioid addiction,3,2017,completed,in trial,-,
106,lurasidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,
107,lurasidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,
108,lurasidone,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,
109,lurasidone,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,
110,lurasidone,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,
111,almorexant,small molecule,Peptide,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,119,"almorexant, act-078573",sleep disorder treatment,3,2009,discontinued,in trial,-,Not marketed-dropped in 2011 because of side effects profile
112,almorexant,small molecule,Peptide,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,119,"almorexant, act-078573",sleep disorder treatment,3,2009,discontinued,in trial,-,Not marketed-dropped in 2011 because of side effects profile
113,ly2140023,small molecule,Amino acid ,agonist,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,1190,"ly2140023, Pomaglumetad methionil, LY 404039, LY 2140023",schizophrenia,3,2011,discontinued,in trial,-,Ely Lily discontinued due to lack of efficacy
114,ly2140023,small molecule,Amino acid ,agonist,,primary,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,1190,"ly2140023, Pomaglumetad methionil, LY 404039, LY 2140023",schizophrenia,3,2011,discontinued,in trial,-,Ely Lily discontinued due to lack of efficacy
115,almotriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,120,"almotriptan,axert, almogran, amignul",Anti-migraine,4,,-,approved,2001,
116,almotriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,120,"almotriptan,axert, almogran, amignul",Anti-migraine,4,,-,approved,2001,
117,m0002,small molecule,Peptide,antagonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1204,m0002,ascites,2,2010,discontinued,in trial,-,
118,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1207,"m6g, cee 04-410",Analgesics,3,2008,completed,in trial,-,
119,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1207,"m6g, cee 04-410",Analgesics,3,2008,completed,in trial,-,
120,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1207,"m6g, cee 04-410",Analgesics,3,2008,completed,in trial,-,
121,macitentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1209,"macitentan , act-064992",cardiovascular disease,4,,-,approved,2013,
122,macitentan,small molecule,Peptide,antagonist,,primary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1210,"macitentan, act-064992",cardiovascular disease,4,,-,approved,2013,
123,dihydroergotamine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1214,"map-0004, tempo migraine,levadex",Anti-migraine,4,,-,approved,1997,
124,dihydroergotamine,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1214,"map-0004, tempo migraine,levadex",Anti-migraine,4,,-,approved,1997,
125,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1215,map-0005,Bronchodilator,4,,-,approved,2001,
126,mar701,peptide,Peptide,agonist,,primary,GIPR,gipr_human,P48546,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,not established,1217,mar701,Antidiabetic,1,2011,discontinued,in trial,-,
127,mar701,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1217,mar701,Antidiabetic,1,2011,discontinued,in trial,-,
128,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1984,
129,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1984,
130,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1984,
131,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1998,
132,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1998,
133,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1998,
134,mbx-2982,small molecule,Lipid ,agonist,,primary,GPR119,gp119_human,Q8TDV5,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,1225,mbx-2982,Antidiabetic,2,2009,discontinued,in trial,-,
135,mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY1,p2ry1_human,P47900,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
136,mc-1,small molecule,Orphan ,antagonist,,primary,P2RY10,p2y10_human,O00398,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
137,mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY11,p2y11_human,Q96G91,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
138,mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY13,p2y13_human,Q9BPV8,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
139,mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY14,p2y14_human,Q15391,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
140,mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY4,p2ry4_human,P51582,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
141,mc-1,small molecule,Orphan ,antagonist,,primary,P2RY8,p2ry8_human,Q86VZ1,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
142,mc-1,small molecule,Lipid ,antagonist,,secondary,LPAR4,lpar4_human,Q99677,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
143,mc-1,small molecule,Lipid ,antagonist,,secondary,LPAR6,lpar6_human,P43657,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
144,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY1,p2ry1_human,P47900,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
145,mc-4232 + mc-1,small molecule,Orphan ,antagonist,,primary,P2RY10,p2y10_human,O00398,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
146,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY11,p2y11_human,Q96G91,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
147,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
148,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY13,p2y13_human,Q9BPV8,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
149,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY14,p2y14_human,Q15391,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
150,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
151,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY4,p2ry4_human,P51582,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
152,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY6,p2ry6_human,Q15077,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
153,mc-4232 + mc-1,small molecule,Orphan ,antagonist,,primary,P2RY8,p2ry8_human,Q86VZ1,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
154,mc-4232 + mc-1,small molecule,Lipid ,antagonist,,secondary,LPAR4,lpar4_human,Q99677,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
155,mc-4232 + mc-1,small molecule,Lipid ,antagonist,,secondary,LPAR6,lpar6_human,P43657,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
156,mcd-386,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1228,mcd-386,Alzheimer's disease,1,2005,discontinued,in trial,-,
157,leuprolide,peptide,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1250,memryte,Alzheimer's disease,4,,-,approved,1985,
158,methylnaltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1262,methylnaltrexone,opioid-induced constipation,4,,-,approved,2008,
159,metoclopramide,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1268,"metoclopramide hcl,metzoliv odt",motilitant; gastroesophageal reflux disease,4,,-,approved,1979,
160,metoclopramide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1268,"metoclopramide hcl,metzoliv odt",motilitant; gastroesophageal reflux disease,4,,-,approved,1979,
161,metoclopramide,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1269,"metoclopramide,emitasol, pramidin",Antiemetics,4,,-,approved,1979,
162,metoclopramide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1269,"metoclopramide,emitasol, pramidin",Antiemetics,4,,-,approved,1979,
163,metoprolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1270,"metoprolol succinate,toprol-xl",Antihypertensive,4,,-,approved,1978,
164,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1279,"mh-200, tak-453 sr, morphine hcl,anpec",Analgesics,3,2002,completed,in trial,-,
165,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1279,"mh-200, tak-453 sr, morphine hcl,anpec",Analgesics,3,2002,completed,in trial,-,
166,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1279,"mh-200, tak-453 sr, morphine hcl,anpec",Analgesics,3,2002,completed,in trial,-,
167,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,128,"alprostadil,alista",sexual dysfunction,2,2006,discontinued,in trial,-,
168,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,128,"alprostadil,alista",sexual dysfunction,2,2006,discontinued,in trial,-,
169,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,129,"alprostadil,femprox",sexual dysfunction,3,2008,suspended,in trial,-,
170,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,129,"alprostadil,femprox",sexual dysfunction,3,2008,suspended,in trial,-,
171,milveterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1290,"milveterol. td-3327, gsk-159797",Bronchodilator,2,2005,discontinued,in trial,-,
172,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1293,mirapex,Antiparkinson,4,,-,approved,1997,
173,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1293,mirapex,Antiparkinson,4,,-,approved,1997,
174,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1293,mirapex,Antiparkinson,4,,-,approved,1997,
175,mirtazapine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1295,"mirtazapine,remeron, remeron soltab, reflex",Anti-depressant,4,,-,approved,1996,
176,mirtazapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1295,"mirtazapine,remeron, remeron soltab, reflex",Anti-depressant,4,,-,approved,1996,
177,mitemcinal,small molecule,Peptide,agonist,,primary,MLNR,mtlr_human,O43193,Class A (Rhodopsin),GPCR;Rhodopsin,Motilin receptors,not established,1296,"mitemcinal, gm-611",gastroparesis,2,2002,discontinued,in trial,-,
178,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,130,"alprostadil,topiglan",sexual dysfunction,2,2004,discontinued,in trial,-,
179,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,130,"alprostadil,topiglan",sexual dysfunction,2,2004,discontinued,in trial,-,
180,laropiprant,small molecule,Lipid ,antagonist,,primary,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1300,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",for counteracting niacin-induced flushing,3,2007,discontinued,in trial,-,Side effects
181,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1300,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",Antidyslipidaemic,3,2011,discontinued,in trial,-,
182,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1300,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",Antidyslipidaemic,3,2011,discontinued,in trial,-,
183,laropiprant,small molecule,Lipid ,antagonist,,primary,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1301,"mk-0542b, extended release niacin + laropiprant +simvastatin",for counteracting niacin-induced flushing,3,2007,discontinued,in trial,-,Side effects
184,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1301,"mk-0542b, extended release niacin + laropiprant +simvastatin",Antidyslipidaemic,3,2011,discontinued,in trial,-,
185,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1301,"mk-0542b, extended release niacin + laropiprant +simvastatin",Antidyslipidaemic,3,2011,discontinued,in trial,-,
186,suvorexant,small molecule,Peptide,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,1304,mk-4305,Hypnotics and Sedatives,4,,-,approved,2014,
187,suvorexant,small molecule,Peptide,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,1304,mk-4305,Hypnotics and Sedatives,4,,-,approved,2014,
188,mkc-253,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1308,mkc-253,Antidiabetic,1,2008,discontinued,in trial,-,
189,plozalizumab,antibody,Protein,antagonist,MLN-1202,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1310,mln-1202,Anti-inflammatory ; DMARD; Diabetic neophropathy,2,2009,discontinued,in trial,-,
190,plozalizumab,antibody,Protein,antagonist,MLN-1202,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1310,mln-1202,Antineoplastic,2,2015,completed,in trial,-,added entry - new indication
191,mn-221,unknown,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1317,mn-221,Anti-Asthmatic,2,2008,completed,in trial,-,no information on next phase plans
192,mn-246,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1318,mn-246,overactive bladder,1,2010,discontinued,in trial,-,
193,mn-305,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1319,mn-305,Anti-depressant; hypnotic,2,2007,discontinued,in trial,-,
194,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1325,"mometasone furoate + formoterol fumarate dihydrate,dulera",Anti-Asthmatic,4,,-,approved,2010,
195,montelukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,1327,"montelukast sodium,singulair",Anti-Asthmatic,4,,-,approved,1998,
196,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1333,"morphine sulfate,avinza",Analgesics,4,,-,approved,2002,
197,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1333,"morphine sulfate,avinza",Analgesics,4,,-,approved,2002,
198,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1333,"morphine sulfate,avinza",Analgesics,4,,-,approved,2002,
199,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1334,"morphine sulfate,depodur, depomorphine",Analgesics,4,,-,approved,1984,
200,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1334,"morphine sulfate,depodur, depomorphine",Analgesics,4,,-,approved,1984,
201,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1334,"morphine sulfate,depodur, depomorphine",Analgesics,4,,-,approved,1984,
202,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1335,"morphine/dextromethorphan,morphidex",Analgesics,3,2006,discontinued,in trial,-,
203,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1335,"morphine/dextromethorphan,morphidex",Analgesics,3,2006,discontinued,in trial,-,
204,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1335,"morphine/dextromethorphan,morphidex",Analgesics,3,2006,discontinued,in trial,-,
205,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,2,2002,discontinued,in trial,-,
206,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,2,2002,discontinued,in trial,-,
207,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,2,2002,discontinued,in trial,-,
208,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,4,,-,approved,1998,
209,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,4,,-,approved,1998,
210,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,4,,-,approved,1998,
211,mosapride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1337,"mosapride citrate, tak-370,gasmotin",Gastrointestinal reflux disease (GERD),3,2016,recruiting,in trial,-,"Not approved by the FDA, but in other countries for GERD. Trials for many other indications: diabetes, IBS"
212,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,
213,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,
214,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,
215,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,
216,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,
217,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,
218,plerixafor,small molecule,Protein,partial agonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1342,mozobil,Antineoplastic,4,,-,approved,2008,
219,msx-122,small molecule,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1354,msx-122,Antineoplastic,1,2007,discontinued,in trial,-,
220,metoclopramide,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1355,mt 100,Anti-migraine,3,2005,completed,in trial,-,"received not approved letter from FDA in 2005, but mt-400 was approved"
221,metoclopramide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1355,mt 100,Anti-migraine,3,2005,completed,in trial,-,"received not approved letter from FDA in 2005, but mt-400 was approved"
222,dihydroergotamine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1356,mt 300,Anti-migraine,4,,-,approved,1997,
223,dihydroergotamine,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1356,mt 300,Anti-migraine,4,,-,approved,1997,
224,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1357,"mt 400,treximet",Anti-migraine,4,,-,approved,2008,
225,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1357,"mt 400,treximet",Anti-migraine,4,,-,approved,2008,
226,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1357,"mt 400,treximet",Anti-migraine,4,,-,approved,2008,
227,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1357,"mt 400,treximet",Anti-migraine,4,,-,approved,2008,
228,eluxadoline,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1363,"mu delta, eluxadoline",irritable bowel syndrome,4,,-,approved,2015,
229,eluxadoline,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1363,"mu delta, eluxadoline",irritable bowel syndrome,4,,-,approved,2015,
230,nabilone,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1373,"nabilone,cesamet",Antiemetics,4,,-,approved,1985,
231,nabilone,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1373,"nabilone,cesamet",Antiemetics,4,,-,approved,1985,
232,nalbuphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1374,"nalbuphine hydrochloride,  pw-4142",Analgesics,4,,-,approved,1979,
233,nalbuphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1374,"nalbuphine hydrochloride,  pw-4142",Analgesics,4,,-,approved,1979,
234,nalbuphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1374,"nalbuphine hydrochloride,  pw-4142",Analgesics,4,,-,approved,1979,
235,nalmefene,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1375,"nalmefene, cph-101",smoking-cessation ; addiction,4,,-,approved,2013,
236,nalmefene,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1375,"nalmefene, cph-101",smoking-cessation ; addiction,4,,-,approved,2013,
237,nalmefene,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1375,"nalmefene, cph-101",smoking-cessation ; addiction,4,,-,approved,2013,
238,naratriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1381,"naratriptan,naramig, amerge",Anti-migraine,4,,-,approved,1998,
239,naratriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1381,"naratriptan,naramig, amerge",Anti-migraine,4,,-,approved,1998,
240,naratriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1381,"naratriptan,naramig, amerge",Anti-migraine,4,,-,approved,1998,
241,naratriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1381,"naratriptan,naramig, amerge",Anti-migraine,4,,-,approved,1998,
242,Elagolix,small molecule,Peptide,antagonist,nbi-56418,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1388,nbi-56418,"Endometriosis, Antineoplastic",3,2016,recruiting,in trial,-,
243,ncx 1510,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1390,"ncx 1510, ox-nla",Anti-Allergic,2,2009,completed,in trial,-,
244,nebivolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1394,"nebivolol ,bystolic",Antihypertensive,4,,-,approved,2007,
245,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,14,aa-2010,incontinence,4,,-,approved,1975,
246,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,14,aa-2010,incontinence,4,,-,approved,1975,
247,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,14,aa-2010,incontinence,4,,-,approved,1975,
248,rotigotine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1404,neupro,Antiparkinson,4,,-,approved,2006,
249,rotigotine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1404,neupro,Antiparkinson,4,,-,approved,2006,
250,rotigotine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1404,neupro,Antiparkinson,4,,-,approved,2006,
251,ngd-4715,small molecule,Peptide,antagonist,,primary,MCHR1,mchr1_human,Q99705,Class A (Rhodopsin),GPCR;Rhodopsin,Melanin-concentrating hormone,not established,1408,ngd-4715,Appetite suppressant,2,2008,discontinued,in trial,-,
252,ngx267,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1410,ngx267,dry mouth,2,2008,discontinued,in trial,-,
253,niacin receptor agonist,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1412,niacin receptor agonist,Anti-atherosclerotic,2,2009,discontinued,in trial,-,
254,niacin receptor agonist,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1412,niacin receptor agonist,Anti-atherosclerotic,2,2009,discontinued,in trial,-,
255,naloxegol,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1419,nktr-118,opioid-induced constipation,4,,-,approved,2014,
256,nktr-181,small molecule polymer conjugate,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1420,nktr-181,Analgesics,3,2015,ongoing,in trial,-,
257,hydromorphone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1422,"nmed-1077,exalgo, jurnista, dilaudid",Analgesics,4,,-,approved,1984,
258,hydromorphone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1422,"nmed-1077,exalgo, jurnista, dilaudid",Analgesics,4,,-,approved,1984,
259,hydromorphone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1422,"nmed-1077,exalgo, jurnista, dilaudid",Analgesics,4,,-,approved,1984,
260,nn9924,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1429,nn9924,Antidiabetic,3,2016,ongoing,in trial,-,
261,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1436,"nova21027,catioprost",Antiglaucomic,2,2015,completed,in trial,-,
262,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1438,"np101,zelrix",Anti-migraine,4,,-,approved,1992,
263,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1438,"np101,zelrix",Anti-migraine,4,,-,approved,1992,
264,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1438,"np101,zelrix",Anti-migraine,4,,-,approved,1992,
265,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1438,"np101,zelrix",Anti-migraine,4,,-,approved,1992,
266,am-152,small molecule,Lipid ,antagonist,,primary,LPAR1,lpar1_human,Q92633,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,144,"am-152, BMS 986020",Anti-inflammatory ; antifibrotic,2,2015,completed,in trial,-,
267,fluoxetine,small molecule,Aminergic ,antagonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1440,"npl-2008, fluoxetine",autism,4,,-,approved,1987,May be a bit tricky mode of action explanation but seems antagonist suits best
268,nps-2143,small molecule,Ion ,antagonist,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,1441,nps-2143,Anti-osteoporotic,0,2015,completed,preclinical,-,
269,nrp290,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1444,nrp290,Analgesics,1,2006,discontinued,in trial,-,
270,nrp290,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1444,nrp290,Analgesics,1,2006,discontinued,in trial,-,
271,nrp290,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1444,nrp290,Analgesics,1,2006,discontinued,in trial,-,
272,am-211,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,145,am-211,Anti-inflammatory ; antiallergy,1,2011,unknown,in trial,-,
273,glycopyrronium,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1457,"nva237, inhaled glycopyrronium bromide",chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,
274,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1458,"nvd-422, tizanidine oral spray",skeletal muscular spasticity,4,,-,approved,1996,
275,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1458,"nvd-422, tizanidine oral spray",skeletal muscular spasticity,4,,-,approved,1996,
276,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1458,"nvd-422, tizanidine oral spray",skeletal muscular spasticity,4,,-,approved,1996,
277,am-461,small molecule,Lipid ,antagonist,,primary,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,146,am-461,Anti-inflammatory,1,2011,unknown,in trial,-,
278,nxn-188,small molecule,Aminergic ,antagonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1460,nxn-188,Anti-migraine,2,2009,discontinued,in trial,-,
279,nxn-188,small molecule,Aminergic ,antagonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1460,nxn-188,Anti-migraine,2,2009,discontinued,in trial,-,
280,betahistine,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1464,"obe101,histalean,anti-obesity ",Anti-obesity,2,2008,discontinued,in trial,-,
281,betahistine,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1464,"obe101,histalean,anti-obesity ",Anti-obesity,2,2008,discontinued,in trial,-,
282,oc000459 ,small molecule,Lipid ,antagonist,,primary,PD2R2,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,1466,oc000459,Anti-Allergic,2,2016,recruiting,in trial,-,
283,octreotide,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1470,"octrotide,atrigel",Antineoplastic,4,,-,approved,1988,
284,octreotide,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1470,"octrotide,atrigel",Antineoplastic,4,,-,approved,1988,
285,octreotide,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1470,"octrotide,atrigel",Antineoplastic,4,,-,approved,1988,
286,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
287,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
288,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
289,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
290,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
291,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
292,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
293,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
294,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
295,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
296,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
297,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
298,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
299,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
300,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
301,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
302,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
303,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
304,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
305,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
306,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
307,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
308,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
309,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
310,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
311,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
312,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
313,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
314,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
315,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
316,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
317,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
318,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
319,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
320,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
321,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
322,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
323,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
324,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
325,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
326,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
327,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
328,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
329,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
330,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
331,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
332,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
333,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
334,olmesartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1478,"olmesartan medoxomil (cs-866),benicar",Antihypertensive,4,,-,approved,2002,
335,olmesartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1479,"olmesartan, de-092",Antiglaucomic,4,,-,approved,2002,
336,amap102,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,148,amap102,Anti-inflammatory ; DMARD,2,2014,completed,in trial,-,Phase 2 in Europe
337,amap102,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,148,amap102,Anti-inflammatory ; DMARD,2,2014,completed,in trial,-,
338,olopatadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1480,"olopatadine hydrochloride,patanase",Anti-Allergic,4,,-,approved,1996,
339,amitriptyline,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1491,oms-103hp,Analgesics,4,,-,approved,1961,
340,oxymetazoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1491,oms-103hp,Analgesics,4,,-,approved,1986,
341,oxymetazoline,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1491,oms-103hp,Analgesics,4,,-,approved,1986,
342,amd-070,small molecule,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,150,amd-070,antiviral ; HIV,2,2004,discontinued,in trial,-,
343,opc-28326,small molecule,Aminergic ,antagonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1501,opc-28326,vasodilator,2,2006,discontinued,in trial,-,
344,opc-28326,small molecule,Aminergic ,antagonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1501,opc-28326,vasodilator,2,2007,discontinued,in trial,-,
345,brexpiprazole,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1502,brexpiprazole,Anti-depressant,4,,-,approved,2015,
346,brexpiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1502,brexpiprazole,Anti-depressant,4,,-,approved,2015,
347,brexpiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1502,brexpiprazole,Anti-depressant,4,,-,approved,2015,
348,brexpiprazole,small molecule,Aminergic ,partial agonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1502,brexpiprazole,Anti-depressant,4,,-,approved,2015,
349,opc-51803,small molecule,Peptide,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1503,"opc-51803, sou-003",incontinence,2,2006,discontinued,in trial,-,
350,octreotide,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1508,"oral octreotide actetate ,octreolin",Antihypertensive,4,,-,approved,1988,
351,octreotide,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1509,"oral octreotide actetate,octreolin",Antihypertensive,4,,-,approved,1988,
352,octreotide,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1509,"oral octreotide actetate,octreolin",Antihypertensive,4,,-,approved,1988,
353,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
354,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
355,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
356,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
357,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
358,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
359,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
360,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
361,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
362,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
363,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
364,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
365,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
366,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
367,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
368,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
369,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
370,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
371,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
372,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
373,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
374,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
375,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
376,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
377,ormd-0901,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1519,"ormd-0901, oral glp-1 analog",Antidiabetic,1,2016,completed,in trial,-,
378,ostabolin-c,peptide,Peptide,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1530,"ostabolin-c,  zt-031",Anti-osteoporotic,2,2008,discontinued,in trial,-,Change within company direction
379,ostabolin-c,peptide,Peptide,agonist,,primary,PTH2R,pth2r_human,P49190,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1530,"ostabolin-c,  zt-031",Anti-osteoporotic,2,2008,discontinued,in trial,-,Change within company direction
380,ot-730,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1533,ot-730,Antiglaucomic,2,2009,discontinued,in trial,-,
381,ot-730,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1533,ot-730,Antiglaucomic,2,2009,discontinued,in trial,-,
382,desmopressin,peptide,Peptide,not available,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1537,"nocdurna,  desmopressin",Antidiuretic,4,,-,approved,1978,
383,desmopressin,peptide,Peptide,not available,,primary,AVPR1B,v1br_human,P47901,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1537,"nocdurna,  desmopressin",Antidiuretic,4,,-,approved,1978,
384,desmopressin,peptide,Peptide,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1537,"nocdurna,  desmopressin",Antidiuretic,4,,-,approved,1978,
385,famotidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1539,ox17,acid reducer,4,,-,approved,1986,
386,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1545,"oxycodone art, eli216,oxynal",Analgesics,4,,-,approved,1998,
387,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1545,"oxycodone art, eli216,oxynal",Analgesics,4,,-,approved,1998,
388,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1545,"oxycodone art, eli216,oxynal",Analgesics,4,,-,approved,1998,
389,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",substance abuse deterrant,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010
390,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",substance abuse deterrant,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010
391,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",Analgesics,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010
392,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",Analgesics,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010
393,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",Analgesics,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010
394,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1547,"oxycodone, pti-821,remoxy",Analgesics,3,2016,completed,in trial,-,waiting for FDA approval
395,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1547,"oxycodone, pti-821,remoxy",Analgesics,3,2016,completed,in trial,-,waiting for FDA approval
396,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1547,"oxycodone, pti-821,remoxy",Analgesics,3,2016,completed,in trial,-,waiting for FDA approval
397,oxymorphone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1548,"oxymorphone hydrochloride, en3202,opana, opana er",Analgesics,4,,-,approved,1959,
398,oxymorphone,small molecule,Peptide,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1548,"oxymorphone hydrochloride, en3202,opana, opana er",Analgesics,4,,-,approved,1959,
399,pa-401,protein,Protein,antagonist,,primary,CXCR1,cxcr1_human,P25024,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1553,"pa-401, pa04-001",Anti-inflammatory ; immunosuppressant,1,2012,discontinued,in trial,-,
400,pa-401,protein,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1553,"pa-401, pa04-001",Anti-inflammatory ; immunosuppressant,1,2012,discontinued,in trial,-,
401,paliperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1558,"paliperidone er, paliperidone palmitate",schizophrenia,4,,-,approved,2006,
402,paliperidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1558,"paliperidone er, paliperidone palmitate",schizophrenia,4,,-,approved,2006,
403,pardoprunox,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
404,pardoprunox,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
405,pardoprunox,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
406,pardoprunox,small molecule,Aminergic ,agonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
407,pardoprunox,small molecule,Aminergic ,agonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
408,pardoprunox,small molecule,Aminergic ,agonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
409,pardoprunox,small molecule,Aminergic ,agonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
410,pasireotide,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1567,"pasireotide, som230",Antineoplastic ; acromegaly,4,,-,approved,2012,
411,pasireotide,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1567,"pasireotide, som230",Antineoplastic ; acromegaly,4,,-,approved,2012,
412,pasireotide,peptide,Peptide,agonist,,primary,SSTR3,ssr3_human,P32745,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1567,"pasireotide, som230",Antineoplastic ; acromegaly,4,,-,approved,2012,
413,pasireotide,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1567,"pasireotide, som230",Antineoplastic ; acromegaly,4,,-,approved,2012,
414,pb1023,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1569,"pb1023, glp-1-elp-120,glymera",Antidiabetic,2,2012,completed,in trial,-,
415,exendin-4,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1572,pc-dac:exendin-4,Antidiabetic,4,,-,approved,2005,
416,pd-6735,small molecule,Melatonin ,agonist,tik-301,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1575,"pd-6735, ly-156735, tik-301",Hypnotics and Sedatives,2,2004,completed,in trial,-,May still be researched
417,pd-6735,small molecule,Melatonin ,agonist,tik-301,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1575,"pd-6735, ly-156735, tik-301",Hypnotics and Sedatives,2,2004,completed,in trial,-,May still be researched
418,amibegron,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,158,"amibegron, sr 58611",Anti-depressant,3,2008,discontinued,in trial,-,
419,pentoxifylline,small molecule,Nucleotide ,antagonist,,secondary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1586,"pentoxifylline, eht0201",amyotrophic lateral sclerosis (ALS),4,,-,approved,1984,
420,pf-00610355,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1591,pf-00610355,Bronchodilator,2,2009,discontinued,in trial,-,
421,amiodarone,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,160,"amiodarone hcl,amio-aqueous iv",Anti-Arrhythmia,4,,-,approved,1985,
422,amiodarone,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,160,"amiodarone hcl,amio-aqueous iv",Anti-Arrhythmia,4,,-,approved,1985,
423,amisulpride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,161,"amisulpride,solian",schizophrenia,1,1999,discontinued,in trial,-,Amulsipride is marketed in Europe for schizophrenia but not past Phase 1 trials in US
424,amisulpride,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,161,"amisulpride,solian",schizophrenia,1,1999,discontinued,in trial,-,Amulsipride is marketed in Europe for schizophrenia but not past Phase 1 trials in US
425,pimavanserin,small molecule,Aminergic ,inverse agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1610,pimavanserin,Antiparkinson,4,,-,approved,2016,
426,clopidogrel,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,1619,plavix,antithrombotic,4,,-,approved,1997,
427,ponesimod,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,1630,ponesimod,Anti-inflammatory ; multiple sclerosis,3,2016,recruiting,in trial,-,
428,prasugrel,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,1640,"prasugrel, cs-747,efient",antithrombotic,4,,-,approved,2009,
429,preladenant,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1645,"preladenant, sch-420814",Antiparkinson,3,2011,discontinued,in trial,-,
430,alx1-11,protein,Peptide,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1646,preos,Anti-osteoporotic,3,2005,completed,in trial,-,
431,alx1-11,protein,Peptide,agonist,,primary,PTH2R,pth2r_human,P49190,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1646,preos,Anti-osteoporotic,3,2005,completed,in trial,-,
432,pridopidine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1647,"pridopidine, acr-16,huntexil",Huntington's disease,3,2008,completed,in trial,-,Needs another Phase 3 trial before FDA considers approval
433,pro 140,antibody,Protein,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1649,pro 140,antiviral ; HIV,3,2016,recruiting,in trial,-,
434,opc-14523,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1662,"prs-013, opc-14523",Anti-depressant,2,2009,completed,in trial,-,No development reported
435,prucalopride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1665,"prucalopride ,resolor",motilitant,4,,-,approved,2009,
436,prx-00023,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1666,"prx-00023, Naluzotan",Anti-depressant,3,2011,discontinued,in trial,-,
437,prx-07034,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1667,prx-07034,Anti-obesity ; nootropic,1,2007,completed,in trial,-,Sold to undisclosed company in 2009
438,prx-08066,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1668,prx-08066,Antihypertensive,2,2008,completed,in trial,-,
439,prx-3140,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1671,prx-3140,Alzheimer's disease,2,2013,completed,in trial,-,
440,ps433540,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1673,ps433540,"Focal segmental glomerulosclerosis, Antihypertensive",2,2012,recruiting,in trial,-,
441,ps433540,small molecule,Peptide,antagonist,,primary,AGTR2,agtr2_human,P50052,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,not established,1673,ps433540,"Focal segmental glomerulosclerosis, Antihypertensive",2,2012,recruiting,in trial,-,
442,ps433540,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1673,ps433540,"Focal segmental glomerulosclerosis, Antihypertensive",2,2012,recruiting,in trial,-,
443,phenylephrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1675,"psd-503, phenylephrine",incontinence,4,,-,approved,1952,
444,phenylephrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1675,"psd-503, phenylephrine",incontinence,4,,-,approved,1952,
445,phenylephrine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1675,"psd-503, phenylephrine",incontinence,4,,-,approved,1952,
446,psd-506,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1676,psd-506,overactive bladder,2,2009,discontinued,in trial,-,
447,psd-506,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1676,psd-506,overactive bladder,2,2009,discontinued,in trial,-,
448,psn602,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1678,psn602,Anti-obesity,1,2009,discontinued,in trial,-,
449,psn821,small molecule,Lipid ,agonist,,primary,GPR119,gp119_human,Q8TDV5,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,1679,psn821,Antidiabetic,2,2011,discontinued,in trial,-,
450,glycopyrrolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1680,pt001,chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,
451,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1681,"pt003, glycopyrrolate + formoterol inhalation aerosol",chronic obstructive pulmonary disease (COPD),4,,-,approved,2016,
452,glycopyrrolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1681,"pt003, glycopyrrolate + formoterol inhalation aerosol",chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,
453,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1682,"pt005, formoterol fumarate hydrofluoroalkane metered dose inhaler",chronic obstructive pulmonary disease (COPD),3,2015,discontinued,in trial,-,
454,pti-202,unknown,Peptide,not available,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1684,pti-202,Analgesics,1,2006,completed,in trial,-,Not good information - may have changed names within Pain Therapeutics
455,pti-202,unknown,Peptide,not available,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1684,pti-202,Analgesics,1,2006,completed,in trial,-,Not good information - may have changed names within Pain Therapeutics
456,pti-202,unknown,Peptide,not available,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1684,pti-202,Analgesics,1,2006,completed,in trial,-,Not good information - may have changed names within Pain Therapeutics
457,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,
458,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,
459,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,
460,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,
461,tramadol,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,
462,tramadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,
463,hydrocodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,
464,hydrocodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,
465,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,
466,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,
467,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,
468,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching
469,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching
470,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching
471,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching
472,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching
473,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching
474,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1688,pti-901,Analgesics,4,,-,approved,1998,
475,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1688,pti-901,Analgesics,4,,-,approved,1998,
476,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1688,pti-901,Analgesics,4,,-,approved,1998,
477,pw2101,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1690,pw2101,Antihypertensive,1,2005,discontinued,in trial,-,
478,glycopyrronium,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1702,"qva149, glycopyrronium + i/",chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,
479,indacaterol,small molecule,Aminergic ,agonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1702,"qva149, glycopyrronium + indacaterol",chronic obstructive pulmonary disease (COPD),4,,-,approved,2009,
480,ramelteon,small molecule,Melatonin ,agonist,,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1713,"ramelteon, tak-375,rozerem",insomnia,4,,-,approved,2005,
481,ramelteon,small molecule,Melatonin ,agonist,,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1713,"ramelteon, tak-375,rozerem",insomnia,4,,-,approved,2005,
482,ranitidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1716,"ranitidine bismuth citrate,tritec",antiulcer,4,,-,approved,1977,
483,regadenoson,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1726,"regadenoson,lexiscan",Diagnostic,4,,-,approved,2008,
484,eletriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1731,relpax,Anti-migraine,4,,-,approved,2002,
485,remifentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1732,"remifentanil,ultiva",Analgesics,4,,-,approved,1996,
486,nalbuphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,2,2006,discontinued,in trial,-,
487,nalbuphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,2,2006,discontinued,in trial,-,
488,nalbuphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,2,2006,discontinued,in trial,-,
489,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,4,,-,approved,1971,
490,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,4,,-,approved,1971,
491,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,4,,-,approved,1971,
492,renzapride,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1734,renzapride,irritable bowel syndrome,3,2008,discontinued,in trial,-,Terminated due to insufficient over placebo in study
493,renzapride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1734,renzapride,irritable bowel syndrome,3,2008,discontinued,in trial,-,Terminated due to insufficient over placebo in study
494,renzapride,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1734,renzapride,irritable bowel syndrome,3,2008,discontinued,in trial,-,Terminated due to insufficient over placebo in study
495,renzapride,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1734,renzapride,irritable bowel syndrome,3,2008,discontinued,in trial,-,Terminated due to insufficient over placebo in study
496,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1737,ropinirole,Antiparkinson,4,,-,approved,1997,
497,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1737,ropinirole,Antiparkinson,4,,-,approved,1997,
498,rev131,small molecule,Aminergic ,antagonist,,primary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1745,rev131,Anti-Allergic,2,2006,discontinued,in trial,-,
499,rg1068,peptide,Peptide,agonist,,primary,SCTR,sctr_human,P47872,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1749,"rg1068, synthetic secretin,secreflo","autism, schizophrenia",3,2004,discontinued,in trial,-,
500,anamorelin,small molecule,Peptide,agonist,,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,175,"anamorelin, rc-1291",Appetite stimulant,3,2011,completed,in trial,-,
501,chorionic gonadotropin,protein,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,1756,"r-hcg,ovidrel",Antineoplastic,4,,-,approved,1973,
502,rimonabant,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1766,rimonabant,Anti-obesity,4,,-,approved,2007,
503,anatibant,small molecule,Peptide,antagonist,,primary,BDKRB2,bkrb2_human,P30411,Class A (Rhodopsin),GPCR;Rhodopsin,Bradykinin receptors,established,177,anatibant,traumatic brain injury,2,2007,discontinued,in trial,-,
504,risperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1770,risperdal,schizophrenia,4,,-,approved,1993,
505,risperidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1770,risperdal,schizophrenia,4,,-,approved,1993,
506,rocuronium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1776,"rocuronium bromide,esmeron, zemuron, eslax",Muscle Relaxants,4,,-,approved,2008,
507,rolofylline,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1780,"rolofylline, mk-7418, kw-3902",congestive heart failure,3,2007,discontinued,in trial,-,
508,ronacaleret,small molecule,Ion ,antagonist,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,1782,"ronacaleret, 751689",Anti-osteoporotic,2,2007,discontinued,in trial,-,discontinued due to lack of evidence of efficacy
509,ozanimod,small molecule,Lipid ,agonist,rpc1063,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,1790,rpc1063,Multiple Sclerosis,3,2017,completed,in trial,-,
510,saredutant,small molecule,Peptide,antagonist,,primary,TACR2,nk2r_human,P21452,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,not established,1810,"saredutant, sr 48968",Anti-depressant,3,2006,discontinued,in trial,-,Sanofi-aventis discontinued due to reprioritization of RD portfolio
511,nabilone,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1812,sativex,Analgesics; neuropathic pain; restlegs legs syndrome,3,2014,recruiting,in trial,-,
512,nabilone,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1812,sativex,Analgesics; neuropathic pain; restlegs legs syndrome,3,2014,recruiting,in trial,-,
513,tetrahydrocannabinol,plant extract,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1812,sativex,Analgesics; neuropathic pain; restlegs legs syndrome,4,,-,approved,1985,
514,tetrahydrocannabinol,plant extract,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1812,sativex,Analgesics; neuropathic pain; restlegs legs syndrome,4,,-,approved,1985,
515,sch-527123,small molecule,Protein,antagonist,,primary,CXCR1,cxcr1_human,P25024,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1822,"sch-527123, ps-291822, ps-938285, navarixin",chronic obstructive pulmonary disease (COPD),2,2009,discontinued,in trial,-,
516,sch-527123,small molecule,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1822,"sch-527123, ps-291822, ps-938285, navarixin",chronic obstructive pulmonary disease (COPD),2,2009,discontinued,in trial,-,
517,selexipag,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1831,"selexipag, act-293987",Antihypertensive,4,,-,approved,2015,
518,maraviroc,small molecule,Protein,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1834,selzentry,antiviral ; HIV,4,,-,approved,2007,
519,sertindole,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
520,sertindole,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
521,sertindole,small molecule,Aminergic ,inverse agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
522,sertindole,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
523,sertindole,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
524,sertindole,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
525,sertindole,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
526,salmeterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1839,serevent,Bronchodilator,4,,-,approved,1994,
527,quetiapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1840,seroquel,Antipsychotic ; Anti-depressant,4,,-,approved,1997,
528,quetiapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1840,seroquel,Antipsychotic ; Anti-depressant,4,,-,approved,1997,
529,quetiapine,small molecule,Aminergic ,antagonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1840,seroquel,Antipsychotic ; Anti-depressant,4,,-,approved,1997,
530,quetiapine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1840,seroquel,Antipsychotic ; Anti-depressant,4,,-,approved,1997,
531,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
532,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
533,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
534,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
535,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
536,doxepin,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
537,doxepin,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
538,doxepin,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
539,doxepin,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
540,doxepin,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
541,silodosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1852,silodosin,BPH-related urinary symptoms,4,,-,approved,2008,
542,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1861,"skyepharma,flutiform",Bronchodilator,3,2010,completed,in trial,-,Approved in Europe but not FDA
543,amphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,1862,"sli 381, spd 465,adderall, adderall xr, adderall ir",cognitive dysfunction; ADHD,4,,-,approved,1996,
544,gamma hydroxybutyric acid,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,1871,sodium oxybate,Hypnotics and Sedatives,4,,-,approved,2002,
545,gamma hydroxybutyric acid,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,1871,sodium oxybate,Hypnotics and Sedatives,4,,-,approved,2002,
546,solabegron,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1874,"solabegron, gw 427353",Antidiabetic; irritable bowel syndrome; incontinence,1,2016,recruiting,in trial,-,"Had Phase 2 trials for IBS and overactive bladder in 2007, but now after 10 year break clinical trials starting again"
547,solifenacin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,
548,solifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,
549,solifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,
550,solifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,
551,solifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,
552,sou-001,small molecule,Aminergic ,not available,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1881,"sou-001, drp-001",incontinence,2,2006,discontinued,in trial,-,
553,sou-001,small molecule,Aminergic ,not available,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1881,"sou-001, drp-001",incontinence,2,2006,discontinued,in trial,-,
554,sou-001,small molecule,Aminergic ,not available,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1881,"sou-001, drp-001",incontinence,2,2006,discontinued,in trial,-,
555,ap1030,small molecule,Peptide,PAM,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,189,ap1030,Anti-obesity,1,2010,completed,in trial,-,
556,ap1030,small molecule,Peptide,PAM,,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,189,ap1030,Anti-obesity,1,2010,completed,in trial,-,No development reported
557,ozarelix,peptide,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1891,"spi-153, d-63153,ozarelix",Antineoplastic,2,2010,discontinued,in trial,-,
558,ozarelix,peptide,Peptide,antagonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1891,"spi-153, d-63153,ozarelix",Antineoplastic,2,2010,discontinued,in trial,-,
559,spi-1620,peptide,Peptide,agonist,,primary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1892,spi-1620,adjuvant to chemotherapy,2,2013,discontinued,in trial,-,
560,spi-1620,peptide,Peptide,agonist,,secondary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1892,spi-1620,adjuvant to chemotherapy,2,2013,discontinued,in trial,-,Appears to not meet efficacy end point
561,abarelix,peptide,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,19,"abarelix, plenaxis",Antineoplastic,4,,-,approved,2003,
562,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,190,"ap-1034,anturol",overactive bladder,4,,-,approved,1975,
563,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,190,"ap-1034,anturol",overactive bladder,4,,-,approved,1975,
564,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,190,"ap-1034,anturol",overactive bladder,4,,-,approved,1975,
565,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1903,statex,Analgesics,4,,-,approved,1984,
566,chorionic gonadotropin,protein,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,1904,"stem,ntx-265",stroke,4,,-,approved,1973,
567,strontium ranelate,small molecule,Ion ,agonist,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,1905,"strontium ranelate, s12911",Anti-osteoporotic,3,2015,completed,in trial,-,European trials and marketed
568,stx107,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,1906,stx107,Fragile X syndrome,2,2011,completed,in trial,-,
569,homspera,protein,Peptide,agonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,1907,"substance p,homspera, radilex, viprovex",idiopathic pulmonary fibrosis,1,2011,ongoing,in trial,-,
570,sufentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1909,"sufentanil transdermal patch,transdur-sufentanil",Analgesics,2,2015,discontinued,in trial,-,
571,sufentanil,small molecule,Peptide,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1909,"sufentanil transdermal patch,transdur-sufentanil",Analgesics,2,2015,discontinued,in trial,-,
572,sufentanil,small molecule,Peptide,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1909,"sufentanil transdermal patch,transdur-sufentanil",Analgesics,2,2015,discontinued,in trial,-,
573,sufentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1910,"sufentanil,chronogesic",Analgesics,2,2015,discontinued,in trial,-,
574,sufentanil,small molecule,Peptide,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1910,"sufentanil,chronogesic",Analgesics,2,2015,discontinued,in trial,-,
575,sufentanil,small molecule,Peptide,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1910,"sufentanil,chronogesic",Analgesics,2,2015,discontinued,in trial,-,
576,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1914,sumatriptan,Anti-migraine,4,,-,approved,1992,
577,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1914,sumatriptan,Anti-migraine,4,,-,approved,1992,
578,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1914,sumatriptan,Anti-migraine,4,,-,approved,1992,
579,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1914,sumatriptan,Anti-migraine,4,,-,approved,1992,
580,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1915,"sumatriptan, triptan",Anti-migraine,4,,-,approved,1992,
581,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1915,"sumatriptan, triptan",Anti-migraine,4,,-,approved,1992,
582,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1915,"sumatriptan, triptan",Anti-migraine,4,,-,approved,1992,
583,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1915,"sumatriptan, triptan",Anti-migraine,4,,-,approved,1992,
584,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1916,"sumatriptan,imitrex",Anti-migraine,4,,-,approved,1992,
585,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1916,"sumatriptan,imitrex",Anti-migraine,4,,-,approved,1992,
586,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1916,"sumatriptan,imitrex",Anti-migraine,4,,-,approved,1992,
587,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1916,"sumatriptan,imitrex",Anti-migraine,4,,-,approved,1992,
588,surinabant,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1917,"surinabant, sr 147778","smoking-cessation, obesity",2,2007,discontinued,in trial,-,
589,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1918,sustained release latanoprost,Antiglaucomic,4,,-,approved,1996,
590,apd125,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,192,apd125,insomnia,2,2008,discontinued,in trial,-,
591,apd125,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,192,"apd125, Nelotanserin",Dementia with Lewy Bodies,2,2016,recruiting,in trial,-,Added entry because Indication so different
592,suvn-502,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1920,suvn-502,Alzheimer's disease,2,2015,recruiting,in trial,-,
593,svt-40776,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1921,"svt-40776, tarafenacin",incontinence,2,2011,completed,in trial,-,
594,syl040012,sirna,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1922,"syl040012, Bamosiran",Antiglaucomic,2,2014,completed,in trial,-,
595,pramlintide acetate,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,1924,"pramlintide acetate, symlin",Antidiabetic,4,,-,approved,2005,
596,tozadenant,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1926,syn-115,Antiparkinson,3,2017,not open yet,in trial,-,
597,t-62,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1930,t-62,Analgesics,2,2008,discontinued,in trial,-,"discontinued because patients experienced asymptomatic, transient elevations in liver transaminases"
598,apd668,small molecule,Lipid ,agonist,,primary,GPR119,gp119_human,Q8TDV5,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,194,apd668,Antidiabetic,1,2006,discontinued,in trial,-,
599,talnetant,small molecule,Peptide,antagonist,,primary,TACR3,nk3r_human,P29371,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,not established,1943,"talnetant, sb 223412",schizophrenia,2,2006,discontinued,in trial,-,
600,tamsulosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1946,"tamsulosin, ym-617,harnal, flomax",urinary symptoms associated with BPH,4,,-,approved,1997,
601,tamsulosin,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1946,"tamsulosin, ym-617,harnal, flomax",urinary symptoms associated with BPH,4,,-,approved,1997,
602,tamsulosin,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1946,"tamsulosin, ym-617,harnal, flomax",urinary symptoms associated with BPH,4,,-,approved,1997,
603,apd791,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,195,apd791,antithrombotic,1,2008,completed,in trial,-,
604,tapentadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1950,tapentadol,Analgesics,4,,-,approved,2008,
605,tapentadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1951,"tapentadol hydrochloride, cg-5503, r331333",Analgesics,4,,-,approved,2008,
606,taranabant,small molecule,Lipid ,inverse agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1952,"taranabant, mk-0364",Anti-obesity ; smoking-cessation,3,2007,discontinued,in trial,-,discontinued because overall profile does not support development for obesity
607,tasimelteon,small molecule,Melatonin ,agonist,,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1956,"tasimelteon, vec-162",Hypnotics and Sedatives,4,,-,approved,2014,
608,tasimelteon,small molecule,Melatonin ,agonist,,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1956,"tasimelteon, vec-162",Hypnotics and Sedatives,4,,-,approved,2014,
609,taspoglutide,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1958,"taspoglutide, itm-077, r1583, bim-51077",Antidiabetic,3,2011,discontinued,in trial,-,discontinued due to adverse gastrointestinal reactions
610,apd916,small molecule,Aminergic ,agonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,196,apd916,sleep disorders; narcolepsy,1,2010,completed,in trial,-,
611,tbr-652,small molecule,Protein,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1962,"tbr-652, tak-652, Cenicriviroc",antiviral ; HIV; Nonalcoholic Steatohepatitis,3,2017,recruiting,in trial,-,
612,td-1211,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1971,"td-1211, Axelopran",opioid-induced gastrointestinal side-effects,2,2012,completed,in trial,-,
613,td-2749,unknown,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1972,td-2749,motilitant,1,2005,discontinued,in trial,-,
614,tecadenoson,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1973,tecadenoson,Anti-Arrhythmia,3,2009,discontinued,in trial,-,
615,tegaserod,small molecule,Aminergic ,partial agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1975,"tegaserod,zelnorm, zelmac",motilitant,4,,-,approved,2002,
616,telmisartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1977,"telmisartan,micardis, micardis hct",Antihypertensive,4,,-,approved,1998,
617,terguride,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1981,terguride,"Diffuse cutaneous systemic sclerosis, Antihypertensive",3,2016,ongoing,in trial,-,Difficult to get info; 10 year break before investigating again in Europe
618,terguride,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1981,terguride,"Diffuse cutaneous systemic sclerosis, Antihypertensive",3,2016,ongoing,in trial,-,Difficult to get info; 10 year break before investigating again in Europe
619,teriparatide,peptide,Peptide,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1983,"teriparatide, inhaled air",Anti-osteoporotic,4,,-,approved,1987,
620,teriparatide,peptide,Peptide,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1984,"teriparatide, pth1-34 nasal spray",Anti-osteoporotic,4,,-,approved,1987,
621,teriparatide,peptide,Peptide,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1985,"teriparatide,forteo, forsteo",Anti-osteoporotic,4,,-,approved,1987,
622,terlipressin,small molecule,Peptide,agonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1986,"terlipressin,lucassin",hepatorenal syndrome,4,,-,approved,2003,
623,terlipressin,small molecule,Peptide,agonist,,primary,AVPR1B,v1br_human,P47901,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1986,"terlipressin,lucassin",hepatorenal syndrome,4,,-,approved,2003,
624,terlipressin,small molecule,Peptide,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1986,"terlipressin,lucassin",hepatorenal syndrome,4,,-,approved,2003,
625,tesamorelin,peptide,Peptide,agonist,,primary,GHRHR,ghrhr_human,Q02643,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1987,tesamorelin,HIV-associated lipodystrophy,4,,-,approved,2010,
626,tg-0054,small molecule,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,2002,"tg-0054, Burixafor",adjuvant to stem cell transplantation,2,2014,completed,in trial,-,
627,th0318,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2008,th0318,Antidiabetic,1,2004,discontinued,in trial,-,
628,sitaxentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2010,"thelin, sitaxentan",Antihypertensive,4,,-,approved,2006,
629,parathyroid hormone,protein,Peptide,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2012,"bn-003,capthymone,thpth",Anti-osteoporotic,4,,-,approved,2015,
630,parathyroid hormone,protein,Peptide,agonist,,primary,PTH2R,pth2r_human,P49190,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2012,thpth,Anti-osteoporotic,4,,-,approved,2015,
631,pilocarpine,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,4,,-,approved,1974,
632,pilocarpine,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,4,,-,approved,1974,
633,pilocarpine,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,4,,-,approved,1974,
634,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,completed,in trial,-,
635,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,completed,in trial,-,
636,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,completed,in trial,-,
637,tolterodine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,completed,in trial,-,
638,tolterodine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,completed,in trial,-,
639,oxytocin,peptide,Peptide,agonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2014,"ti-001, intranasal oxytocin",Analgesics,4,,-,approved,1980,
640,ticagrelor,small molecule,Nucleotide ,NAM,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,2015,ticagrelor,antithrombotic,4,,-,approved,2010,
641,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2019,"tiotropium bromide,spiriva",cystic fibrosis; chronic obstructive pulmonary disorder (COPD),4,,-,approved,2004,
642,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2019,"tiotropium bromide,spiriva",cystic fibrosis; chronic obstructive pulmonary disorder (COPD),4,,-,approved,2004,
643,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2019,"tiotropium bromide,spiriva",cystic fibrosis; chronic obstructive pulmonary disorder (COPD),4,,-,approved,2004,
644,misoprostol,small molecule,Lipid ,agonist,,secondary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,202,"apl-202,isprelor",Labor Inducing,4,,-,approved,1988,
645,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2021,"tizanidine hydrochloride,zanaflex",Muscle Relaxants,4,,-,approved,1996,
646,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2021,"tizanidine hydrochloride,zanaflex",Muscle Relaxants,4,,-,approved,1996,
647,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2021,"tizanidine hydrochloride,zanaflex",Muscle Relaxants,4,,-,approved,1996,
648,obinepitide,small molecule,Peptide,agonist,,primary,NPY2R,npy2r_human,P49146,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,2027,"tm30338,obinepitide",Anti-obesity,2,2010,completed,in trial,-,Sweden
649,obinepitide,small molecule,Peptide,agonist,,primary,PPYR1,npy4r_human,P50391,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,2027,"tm30338,obinepitide",Anti-obesity,2,2010,completed,in trial,-,Sweden
650,tm30339,small molecule,Peptide,agonist,,primary,PPYR1,npy4r_human,P50391,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,2028,tm30339,Anti-obesity,2,2008,discontinued,in trial,-,
651,tm38837,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,2029,tm38837,Anti-obesity,1,2013,completed,in trial,-,
652,aplindore,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,203,"aplindore, dab-452",Antiparkinson ; restlegs legs syndrome,2,2008,discontinued,in trial,-,
653,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,
654,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,
655,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,
656,tolterodine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,
657,tolvaptan,small molecule,Peptide,antagonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2037,"tolvaptan, opc-41061,samsca",Antihypertensive,4,,-,approved,2009,
658,tonabersat,small molecule,Aminergic ,antagonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2038,tonabersat,Anti-migraine,2,2007,discontinued,in trial,-,
659,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2039,"topical alprostadil cream,alprox-td, befar, vitaros",sexual dysfunction,4,,-,approved,1981,
660,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2039,"topical alprostadil cream,alprox-td, befar, vitaros",sexual dysfunction,4,,-,approved,1981,
661,rusalatide,peptide,Peptide,agonist,,primary,F2R,par1_human,P25116,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2048,"tp-508,chrysalin",diabetic foot ulcers,3,2005,discontinued,in trial,-,
662,rusalatide,peptide,Peptide,agonist,,primary,F2RL2,par3_human,O00254,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2048,"tp-508,chrysalin",diabetic foot ulcers,3,2005,discontinued,in trial,-,
663,rusalatide,peptide,Peptide,agonist,,primary,F2RL3,par4_human,Q96RI0,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2048,"tp-508,chrysalin",diabetic foot ulcers,3,2005,discontinued,in trial,-,
664,tpi-asm8,antisense oligo,Protein,antagonist,,primary,CCR3,ccr3_human,P51677,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,2049,tpi-asm8,Anti-Asthmatic,2,2010,discontinued,in trial,-,
665,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2051,tpm-1/morphine,Analgesics,4,,-,approved,1984,
666,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2051,tpm-1/morphine,Analgesics,4,,-,approved,1984,
667,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2051,tpm-1/morphine,Analgesics,4,,-,approved,1984,
668,bosentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2053,tracleer,Antihypertensive,4,,-,approved,2001,
669,bosentan,small molecule,Peptide,antagonist,,primary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2053,tracleer,Antihypertensive,4,,-,approved,2001,
670,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2055,"tramadol extended-release,raliva er",Analgesics,4,,-,approved,1995,
671,tramadol,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2055,"tramadol extended-release,raliva er",Analgesics,4,,-,approved,1995,
672,tramadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2055,"tramadol extended-release,raliva er",Analgesics,4,,-,approved,1995,
673,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2056,"tramadol hydrochloride,ultram",Analgesics,4,,-,approved,1995,
674,tramadol,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2056,"tramadol hydrochloride,ultram",Analgesics,4,,-,approved,1995,
675,tramadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2056,"tramadol hydrochloride,ultram",Analgesics,4,,-,approved,1995,
676,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2057,"tramadol,tridural, ryzolt",Analgesics,4,,-,approved,1995,
677,tramadol,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2057,"tramadol,tridural, ryzolt",Analgesics,4,,-,approved,1995,
678,tramadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2057,"tramadol,tridural, ryzolt",Analgesics,4,,-,approved,1995,
679,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,206,"apomorphine hcl,uprima, ixense",erectile dysfunction,1,2005,discontinued,in trial,-,
680,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,206,"apomorphine hcl,uprima, ixense",erectile dysfunction,1,2005,discontinued,in trial,-,
681,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,206,"apomorphine hcl,uprima, ixense",erectile dysfunction,1,2005,discontinued,in trial,-,
682,epinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
683,epinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
684,epinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
685,epinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
686,epinephrine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
687,epinephrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
688,epinephrine,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
689,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2067,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",incontinence,4,,-,approved,1975,
690,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2067,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",incontinence,4,,-,approved,1975,
691,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2067,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",incontinence,4,,-,approved,1975,
692,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2068,transdermal oxycodone,Analgesics,4,,-,approved,1998,
693,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2068,transdermal oxycodone,Analgesics,4,,-,approved,1998,
694,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2068,transdermal oxycodone,Analgesics,4,,-,approved,1998,
695,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2069,"transmucosal fentanyl,actiq",Analgesics,4,,-,approved,1968,
696,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2069,"transmucosal fentanyl,actiq",Analgesics,4,,-,approved,1968,
697,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,207,"apomorphine hydrochloride,apokyn, apo-go",anti-parkisonian,4,,-,approved,2004,
698,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,207,"apomorphine hydrochloride,apokyn, apo-go",anti-parkisonian,4,,-,approved,2004,
699,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,207,"apomorphine hydrochloride,apokyn, apo-go",anti-parkisonian,4,,-,approved,2004,
700,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2071,"travoprost + timolol,extravan, duotrav",Antiglaucomic,4,,-,approved,1981,
701,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2071,"travoprost + timolol,extravan, duotrav",Antiglaucomic,4,,-,approved,1981,
702,travoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2071,"travoprost + timolol,extravan, duotrav",Antiglaucomic,4,,-,approved,2001,
703,trazodone,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2072,"trazodone extended release, dds-04a,oleptro",Anti-depressant,4,,-,approved,1981,
704,trazodone,small molecule,Aminergic ,partial agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2072,"trazodone extended release, dds-04a,oleptro",Anti-depressant,4,,-,approved,1981,
705,trazodone,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2072,"trazodone extended release, dds-04a,oleptro",Anti-depressant,4,,-,approved,1981,
706,SL 650472,small molecule,Aminergic ,antagonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2074,"trelanserin, sl 65.0472",intermittent claudication,2,2006,discontinued,in trial,-,
707,SL 650472,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2074,"trelanserin, sl 65.0472",intermittent claudication,2,2006,discontinued,in trial,-,
708,olmesartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,2080,tribenzor,Antihypertensive,4,,-,approved,2002,
709,triptorelin,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2084,"triptorelin pamoate,trelstar, decapeptyl, salvacyl, moapar, pamorelin",Antineoplastic,4,,-,approved,2001,
710,triptorelin,small molecule,Peptide,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2084,"triptorelin pamoate,trelstar, decapeptyl, salvacyl, moapar, pamorelin",Antineoplastic,4,,-,approved,2001,
711,trospium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,
712,trospium,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,
713,trospium,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,
714,trospium,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,
715,trospium,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,
716,aprepitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,209,"aprepitant, mk-869, fosaprepitant dimeglumine, mk-0517,emend",Antiemetics,4,,-,approved,2003,
717,ts-032,unknown,Amino acid ,agonist,pf-4802540,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,2090,"ts-032, pf-4802540",schizophrenia,1,2008,discontinued,in trial,-,
718,ts-032,unknown,Amino acid ,agonist,pf-4802540,primary,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,2090,"ts-032, pf-4802540",schizophrenia,1,2008,discontinued,in trial,-,
719,tt-223,injectible islet neogenesis therapy,Peptide,agonist,,primary,CCKBR,gasr_human,P32239,Class A (Rhodopsin),GPCR;Rhodopsin,Cholecystokinin receptors,established,2092,tt-223,Antidiabetic; injectable islet neogenesis therapy for diabetes,2,2008,discontinued,in trial,-,
720,tt-223,injectible islet neogenesis therapy,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2092,tt-223,Antidiabetic; injectable islet neogenesis therapy for diabetes,2,2008,discontinued,in trial,-,
721,ulimorelin,small molecule,Peptide,agonist,,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,2095,"tzp-101, Ulimorelin",gastroparesis,2,2016,recruiting,in trial,-,
722,tzp-102,small molecule,Peptide,agonist,,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,2096,tzp-102,gastroparesis,2,2012,terminated,in trial,-,Clinical trial terminated due to Insufficient efficacy in planned interim futility analysis; no development reported on drug itself
723,luteinizing hormone-releasing hormone,peptide,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2097,"tztx-001,teverelix la",Antineoplastic,2,2005,completed,in trial,-,"Seems to be planning Phase 3, but can't find recent dated information"
724,luteinizing hormone-releasing hormone,peptide,Peptide,antagonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2097,"tztx-001,teverelix la",Antineoplastic,2,2005,completed,in trial,-,"Seems to be planning Phase 3, but can't find recent dated information"
725,urocortin 2,peptide,Peptide,agonist,,primary,CRHR2,crfr2_human,Q13324,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,2105,"urocortin 2, 358-086-15",congestive heart failure,2,2012,discontinued,in trial,-,
726,buprenorphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2109,v1003,Anti-depressant; Analgesics; opioid addiction,2,2006,completed,in trial,-,
727,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2109,v1003,Anti-depressant; Analgesics; opioid addiction,2,2006,completed,in trial,-,
728,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2109,v1003,Anti-depressant; Analgesics; opioid addiction,2,2006,completed,in trial,-,
729,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,
730,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,
731,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,
732,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,
733,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,
734,v24343,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,2112,v24343,Anti-obesity,1,2008,discontinued,in trial,-,
735,va106483,small molecule,Peptide,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2115,"va106483, Fedovapagon",BPH-related urinary symptoms,3,2015,recruiting,in trial,-,
736,va111913,small molecule,Peptide,antagonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2116,va111913,dysmenorrhea,2,2010,completed,in trial,-,
737,va111913,small molecule,Peptide,antagonist,,secondary,AVPR1B,v1br_human,P47901,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2116,va111913,dysmenorrhea,2,2010,completed,in trial,-,
738,va111913,small molecule,Peptide,antagonist,,secondary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2116,va111913,dysmenorrhea,2,2010,completed,in trial,-,
739,valsartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,2122,"valsartan,diovan",Antihypertensive,4,,-,approved,2012,
740,vapitadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,2123,"vapitadine dihydrochloride,hivenyl","Anti-Allergic, pruritus",2,2006,completed,in trial,-,No development reported
741,vapreotide,small molecule,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2124,"vapreotide, debio 8609,sanvar, docrised",liver cirrhosis-related variceal bleeding,4,,-,approved,-,
742,vapreotide,small molecule,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2124,"vapreotide, debio 8609,sanvar, docrised",liver cirrhosis-related variceal bleeding,4,,-,approved,-,
743,velneperit,small molecule,Peptide,antagonist,,primary,NPY5R,npy5r_human,Q15761,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,2144,"velneperit, s-2367",Anti-obesity,2,2010,discontinued,in trial,-,
744,velusetrag,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2145,"velusetrag, td-5108",motilitant,2,2014,ongoing,in trial,-,
745,vestipitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,2148,"vestipitant, gw 597599",tinnitus; hypnotic,2,2012,discontinued,in trial,-,
746,h-pth 1-34,peptide,Peptide,partial agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2153,viaderm hpth 1-34,Anti-osteoporotic,2,2009,discontinued,in trial,-,
747,h-pth 1-34,peptide,Peptide,partial agonist,,primary,PTH2R,pth2r_human,P49190,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2153,viaderm hpth 1-34,Anti-osteoporotic,2,2009,discontinued,in trial,-,
748,calcitonin human,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,2154,viaderm-calcitonin,Anti-osteoporotic,1,2011,completed,in trial,-,
749,glp1 agonist ,unknown,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2155,viaderm-glp1 agonist,Antidiabetic,1,2010,completed,in trial,-,
750,vicriviroc,small molecule,Protein,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,2157,vicriviroc,antiviral ; HIV,3,2007,discontinued,in trial,-,
751,vigabatrin,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,2159,"vigabatrin is a selective, irreversible enzyme-activated gaba transaminase inhibitor. gaba (gamma-aminobutyric acid) is a n/",addiction,4,,-,approved,2009,
752,arbaclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,216,arbaclofen,Fragile X syndrome,3,2017,discontinued,in trial,-,
753,arbaclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,216,arbaclofen,Fragile X syndrome,3,2017,discontinued,in trial,-,
754,vilazodone,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2160,"vilazodone hydrochloride, sb 659746a",Anti-depressant,4,,-,approved,2011,
755,biib014,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2164,vipadenantis,Antiparkinson,2,2006,discontinued,in trial,-,
756,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2168,vivitrol,substance abuse,4,,-,approved,1998,
757,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2168,vivitrol,substance abuse,4,,-,approved,1998,
758,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2168,vivitrol,substance abuse,4,,-,approved,1998,
759,vofopitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,2170,"vofopitant, gr-205171",post-traumatic stress disorder; hypnotic,2,2008,discontinued,in trial,-,
760,volinanserin,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2172,volinanserin,Hypnotics and Sedatives,3,2008,discontinued,in trial,-,discontinued due to absence of demonstration of efficacy of volinanserin in primary insomnia with predominant sleep maintenance problems
761,vorapaxar,small molecule,Peptide,antagonist,,primary,F2R,par1_human,P25116,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2175,"vorapaxar , sch-530348",cardiovascular disease,4,,-,approved,2014,
762,vorapaxar,small molecule,Peptide,antagonist,,secondary,F2RL2,par3_human,O00254,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2175,"vorapaxar , sch-530348",cardiovascular disease,4,,-,approved,2014,
763,vorapaxar,small molecule,Peptide,antagonist,,secondary,F2RL3,par4_human,Q96RI0,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2175,"vorapaxar , sch-530348",cardiovascular disease,4,,-,approved,2014,
764,histrelin,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2177,"vp 002, histrelin implant,vantas, supprelin",Antineoplastic,4,,-,approved,1991,
765,histrelin,small molecule,Peptide,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2177,"vp 002, histrelin implant,vantas, supprelin",Antineoplastic,4,,-,approved,1991,
766,vr-147,small molecule,Aminergic ,not available,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2179,vr-147,Anti-migraine,1,2008,discontinued,in trial,-,
767,vr-147,small molecule,Aminergic ,not available,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2179,vr-147,Anti-migraine,1,2008,discontinued,in trial,-,
768,vrs-859,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2182,"vrs-859, Exenatide-XTEN",Antidiabetic,1,2017,ongoing,in trial,-,
769,propranolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2183,vt-122,cancer cachexia,4,,-,approved,1967,
770,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,22,abilify,schizophrenia,4,,-,approved,2002,
771,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,22,abilify,schizophrenia,4,,-,approved,2002,
772,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,22,abilify,schizophrenia,4,,-,approved,2002,
773,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,220,"arc-4558, 0.1% clonidine hycrochloride gel",diabetic neuropathy; ADHD; antimucositic,3,2016,discontinued,in trial,-,
774,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,220,"arc-4558, 0.1% clonidine hycrochloride gel",diabetic neuropathy; ADHD; antimucositic,3,2016,discontinued,in trial,-,
775,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,220,"arc-4558, 0.1% clonidine hycrochloride gel",diabetic neuropathy; ADHD; antimucositic,3,2016,discontinued,in trial,-,
776,xaliproden,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2200,"xaliproden, sr 57746a",neuroprotectant,3,2006,discontinued,in trial,-,
777,arbaclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,2222,"xp19986, arbaclofen",gastrointestinal reflux disease,2,2009,discontinued,in trial,-,
778,arbaclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,2222,"xp19986, arbaclofen",gastrointestinal reflux disease,2,2009,discontinued,in trial,-,
779,xp21279,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,completed,in trial,-,
780,xp21279,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,completed,in trial,-,
781,xp21279,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,completed,in trial,-,
782,xp21279,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,completed,in trial,-,
783,xp21279,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,completed,in trial,-,
784,ykp-1358,unknown,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2226,"ykp-1358, Relenopride",schizophrenia,2,2008,completed,in trial,-,Inferred dates
785,ykp-1358,unknown,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2226,"ykp-1358, Relenopride",schizophrenia,2,2008,completed,in trial,-,Inferred dates
786,ym-178,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2229,"ym-178, Mirabegron",overactive bladder,3,2016,recruiting,in trial,-,
787,ym-598,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2230,ym-598,Antineoplastic,2,2002,discontinued,in trial,-,
788,yttrium-90 edotreotide,peptide,Peptide,antagonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2232,"yttrium-90 edotreotide,onalta",Antineoplastic,2,2010,not open yet,in trial,-,Issue with drug not being available
789,yttrium-90 edotreotide,peptide,Peptide,antagonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2232,"yttrium-90 edotreotide,onalta",Antineoplastic,2,2010,not open yet,in trial,-,Issue with drug not being available
790,yttrium-90 edotreotide,peptide,Peptide,antagonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2232,"yttrium-90 edotreotide,onalta",Antineoplastic,2,2010,not open yet,in trial,-,Issue with drug not being available
791,zafirlukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,2235,"zafirlukast,accolate",Anti-Asthmatic,4,,-,approved,1996,
792,ranitidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,2238,"zantac,ranitidine hydrochloride",antiulcer,4,,-,approved,1977,
793,zibotentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2241,"zibotentan, zd-4054, azd-4054",Antineoplastic,3,2008,discontinued,in trial,-,discontinued because early efficacy review by the Independent Data Monitoring Committee indicated it was unlikely to meet its primary efficacy endpoints
794,ziprasidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2243,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",schizophrenia,4,,-,approved,2001,
795,ziprasidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2243,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",schizophrenia,4,,-,approved,2001,
796,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2246,"zolmitriptan,zomig",Anti-migraine,4,,-,approved,1997,
797,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2246,"zolmitriptan,zomig",Anti-migraine,4,,-,approved,1997,
798,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2246,"zolmitriptan,zomig",Anti-migraine,4,,-,approved,1997,
799,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2246,"zolmitriptan,zomig",Anti-migraine,4,,-,approved,1997,
800,zp1848,peptide,Peptide,agonist,,primary,GLP2R,glp2r_human,O95838,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2251,zp1848,Crohn's disease,2,2016,recruiting,in trial,-,
801,teriparatide,peptide,Peptide,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2252,"zt-034, teriparatide nasal spray",Anti-osteoporotic,4,,-,approved,1987,
802,teriparatide,peptide,Peptide,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2252,"zt-034, teriparatide nasal spray",Anti-osteoporotic,4,,-,approved,1987,
803,hydrocodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2254,"zx002, hydrocodone bitartrate",Analgesics,4,,-,approved,1943,
804,hydrocodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2254,"zx002, hydrocodone bitartrate",Analgesics,4,,-,approved,1943,
805,zyd1,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2256,zyd1,Antidiabetic,1,2012,completed,in trial,-,
806,ari-3037mo,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,226,ari-3037mo,Vitamin B analog; for treatment for hyperlipidemia,2,2015,completed,in trial,-,
807,ari-3037mo,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,226,ari-3037mo,Vitamin B analog; for treatment for hyperlipidemia,2,2015,completed,in trial,-,
808,adenosine,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2267,"adenogesic, adenosine (intravenous)",Analgesics,4,,-,approved,1989,
809,adenosine,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2267,"adenogesic, adenosine (intravenous)",Analgesics,4,,-,approved,1989,
810,adenosine,small molecule,Nucleotide ,agonist,,primary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2267,"adenogesic, adenosine (intravenous)",Analgesics,4,,-,approved,1989,
811,adenosine,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2267,"adenogesic, adenosine (intravenous)",Analgesics,4,,-,approved,1989,
812,ctp-499,small molecule,Nucleotide ,not available,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2268,ctp-499,diabetic nephropathy,2,2011,completed,in trial,-,
813,ctp-499,small molecule,Nucleotide ,not available,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2268,ctp-499,diabetic nephropathy,2,2011,completed,in trial,-,
814,avr118,peptide nucleic acid,Nucleotide ,not available,,secondary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2269,"avr123, AVR118","Antineoplastic agent, wound healing accelerant",2,2011,discontinued,in trial,-,
815,avr118,peptide nucleic acid,Nucleotide ,not available,,secondary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2269,"avr123, AVR118","Antineoplastic agent, wound healing accelerant",2,2011,discontinued,in trial,-,
816,avr118,peptide nucleic acid,Nucleotide ,not available,,secondary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2269,"avr123, AVR118","Antineoplastic agent, wound healing accelerant",2,2011,discontinued,in trial,-,
817,dronedarone,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2270,dronedarone,Anti-Arrhythmia,4,,-,approved,2009,
818,dronedarone,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2270,dronedarone,Anti-Arrhythmia,4,,-,approved,2009,
819,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,Diuretic
820,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,
821,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,
822,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,
823,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,
824,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,
825,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
826,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
827,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
828,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
829,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
830,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
831,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
832,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
833,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
834,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
835,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
836,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
837,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
838,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
839,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
840,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
841,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
842,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
843,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2274,"cd07805/47, sansrosa, col-118",erythema,2,2008,completed,in trial,-,
844,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2274,"cd07805/47, sansrosa, col-118",erythema,2,2008,completed,in trial,-,
845,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2274,"cd07805/47, sansrosa, col-118",erythema,2,2008,completed,in trial,-,
846,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2275,apd209,Appetite stimulant,2,2013,completed,in trial,-,
847,arformoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2276,brovana,Bronchodilator,4,,-,approved,2006,
848,trv120027,protein,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,2279,trv120027,Antihypertensive,2,2013,recruiting,in trial,-,
849,dsc127,peptide,Peptide,agonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,2280,dsc127,diabetic foot ulcers,3,2013,discontinued,in trial,-,
850,danazol,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2297,optina,diabetic macular edema,4,,-,approved,1976,
851,danazol,small molecule,Peptide,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2297,optina,diabetic macular edema,4,,-,approved,1976,
852,rx-10045,small molecule,Protein,agonist,,primary,CMKLR1,cml1_human,Q99788,Class A (Rhodopsin),GPCR;Rhodopsin,Chemerin receptor,not established,2317,rx-10045,dry eye,2,2014,completed,in trial,-,
853,rx-10045,small molecule,Lipid ,partial agonist,,primary,LTB4R,lt4r1_human,Q15722,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,not established,2317,rx-10045,dry eye,2,2014,completed,in trial,-,
854,cinacalcet,small molecule,Ion ,PAM,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,2327,"cinacalcet hcl, amg 073,sensipar",hyperparathyroidism,4,,-,approved,2004,
855,azd2423,small molecule,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,2331,azd2423,chronic obstructive pulmonary disorder;Analgesics; neuropathic pain,2,2010,discontinued,in trial,-,
856,trospium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2350,alks 27,chronic obstructive pulmonary disease (COPD),2,2007,discontinued,in trial,-,
857,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2351,dr-3001,incontinence,3,2013,discontinued,in trial,-,
858,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2351,dr-3001,incontinence,3,2013,discontinued,in trial,-,
859,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2351,dr-3001,incontinence,3,2013,discontinued,in trial,-,
860,ajulemic acid,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,2361,"ip 751, ct-3",Analgesics;neuropathic pain,2,2017,not open yet,in trial,-,May have improved CB2 selectivity but still had CB1 affinity
861,ajulemic acid,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,2361,"ip 751, ct-3",Analgesics;neuropathic pain,2,2017,not open yet,in trial,-,May have improved CB2 selectivity but still had CB1 affinity
862,ctce-9908,protein,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,2376,ctce-9908,Antineoplastic,2,2007,discontinued,in trial,-,
863,sufentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,242,"arx-01, sufentanil nanotab",Analgesics; adjuvant to anesthesia,4,,-,approved,1984,
864,sufentanil,small molecule,Peptide,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,242,"arx-01, sufentanil nanotab",Analgesics; adjuvant to anesthesia,4,,-,approved,1984,
865,sufentanil,small molecule,Peptide,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,242,"arx-01, sufentanil nanotab",Analgesics; adjuvant to anesthesia,4,,-,approved,1984,
866,np2 enkephalin,viral gene delivery,Peptide,agonist,,primary,DOR,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2421,np2 enkephalin,Analgesics,2,2011,discontinued,in trial,-,
867,ordopidine,small molecule,Aminergic ,not available,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2422,acr325,Antiparkinson,1,2009,completed,in trial,-,mode of action termed a 'dopamine stabilizer'
868,ati-9242,small molecule,Aminergic ,not available,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2423,ati-9242,schizophrenia,1,2016,ongoing,in trial,-,
869,ati-9242,small molecule,Aminergic ,not available,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2423,ati-9242,schizophrenia,1,2016,ongoing,in trial,-,
870,bl-1020,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2424,bl-1020,schizophrenia,3,2011,terminated,in trial,-,
871,bl-1020,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,2424,bl-1020,schizophrenia,3,2011,terminated,in trial,-,
872,bl-1020,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2424,bl-1020,schizophrenia,3,2011,terminated,in trial,-,
873,molindone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2425,"spn810 ,zalvari",ADHD,3,2016,recruiting,in trial,-,
874,sufentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,243,"arx-03, sufentanil + triazolam nanotab",Analgesics; adjuvant to anesthesia,2,2011,suspended,in trial,-,
875,sufentanil,small molecule,Peptide,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,243,"arx-03, sufentanil + triazolam nanotab",Analgesics; adjuvant to anesthesia,2,2011,suspended,in trial,-,
876,sufentanil,small molecule,Peptide,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,243,"arx-03, sufentanil + triazolam nanotab",Analgesics; adjuvant to anesthesia,2,2011,suspended,in trial,-,
877,vantictumab,antibody,Protein,antagonist,omp-18r5,primary,FZD7,fzd7_human,O75084,Class F (Frizzled),GPCR;Frizzled,Frizzled,not established,2457,omp-18r5,Antineoplastic,1,2013,ongoing,in trial,-,
878,glucagon,peptide,Peptide,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2458,dio-901,for prevention of hypoglycemia,4,,-,approved,1960,
879,teduglutide,peptide,Peptide,agonist,,primary,GLP2R,glp2r_human,O95838,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2463,teduglutide,short bowel syndrome,4,,-,approved,2012,
880,elsiglutide,peptide,Peptide,agonist,,primary,GLP2R,glp2r_human,O95838,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2464,zp1846,Antidiuretic,2,2012,completed,in trial,-,
881,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,2468,"niacin extended-release tablets,niaspan",Antihyperlipidemic,4,,-,approved,1997,
882,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,2468,"niacin extended-release tablets,niaspan",Antihyperlipidemic,4,,-,approved,1997,
883,apd597,small molecule,Lipid ,agonist,,primary,GPR119,gp119_human,Q8TDV5,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,2469,"apd597, JNJ-38431055",Antidiabetic,1,2008,discontinued,in trial,-,
884,adx-48621,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,2472,adx-48621,Antiparkinson,2,2011,completed,in trial,-,
885,cyclobenzaprine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2489,"cyclobenzaprine hydrochloride extended-release capsules,amrix",Muscle Relaxants,4,,-,approved,1977,
886,avn-397,small molecule,Aminergic ,unknown,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2490,avn-397,Alzheimer's disease,2,2010,discontinued,in trial,-,Undefined or unknown MoA
887,asenapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
888,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
889,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
890,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
891,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
892,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR5A,5ht5a_human,P47898,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
893,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
894,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
895,asenapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
896,asenapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
897,asenapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
898,asenapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
899,asenapine,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
900,asenapine,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
901,asenapine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
902,asenapine,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
903,asenapine,small molecule,Aminergic ,antagonist,,secondary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
904,asenapine,small molecule,Aminergic ,antagonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
905,nu206,protein,Orphan ,not available,,primary,LGR4,lgr4_human,Q9BXB1,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,2528,"nu206, r-spondin1",gastrointestinal disease,1,2006,discontinued,in trial,-,
906,nu206,protein,Orphan ,not available,,primary,LGR5,lgr5_human,O75473,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,2528,"nu206, r-spondin1",gastrointestinal disease,1,2006,discontinued,in trial,-,
907,chorionic gonadotropin,protein,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,2529,"ml-04, LDI-100",Antineoplastic,3,2016,not open yet,in trial,-,
908,asimadoline,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,253,asimadoline,Analgesics,3,2015,discontinued,in trial,-,
909,ap214,peptide,Peptide,agonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,2538,ap214,post-surgical kidney injury,2,2008,discontinued,in trial,-,
910,ap214,peptide,Peptide,agonist,,primary,MC3R,mc3r_human,P41968,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,2538,ap214,post-surgical kidney injury,2,2008,discontinued,in trial,-,
911,ap214,peptide,Peptide,agonist,,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,2538,ap214,post-surgical kidney injury,2,2008,discontinued,in trial,-,
912,ap214,peptide,Peptide,agonist,,primary,MC5R,mc5r_human,P33032,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,2538,ap214,post-surgical kidney injury,2,2008,discontinued,in trial,-,
913,alvimopan,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2549,entereg,opioid-induced bowel dysfunction,4,,-,approved,2008,
914,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,259,at3022,Analgesics,1,2011,discontinued,in trial,-,
915,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,259,at3022,Analgesics,1,2011,discontinued,in trial,-,
916,athx-105,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,263,athx-105,Anti-obesity,2,2008,discontinued,in trial,-,
917,ati-7505,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,265,ati-7505,Parasympathomimetic,2,2009,completed,in trial,-,
918,atrasentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,270,"atrasentan, abt-627,xinlay",Antineoplastic,3,2005,discontinued,in trial,-,discontinued for this indication
919,atrasentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,270,Atrasentan,Diabetic nephropathy,3,2013,recruiting,in trial,-,Added entry because Indication so different
920,nalmefene,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2766,srd174,pruritus,4,,-,approved,1995,
921,nalmefene,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2766,srd174,pruritus,4,,-,approved,1995,
922,nalmefene,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2766,srd174,pruritus,4,,-,approved,1995,
923,treprostinil,small molecule,Nucleotide ,agonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,2767,"treprostinil inhaled/oral,tyvaso, viveta",Antihypertensive,4,,-,approved,2002,
924,treprostinil,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2767,"treprostinil inhaled/oral,tyvaso, viveta",Antihypertensive,4,,-,approved,2002,
925,treprostinil,small molecule,Nucleotide ,agonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,2768,"treprostinil subcutaneous/intravenous,remodulin",Antihypertensive,4,,-,approved,2002,
926,treprostinil,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2768,"treprostinil subcutaneous/intravenous,remodulin",Antihypertensive,4,,-,approved,2002,
927,av608,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,278,av608,Anti-depressant; irritable bowel syndrome; antispasmodic,2,2006,discontinued,in trial,-,
928,parathyroid hormone,protein,Peptide,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2799,"air parathyroid hormone, air pth",hypoparathyroidism,4,,-,approved,2015,
929,vismodegib,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,2822,"gdc-0449, hedgehog pathway inhibitor",Antineoplastic,4,,-,approved,2012,
930,cur-61414,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,2823,cur-61414,Antineoplastic,1,2010,completed,in trial,-,
931,ipi-926,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,2824,"ipi-926, Patidegib",Antineoplastic,2,2016,recruiting,in trial,-,Continual inhibition as mode of action
932,ave-1625,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,284,ave-1625,Anti-obesity ; Alzheimer's disease,2,2007,discontinued,in trial,-,
933,phentolamine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,288,"aviptadil,invicorp",sexual dysfunction,4,,-,approved,1952,
934,phentolamine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,288,"aviptadil,invicorp",sexual dysfunction,4,,-,approved,1952,
935,vasoactive intestinal peptide,peptide,Peptide,antagonist,,primary,VIPR1,vipr1_human,P32241,Class B1 (Secretin),GPCR;Secretin,VIP and PACAP receptors,not established,288,"aviptadil,invicorp",sexual dysfunction,3,2016,completed,in trial,-,Difficult to get info; trials in Europe
936,vasoactive intestinal peptide,peptide,Peptide,antagonist,,primary,VIPR2,vipr2_human,P41587,Class B1 (Secretin),GPCR;Rhodopsin,VIP and PACAP receptors,not established,288,"aviptadil,invicorp",sexual dysfunction,3,2016,completed,in trial,-,Difficult to get info; trials in Europe
937,ac-100,peptide,Lipid ,not available,dentonin,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,29,"ac-100,dentonin",dental ossificant,1,2010,discontinued,in trial,-,
938,ac-100,peptide,Lipid ,not available,dentonin,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,29,"ac-100,dentonin",periodontal ossificant,1,2010,discontinued,in trial,-,
939,ac-100,peptide,Lipid ,not available,dentonin,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,29,"ac-100,dentonin",periodontal ossificant,1,2010,discontinued,in trial,-,
940,ac-100,peptide,Lipid ,not available,dentonin,primary,PTGER4,pe2r4_human,P35408,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,29,"ac-100,dentonin",periodontal ossificant,1,2010,discontinued,in trial,-,
941,avn-101,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,290,avn-101,Alzheimer's disease,1,2009,completed,in trial,-,
942,avn-211,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,291,avn-211,schizophrenia,2,2010,unknown,in trial,-,
943,avn-322,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,292,avn-322,Alzheimer's disease,1,2010,discontinued,in trial,-,
944,avosentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,295,"avosentan, spp 301",Diabetic nephropathy,3,2005,terminated,in trial,-,
945,prochlorperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,301,"az-001, staccato prochlorperazine",Anti-migraine,2,2016,recruiting,in trial,-,
946,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,303,"az-003, staccato fentanyl",adjuvant to anesthesia,4,,-,approved,1968,
947,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,303,"az-003, staccato fentanyl",adjuvant to anesthesia,4,,-,approved,1968,
948,loxapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,304,az-004,schizophrenia,4,,-,approved,1975,
949,loxapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,304,az-004,schizophrenia,4,,-,approved,1975,
950,azd2066,small molecule,Amino acid ,antagonist,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,308,azd2066,Analgesics; gastroesophageal reflux disease,2,2010,discontinued,in trial,-,
951,azelastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,313,azelastine,Anti-Allergic,4,,-,approved,1996,
952,azelastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,314,"azelastine hydrochloride nasal spray,astepro",Anti-Allergic,4,,-,approved,1996,
953,azilsartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,315,"azilsartan medoxomil, tak-491",Antihypertensive,4,,-,approved,2011,
954,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,333,"bema buprenorphine, buccal mucosa adhesive",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
955,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,333,"bema buprenorphine, buccal mucosa adhesive",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
956,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,334,"bema fentanyl,onsolis, breakyl",Analgesics,4,,-,approved,1968,
957,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,334,"bema fentanyl,onsolis, breakyl",Analgesics,4,,-,approved,1968,
958,bepotastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,336,"bepotastine besilate,bepreve, talion",Anti-Allergic,4,,-,approved,2009,
959,beraprost,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,337,beraprost,Antihypertensive,3,2011,withdrawn,in trial,-,"No longer marketed, but may still be available"
960,acamprosate,small molecule,Amino acid ,antagonist,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,34,"acamprosate,campral",Antineoplastic,4,,-,approved,2004,
961,bf-1,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,343,bf-1,Anti-migraine,1,2016,ongoing,in trial,-,
962,bg-9928,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,345,bg-9928,congestive heart failure,2,2008,terminated,in trial,-,
963,bgc20-1531 ,small molecule,Lipid ,antagonist,,primary,PTGER4,pe2r4_human,P35408,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,347,bgc20-1531,Anti-migraine,2,2009,discontinued,in trial,-,
964,bifeprunox,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,
965,bifeprunox,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,
966,bifeprunox,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,
967,bifeprunox,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,
968,bifeprunox,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,
969,bifeprunox,small molecule,Aminergic ,agonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,
970,bim23a760,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,358,bim23a760,Antineoplastic ; treatment for acromegaly,2,2009,discontinued,in trial,-,
971,bim23a760,small molecule,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,358,bim23a760,Antineoplastic ; treatment for acromegaly,2,2009,discontinued,in trial,-,
972,bim23a760,small molecule,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,358,bim23a760,Antineoplastic ; treatment for acromegaly,2,2009,discontinued,in trial,-,
973,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,359,"bimatoprost,  agn 192024,lumigan",Antiglaucomic,4,,-,approved,2001,
974,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,359,"bimatoprost,  agn 192024,lumigan",Antiglaucomic,4,,-,approved,2001,
975,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,359,"bimatoprost,  agn 192024,lumigan",Antiglaucomic,4,,-,approved,2001,
976,binodenoson,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,363,"binodenoson, mre 0470,corvue",Diagnostic,3,2009,completed,in trial,-,No development reported
977,ulocuplumab,antibody,Protein,antagonist,bms 936564,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,369,"bms 936564, mdx-1338",Antineoplastic,3,2017,ongoing,in trial,-,"discontinued for sole intervention, now in combination trials"
978,calcitonin human,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,376,"bn-002,capsitonin",Anti-osteoporotic,2,2013,completed,in trial,-,
979,ncx116,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,378,"bol-303259-x, ncx 116, pf-03187207, Latanoprostene bunod",Antiglaucomic,3,2013,ongoing,in trial,-,
980,bremelanotide,peptide,Peptide,agonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,383,bremelanotide,sexual dysfunction,3,2015,ongoing,in trial,-,
981,bremelanotide,peptide,Peptide,agonist,,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,383,bremelanotide,sexual dysfunction,3,2015,ongoing,in trial,-,
982,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,385,"brimonidine tartrate,alphagan",Antiglaucomic,4,,-,approved,1996,
983,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,385,"brimonidine tartrate,alphagan",Antiglaucomic,4,,-,approved,1996,
984,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,385,"brimonidine tartrate,alphagan",Antiglaucomic,4,,-,approved,1996,
985,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1996,
986,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1996,
987,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1996,
988,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1981,
989,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1981,
990,bromocriptine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,389,"bromocriptine mesylate,cycloset, ergoset",Antidiabetic,4,,-,approved,1978,
991,bromocriptine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,389,"bromocriptine mesylate,cycloset, ergoset",Antidiabetic,4,,-,approved,1978,
992,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,394,buccal fentanyl,Analgesics,4,,-,approved,1968,
993,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,394,buccal fentanyl,Analgesics,4,,-,approved,1968,
994,prochlorperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,395,"buccal prochlorperazine maleate,emezine",Antiemetics,4,,-,approved,1956,
995,bucindolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,396,"bucindolol hydrochloride,gencaro",heart failure,2,2013,recruiting,in trial,-,
996,bucindolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,396,"bucindolol hydrochloride,gencaro",heart failure,2,2013,recruiting,in trial,-,
997,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,397,"budesonide + formoterol,symbicort",Bronchodilator,4,,-,approved,2001,
998,budiodarone,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,404,"budiodarone, ati-2042",Anti-Arrhythmia,2,2005,completed,in trial,-,
999,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Anti-depressant; Analgesics; opioid addiction,1,2010,completed,in trial,-,
1000,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Anti-depressant; Analgesics; opioid addiction,1,2010,completed,in trial,-,
1001,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Analgesics,4,,-,approved,1971,
1002,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Analgesics,4,,-,approved,1971,
1003,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Analgesics,4,,-,approved,1971,
1004,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
1005,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
1006,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Analgesics; opioid addiction,4,,-,approved,1971,
1007,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Analgesics; opioid addiction,4,,-,approved,1971,
1008,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Analgesics; opioid addiction,4,,-,approved,1971,
1009,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,407,"buprenorphine subcutaneous implant,probuphine",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,2016,
1010,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,407,"buprenorphine subcutaneous implant,probuphine",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,2016,
1011,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,408,"buprenorphine sublingual tablet,subutex",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
1012,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,408,"buprenorphine sublingual tablet,subutex",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
1013,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,409,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
1014,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,409,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
1015,bvt.115959,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,411,bvt.115959,Analgesics,2,2007,discontinued,in trial,-,
1016,bvt.28949,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,412,bvt.28949,Antiglaucomic,2,2010,unknown,in trial,-,Sweden
1017,amphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,413,"c105, levo-amphetamine sulfate",cognitive dysfunction; ADHD,2,2008,completed,in trial,-,
1018,octreotide,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,421,cam-2029,Antineoplastic,4,,-,approved,1988,
1019,octreotide,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,421,cam-2029,Antineoplastic,4,,-,approved,1988,
1020,octreotide,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,421,cam-2029,Antineoplastic,4,,-,approved,1988,
1021,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,422,cam2038,Anti-depressant; Analgesics; opioid addiction,3,2016,recruiting,in trial,-,
1022,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,422,cam2038,Anti-depressant; Analgesics; opioid addiction,3,2016,recruiting,in trial,-,
1023,candesartan cilexetil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,427,"candesartan cilexetil,atacand",Antihypertensive,4,,-,approved,1998,
1024,cangrelor,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,428,"cangrelor, ar69931",antithrombotic,4,,-,approved,2015,
1025,prs-211375,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,429,cannabinor,Analgesics,2,2007,discontinued,in trial,-,
1026,cariprazine,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,433,"cariprazine, rgh-188",schizophrenia,4,,-,approved,2015,
1027,cariprazine,small molecule,Aminergic ,partial agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,433,"cariprazine, rgh-188",schizophrenia,4,,-,approved,2015,
1028,carvedilol,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,434,"carvedilol, coreg",congestive heart failure,4,,-,approved,1995,
1029,carvedilol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,435,"carvedilol,coreg",cardiovascular disease,4,,-,approved,1995,
1030,carvedilol,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,435,"carvedilol,coreg",cardiovascular disease,4,,-,approved,1995,
1031,casopitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,436,"casopitant mesilate, 679769,rezonic, zunrisa",Antiemetics,3,2009,discontinued,in trial,-,discontinued due to safety data
1032,dronabinol,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,437,"cat-310 , relivar",Analgesics,4,,-,approved,1985,
1033,dronabinol,small molecule,Lipid ,agonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,438,"cat-310,relivar",Analgesics,4,,-,approved,1985,
1034,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,
1035,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,
1036,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,
1037,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,
1038,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,
1039,ccl2-lpm,protein,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,445,ccl2-lpm,Anti-inflammatory,1,2009,terminated,in trial,-,Terminated due to resources and slow enrollment not safety
1040,ccx025,small molecule,Protein,antagonist,,primary,CCR9,ccr9_human,P51686,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,446,ccx025,Anti-inflammatory,1,2009,unknown,in trial,-,
1041,ccx140,small molecule,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,447,ccx140,Anti-inflammatory ; Antidiabetic,2,2011,completed,in trial,-,
1042,ccx168,small molecule,Peptide,antagonist,,primary,C5AR1,c5ar1_human,P21730,Class A (Rhodopsin),GPCR;Rhodopsin,Complement peptide receptors,not established,448,ccx168,Anti-inflammatory,3,2016,recruiting,in trial,-,
1043,ccx282,small molecule,Protein,antagonist,,primary,CCR9,ccr9_human,P51686,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,449,"ccx282, traficet-en",Anti-inflammatory ; Crohn's disease; ulceraite colitis,3,2012,terminated,in trial,-,Terminated due to lack of efficacy
1044,ccx354,small molecule,Protein,antagonist,,primary,CCR1,ccr1_human,P32246,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,450,ccx354,Anti-inflammatory ; DMARD,2,2010,completed,in trial,-,
1045,ccx832,small molecule,Protein,antagonist,,primary,CMKLR1,cml1_human,Q99788,Class A (Rhodopsin),GPCR;Rhodopsin,Chemerin receptor,not established,451,ccx832,Anti-inflammatory ; for treatment for autoimmune disease,1,2011,discontinued,in trial,-,
1046,azelastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,456,"cdx-313, budesonide + azelastine nasal spray",Anti-Allergic,2,2009,completed,in trial,-,
1047,histamine,small molecule,Aminergic ,agonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,463,ceplene,cytorprotective  during cancer treatment,3,2015,recruiting,in trial,-,Has orphan designation to be used as adjunct with IL-2 for acute myeloid leukemia
1048,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,467,cer627,Antidyslipidaemic,1,2010,discontinued,in trial,-,
1049,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,467,cer627,Antidyslipidaemic,1,2010,discontinued,in trial,-,
1050,acp-104,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,47,acp-104,schizophrenia,2,2007,discontinued,in trial,-,The D2 and D3 partial agonism creates less side effects - different from typical anti-psychotics
1051,acp-104,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,47,acp-104,schizophrenia,2,2007,discontinued,in trial,-,The D2 and D3 partial agonism creates less side effects - different from typical anti-psychotics
1052,acp-104,small molecule,Aminergic ,partial agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,47,acp-104,schizophrenia,2,2007,discontinued,in trial,-,The D2 and D3 partial agonism creates less side effects - different from typical anti-psychotics
1053,acp-104,small molecule,Aminergic ,inverse agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,47,acp-104,schizophrenia,2,2007,discontinued,in trial,-,The D2 and D3 partial agonism creates less side effects - different from typical anti-psychotics
1054,cetirizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,471,"cetirizine hcl,zyrtec",Anti-Allergic,4,,-,approved,2007,
1055,cetrorelix,peptide,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,472,"cetrorelix,cetrotide",Antineoplastic,4,,-,approved,2000,
1056,cf-101,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,473,cf-101,Anti-inflammatory ; DMARD,3,2015,not open yet,in trial,-,
1057,cf-102,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,474,cf-102,Antineoplastic,2,2014,recruiting,in trial,-,
1058,cgrp,peptide,Peptide,agonist,,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,477,"cgrp, Akela Pharma",Anti-Asthmatic,2,2013,discontinued,in trial,-,EU
1059,clopidogrel,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,478,cgt-2168,antiplatelet,4,,-,approved,1997,
1060,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,481,"chf-1535, beclomethasone dipropionate + formoterol fumarate",Anti-Asthmatic,4,,-,approved,2001,
1061,clazosentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,495,"clazosentan, axv-343434,pivlaz",vasospasm,2,2015,recruiting,in trial,-,
1062,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,501,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",diabetic neuropathy; ADHD; antimucositic,4,,-,approved,1974,
1063,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,501,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",diabetic neuropathy; ADHD; antimucositic,4,,-,approved,1974,
1064,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,501,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",diabetic neuropathy; ADHD; antimucositic,4,,-,approved,1974,
1065,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,502,"clonidine lauriad, ba-028",diabetic neuropathy; ADHD; antimucositic,2,2011,completed,in trial,-,
1066,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,502,"clonidine lauriad, ba-028",diabetic neuropathy; ADHD; antimucositic,2,2011,completed,in trial,-,
1067,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,502,"clonidine lauriad, ba-028",diabetic neuropathy; ADHD; antimucositic,2,2011,completed,in trial,-,
1068,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,51,ad 923,Analgesics,4,,-,approved,1968,
1069,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,51,ad 923,Analgesics,4,,-,approved,1968,
1070,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,514,"col-003, sustained release oxycodone",Analgesics,4,,-,approved,2016,
1071,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,514,"col-003, sustained release oxycodone",Analgesics,4,,-,approved,2016,
1072,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,514,"col-003, sustained release oxycodone",Analgesics,4,,-,approved,2016,
1073,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,515,"col-172, extended-release oxycodone",Analgesics,4,,-,approved,2011,
1074,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,515,"col-172, extended-release oxycodone",Analgesics,4,,-,approved,2011,
1075,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,515,"col-172, extended-release oxycodone",Analgesics,4,,-,approved,2011,
1076,conivaptan,small molecule,Peptide,antagonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,519,"conivaptan, ym-087,vaprisol",hyponatremia,4,,-,approved,2005,
1077,conivaptan,small molecule,Peptide,antagonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,519,"conivaptan, ym-087,vaprisol",hyponatremia,4,,-,approved,2005,
1078,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,522,contrave,Appetite suppressant,4,,-,approved,1998,
1079,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,522,contrave,Appetite suppressant,4,,-,approved,1998,
1080,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,522,contrave,Appetite suppressant,4,,-,approved,1998,
1081,corifollitropin alfa,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,526,"corifollitropin alfa,elonva",Fertility,3,2015,recruiting,in trial,-,
1082,corticotropin-releasing factor,peptide,Peptide,agonist,,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,528,"corticotropin-releasing factor,xerecept",peritumoral brain edema,3,2005,discontinued,in trial,-,
1083,corticotropin-releasing factor,peptide,Peptide,agonist,,secondary,CRHR2,crfr2_human,Q13324,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,528,"corticotropin-releasing factor,xerecept",peritumoral brain edema,3,2005,discontinued,in trial,-,
1084,theophylline,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,53,"adc4022, low-dose inhaled theophylline",Bronchodilator,4,,-,approved,1976,
1085,theophylline,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,53,"adc4022, low-dose inhaled theophylline",Bronchodilator,4,,-,approved,1976,
1086,theophylline,small molecule,Nucleotide ,antagonist,,primary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,53,"adc4022, low-dose inhaled theophylline",Bronchodilator,4,,-,approved,1976,
1087,cr665,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,539,"cr665, JNJ 38488502",Analgesics,2,2004,discontinued,in trial,-,
1088,cr845,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,540,cr845,Analgesics,3,2015,recruiting,in trial,-,
1089,adl5747,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,55,adl5747,osteoarthritis,2,2010,discontinued,in trial,-,
1090,olmesartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,557,"cs-8663, amlodipine + olmesartan,azor, sevikar",Antihypertensive,4,,-,approved,2002,
1091,adl5859,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,56,"adl5859, pf-04856880",osteoarthritis,2,2009,discontinued,in trial,-,
1092,avicine,vaccine,Protein,not available,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,563,"ctp-37,avicine",Antineoplastic,1,1997,discontinued,in trial,-,
1093,cvt-3619,small molecule,Nucleotide ,partial agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,568,cvt-3619,Antihyperlipidemic,1,2010,completed,in trial,-,
1094,cvt-6883,small molecule,Nucleotide ,antagonist,,primary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,569,cvt-6883,Anti-Asthmatic,1,2008,completed,in trial,-,
1095,adl5945,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,57,adl5945,motilitant,3,2013,terminated,in trial,-,Terminated lack of enrollment
1096,adl7445,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,58,adl7445,motilitant,1,2011,terminated,in trial,-,Terminated lack of enrollment
1097,dac:glp-1,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,590,"dac:glp-1, cjc-1131",Antidiabetic,2,2007,discontinued,in trial,-,
1098,dac:grf,peptide,Peptide,agonist,,primary,GHRHR,ghrhr_human,Q02643,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,591,dac:grf,hormone replacement,2,2007,discontinued,in trial,-,
1099,darifenacin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,598,"darifenacin,enablex, emselex",overactive bladder,4,,-,approved,2004,
1100,darusentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,599,darusentan,Antihypertensive,3,2006,discontinued,in trial,-,
1101,salmeterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,61,advair/seretide/adoair,Bronchodilator,4,,-,approved,1994,
1102,degarelix,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,610,degarelix,Antineoplastic,4,,-,approved,2008,
1103,degarelix,small molecule,Peptide,antagonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,610,degarelix,Antineoplastic,4,,-,approved,2008,
1104,denufosol,small molecule,Nucleotide ,agonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,614,"denufosol tetrasodium, ins37217 respiratory",cystic fibrosis,3,2009,discontinued,in trial,-,
1105,adx10059,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,62,adx10059,Anti-migraine ; gastroesophageal reflux disease,2,2008,discontinued,in trial,-,
1106,desloratadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,620,"desloratadine , clarinex",Anti-Allergic,4,,-,approved,2001,
1107,dexloxiglumide,small molecule,Peptide,antagonist,,primary,CCKAR,cckar_human,P32238,Class A (Rhodopsin),GPCR;Rhodopsin,Cholecystokinin receptors,established,626,"dexloxiglumide, cr 2017",motilitant,3,2005,discontinued,in trial,-,
1108,dexpramipexole,small molecule,Aminergic ,agonist,,secondary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,627,"dexpramipexole, kns-760704",amyotrophic lateral sclerosis (ALS),3,2012,terminated,in trial,-,Did not meet its primary efficacy endpoint
1109,dexpramipexole,small molecule,Aminergic ,agonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,627,"dexpramipexole, kns-760704",amyotrophic lateral sclerosis (ALS),3,2012,terminated,in trial,-,Did not meet its primary efficacy endpoint
1110,dexpramipexole,small molecule,Aminergic ,agonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,627,"dexpramipexole, kns-760704",amyotrophic lateral sclerosis (ALS),3,2012,terminated,in trial,-,Did not meet its primary efficacy endpoint
1111,dg041,small molecule,Lipid ,antagonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,629,dg041,Platelet Aggregation Inhibitor,2,2006,discontinued,in trial,-,Iceland
1112,adx415,small molecule,Aminergic ,NAM,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,63,adx415,Antihypertensive,2,2008,completed,in trial,-,
1113,dg3173,small molecule,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,632,dg3173,hormone replacement,2,2014,ongoing,in trial,-,
1114,dg3173,small molecule,Peptide,agonist,,primary,SSTR4,ssr4_human,P31391,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,632,dg3173,hormone replacement,2,2014,ongoing,in trial,-,
1115,dg3173,small molecule,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,632,dg3173,hormone replacement,2,2014,ongoing,in trial,-,
1116,dg3173,small molecule,Peptide,agonist,,secondary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,632,dg3173,hormone replacement,2,2014,ongoing,in trial,-,
1117,adx-71149,small molecule,Amino acid ,PAM,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,64,"adx-71149,  JNJ-40411813",Antipsychotic ; Anti-depressant; anxiolytic,2,2011,completed,in trial,-,
1118,diquafosol,small molecule,Nucleotide ,agonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,644,"diquafosol tetrasodium, ins365 ophthalmic,prolacria",opthalmological,3,2009,discontinued,in trial,-,
1119,levodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,
1120,levodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,
1121,levodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,
1122,levodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,
1123,levodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,
1124,betanechol,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,648,dm-71,Antidiabetic,4,,-,approved,1970,
1125,dronabinol,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,667,"dronabinol ,marinol",Appetite stimulant,4,,-,approved,1985,
1126,dronabinol,small molecule,Lipid ,agonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,667,"dronabinol ,marinol",Appetite stimulant,4,,-,approved,1985,
1127,tamsulosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,675,"dutasteride + tamsulosin,jalyn",benign prostatic hyperplasia,4,,-,approved,1997,
1128,azelastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,679,"dymista, azelastine hydrochloride + fluticasone propionate, mp29-02",Anti-Allergic,4,,-,approved,2012,
1129,ecopipam,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,686,ecopipam,Speech and language disorders,3,2016,recruiting,in trial,-,
1130,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,69,aerolef,Analgesics,2,2010,completed,in trial,-,
1131,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,69,aerolef,Analgesics,2,2010,completed,in trial,-,
1132,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,696,"eli-154, oxycodone (once daily)",Analgesics,2,2012,discontinued,in trial,-,
1133,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,696,"eli-154, oxycodone (once daily)",Analgesics,2,2012,discontinued,in trial,-,
1134,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,696,"eli-154, oxycodone (once daily)",Analgesics,2,2012,discontinued,in trial,-,
1135,leuprolide,peptide,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,697,eligard,Antineoplastic,4,,-,approved,1985,
1136,glp,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,699,eligen pyy-3-36 + glp-1,Appetite suppressant,2,2009,completed,in trial,-,
1137,peptide yy,peptide,Peptide,agonist,,primary,NPY2R,npy2r_human,P49146,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,699,eligen pyy-3-36 + glp-1,Appetite suppressant,1,2009,completed,in trial,-,
1138,elinogrel,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,701,"elinogrel, prt060128, adp receptor antagonist",antiplatelet,2,2008,discontinued,in trial,-,
1139,levodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,
1140,levodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,
1141,levodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,
1142,levodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,
1143,levodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,
1144,ep-100,peptide,Peptide,not available,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,715,ep-100,Antineoplastic,2,2011,completed,in trial,-,Seems like still investigating as of 2014 article
1145,ep-100,peptide,Peptide,not available,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,715,ep-100,Antineoplastic,2,2011,completed,in trial,-,Seems like still investigating as of 2014 article
1146,epinastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,719,epinastine,Anti-Allergic,4,,-,approved,2003,
1147,epinastine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,719,epinastine,Anti-Allergic,4,,-,approved,2003,
1148,eplivanserine,small molecule,Aminergic ,inverse agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,721,"eplivanserine, sr 46349,ciltyri",insomnia,3,2009,discontinued,in trial,-,Sanofi withdrew application for fda approval 2009
1149,eplivanserine,small molecule,Aminergic ,inverse agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,721,"eplivanserine, sr 46349,ciltyri",insomnia,3,2009,discontinued,in trial,-,Sanofi withdrew application for fda approval 2009
1150,afamelanotide,small molecule,Peptide,agonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,73,afamelanotide,dermatological,3,2009,completed,in trial,-,Seeking FDA approval
1151,esmirtazapine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,732,"esmirtazapine, org-4420",insomnia; menopausal symptoms,3,2009,discontinued,in trial,-,discontinued by Organon
1152,esmirtazapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,732,"esmirtazapine, org-4420",insomnia; menopausal symptoms,3,2009,discontinued,in trial,-,discontinued by Organon
1153,etilevodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,
1154,etilevodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,
1155,etilevodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,
1156,etilevodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,
1157,etilevodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,
1158,metoclopramide,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,758,evk-001,diabetic gastroparesis,3,2016,completed,in trial,-,
1159,metoclopramide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,758,evk-001,diabetic gastroparesis,3,2016,completed,in trial,-,
1160,exenatide,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,769,exenatide,Antidiabetic,4,,-,approved,2005,
1161,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,775,"febt,fentora, effentora",Analgesics,4,,-,approved,1968,
1162,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,775,"febt,fentora, effentora",Analgesics,4,,-,approved,1968,
1163,fenoldopam,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,778,"fenoldopam mesylate, skf-82526,corlopam",Antihypertensive,4,,-,approved,1997,
1164,fenoldopam,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,778,"fenoldopam mesylate, skf-82526,corlopam",Antihypertensive,4,,-,approved,1997,
1165,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,780,"fentanyl (sublingual), kw-2246,abstral, rapinyl",Analgesics,4,,-,approved,1968,
1166,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,780,"fentanyl (sublingual), kw-2246,abstral, rapinyl",Analgesics,4,,-,approved,1968,
1167,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,781,"fentanyl citrate,pecfent, nasalfent",Analgesics,4,,-,approved,1968,
1168,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,781,"fentanyl citrate,pecfent, nasalfent",Analgesics,4,,-,approved,1968,
1169,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,782,"fentanyl lauriad, ba-041",Analgesics,2,2014,discontinued,in trial,-,
1170,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,782,"fentanyl lauriad, ba-041",Analgesics,2,2014,discontinued,in trial,-,
1171,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,783,fentanyl mdts,Analgesics,1,2009,discontinued,in trial,-,
1172,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,783,fentanyl mdts,Analgesics,1,2009,discontinued,in trial,-,
1173,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,784,"fentanyl spray, intranasal,instanyl",Analgesics,4,,-,approved,1968,
1174,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,784,"fentanyl spray, intranasal,instanyl",Analgesics,4,,-,approved,1968,
1175,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,785,fentanyl sublingual spray,Analgesics,4,,-,approved,1968,
1176,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,785,fentanyl sublingual spray,Analgesics,4,,-,approved,1968,
1177,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,786,fentanyl taifun,Analgesics,3,2011,discontinued,in trial,-,
1178,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,786,fentanyl taifun,Analgesics,3,2011,discontinued,in trial,-,
1179,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,787,"fentanyl transdermal system,duragesic, ionsys",Analgesics,4,,-,approved,1968,
1180,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,787,"fentanyl transdermal system,duragesic, ionsys",Analgesics,4,,-,approved,1968,
1181,fesoterodine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,788,"fesoterodine fumarate, spm 907,toviaz",overactive bladder syndrome,4,,-,approved,2007,
1182,fexofenadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,789,fexofenadine + ps/,Anti-Allergic,4,,-,approved,1996,
1183,pseudoephedrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,789,fexofenadine + ps/,Anti-Allergic,4,,-,approved,1975,
1184,pseudoephedrine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,789,fexofenadine + ps/,Anti-Allergic,4,,-,approved,1975,
1185,fingolimod,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,794,"fingolimod, fty 720,gilenia, gilenya",Multiple Sclerosis,4,,-,approved,2010,
1186,fipamezole,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,795,"fipamezole , jp-1730",Antiparkinson,2,2010,discontinued,in trial,-,
1187,fipamezole,small molecule,Aminergic ,antagonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,796,"fipamezole, jp-1730",Antiparkinson,2,2010,discontinued,in trial,-,
1188,fipamezole,small molecule,Aminergic ,antagonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,796,"fipamezole, jp-1730",Antiparkinson,2,2010,discontinued,in trial,-,
1189,icatibant,small molecule,Peptide,antagonist,,primary,BDKRB2,bkrb2_human,P30411,Class A (Rhodopsin),GPCR;Rhodopsin,Bradykinin receptors,established,797,"firazyr, icatibant, je049",hereditary angioedema,4,,-,approved,2008,
1190,fk352b,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,799,fk352b,Antihypertensive,2,2005,discontinued,in trial,-,
1191,flibanserin,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,801,flibanserin,sexual dysfunction,4,,-,approved,2015,
1192,flibanserin,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,801,flibanserin,sexual dysfunction,4,,-,approved,2015,
1193,follitropin,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,814,"follitropin alpha ,gonal-f",Fertility,4,,-,approved,1997,
1194,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,815,"formoterol ,foradil",Bronchodilator,4,,-,approved,2001,
1195,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,816,"formoterol fumarate,perforomist",chronic obstructive pulmonary disease (COPD),4,,-,approved,2001,
1196,calcitonin salmon recombinant,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,817,fortical,Anti-osteoporotic,3,2008,discontinued,in trial,-,
1197,frovatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,823,"frovatriptan,frovelan, frova",Anti-migraine,4,,-,approved,2001,
1198,frovatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,823,"frovatriptan,frovelan, frova",Anti-migraine,4,,-,approved,2001,
1199,fsh-gex,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,825,fsh-gex,Fertility,2,2013,completed,in trial,-,
1200,fx125l,small molecule,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,831,fx125l,Anti-Asthmatic,1,2009,completed,in trial,-,Great Britain
1201,gepirone,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,848,gepirone,Anti-depressant,3,1999,completed,in trial,-,"Was rejected 3 times for fda approval, reversed decision in march 2016 - headed for approval and martketing"
1202,agn-214868,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,terminated,in trial,-,Lack of efficacy
1203,agn-214868,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,terminated,in trial,-,Lack of efficacy
1204,agn-214868,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,terminated,in trial,-,Lack of efficacy
1205,agn-214868,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,terminated,in trial,-,Lack of efficacy
1206,agn-214868,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,terminated,in trial,-,Lack of efficacy
1207,agn-214868,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,terminated,in trial,-,Lack of efficacy
1208,agomelatine,small molecule,Melatonin ,agonist,,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,86,"agomelatine , ago178c, s-20098,valdoxan, thymanax",Anti-depressant,4,,-,approved,2009,
1209,glycopyrrolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,864,"glycopyrrolate, fhpc-02,cuvposa",Antineoplastic,4,,-,approved,1961,
1210,nbi-42902,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,869,"gnrh receptor antagonist, nbi-42902",postmenopausal symptoms; Antineoplastic,2,2005,discontinued,in trial,-,
1211,nbi-42902,small molecule,Peptide,antagonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,869,"gnrh receptor antagonist, nbi-42902",postmenopausal symptoms; Antineoplastic,2,2005,discontinued,in trial,-,
1212,agomelatine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,87,"agomelatine, ago178c, s-20098,valdoxan, thymanax",Anti-depressant,4,,-,approved,2009,
1213,agomelatine,small molecule,Melatonin ,agonist,,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,87,"agomelatine, ago178c, s-20098,valdoxan, thymanax",Anti-depressant,4,,-,approved,2009,
1214,agomelatine,small molecule,Aminergic ,antagonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,87,"agomelatine, ago178c, s-20098,valdoxan, thymanax",Anti-depressant,4,,-,approved,2009,
1215,gsk-1004723,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,878,gsk-1004723,Anti-Allergic,2,2009,discontinued,in trial,-,
1216,gsk-1004723,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,878,gsk-1004723,Anti-Allergic,2,2009,discontinued,in trial,-,
1217,gsk-961081,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,881,gsk-961081,Bronchodilator,2,2015,completed,in trial,-,
1218,gsk-961081,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,881,gsk-961081,Bronchodilator,2,2015,completed,in trial,-,
1219,gtp-010,protein,Peptide,antagonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,885,gtp-010,irritable bowel syndrome,2,2008,discontinued,in trial,-,
1220,gtp-200,peptide,Peptide,agonist,,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,886,gtp-200,Appetite stimulant,2,2006,discontinued,in trial,-,
1221,gtx-758,small molecule,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,888,gtx-758,Antineoplastic,2,2012,recruiting,in trial,-,Other studies were terminated from FDA hold
1222,guanfacine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,889,"guanfacine, spd 503,intuniv",ADHD,4,,-,approved,1986,
1223,aiko-150,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,92,aiko-150,opioid antagonist,1,2009,completed,in trial,-,
1224,famotidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,929,"hzt-501,  ibuprofen + famotidine,duexa",acid reducer,4,,-,approved,1986,
1225,famotidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,929,"hzt-501,  ibuprofen + famotidine,duexa",gastric ulcer and gastroesophageal reflux,4,,-,approved,1986,
1226,iloperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1227,iloperidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1228,iloperidone,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1229,iloperidone,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1230,iloperidone,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1231,iloperidone,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1232,iloperidone,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1233,iloperidone,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1234,iloperidone,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1235,iloperidone,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1236,iloprost,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,952,"iloprost,ventavis",Antihypertensive,4,,-,approved,2004,
1237,iloprost,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,952,"iloprost,ventavis",Antihypertensive,4,,-,approved,2004,
1238,akl-0707,small molecule,Peptide,agonist,,primary,GHRH,ghrhr_human,Q02643,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,96,"akl-0707, ghrh analog",hormone replacement,2,2013,discontinued,in trial,-,
1239,incb3284,small molecule,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,966,incb3284,Anti-inflammatory ; DMARD,2,2005,discontinued,in trial,-,
1240,indacaterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,969,indacaterol,Bronchodilator,4,,-,approved,2009,
1241,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,976,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2012,discontinued,in trial,-,
1242,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,976,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2012,discontinued,in trial,-,
1243,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,976,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2012,discontinued,in trial,-,
1244,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,
1245,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,
1246,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,
1247,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,
1248,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,
1249,octreotide,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,981,"injectable octreotide acetate,sandostatin lar",Antineoplastic,4,,-,approved,1988,
1250,octreotide,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,981,"injectable octreotide acetate,sandostatin lar",Antineoplastic,4,,-,approved,1988,
1251,octreotide,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,981,"injectable octreotide acetate,sandostatin lar",Antineoplastic,4,,-,approved,1988,
1252,nemifitide,peptide,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,983,"inn-00835, nemifitide",Anti-depressant,3,2010,discontinued,in trial,-,Dates approximate - difficult to get info
1253,ino-8875,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,985,ino-8875,Antiglaucomic,3,2015,completed,in trial,-,
1254,Denufosol,small molecule,Nucleotide ,agonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,990,"Denufosol, ins37217",rhegmatogenous retinal detachment,2,2004,discontinued,in trial,-,
1255,Denufosol,small molecule,Nucleotide ,agonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,991,"Denufosol, ins37217 intranasal",cystic fibrosis; perennial allergic rhinitis,3,2009,discontinued,in trial,-,
1256,ins-50589,unknown,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,992,ins-50589,antithrombotic,2,2006,discontinued,in trial,-,
1257,bl-8040,peptide,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,APR13_0001,bl-8040,Antineoplastic,2,2016,recruiting,in trial,-,"discontinued for sole intervention, now in combination trials"
1258,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1259,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1260,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1261,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1262,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1263,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1264,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1265,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1266,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1267,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1268,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1269,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1270,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1271,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1272,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1273,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1274,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1275,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1276,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1277,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1278,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1279,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1280,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1281,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1282,samidoprhan,small molecule,Peptide,antagonist,,primary,MOR,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,APR13_0013,alks 3831,addiction,3,2016,recruiting,in trial,-,
1283,ly2881835,small molecule,Lipid ,agonist,,primary,FFAR1,ffar1_human,O14842,Class A (Rhodopsin),GPCR;Rhodopsin,Free fatty acid receptors,not established,ASH_Jul2017_01,LY2881835,Antidiabetic,1,2011,completed,in trial,-,
1284,iph5401,antibody,Peptide,antagonist,,primary,C5AR1,c5ar1_human,P21730,Class A (Rhodopsin),GPCR;Rhodopsin,Complement peptide receptors,not established,ASH_Jul2017_02,IPH5401,Antineoplastic,1,2017,recruiting,in trial,-,
1285,BI 665088,antibody,Protein,antagonist,,primary,CX3CR1,cx3c1_human,P49238,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Jul2017_03,BI 665088,kidney disease,1,2017,ongoing,in trial,-,
1286,ipafricept,antibody,Protein,antagonist,FZD8-IgG;OMP-54F28,primary,FZD8,fzd8_human,Q9H461,Class A (Rhodopsin),GPCR;Rhodopsin,Frizzled,not established,ASH_Jul2017_04,FZD8IgG,Antineoplastic,1,2017,ongoing,in trial,-,
1287,OTSA-101-DTPA-90Y,antibody,Protein,antagonist,Yttrium,primary,FZD10,fzd10_human,Q9ULW2,Class A (Rhodopsin),GpCR;Rhodopsin,Frizzled,not established,ASH_Jul2017_05,OTSA101DTPA90Y,Antineoplastic,1,2017,ongoing,in trial,-,
1288,Anti-CXCR2 biparatopic nanobody,antibody,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GpCR;Rhodopsin,Chemokine receptors,not established,ASH_Jul2017_07,AntiCXCR2 biparatopic nanobody,Anti-inflammatory,1,2017,ongoing,in trial,-,
1289,BNC-101,antibody,Orphan ,antagonist,,primary,LGR5,lgr5_human,O75473,Class A (Rhodopsin),GpCR;Rhodopsin,Class A orphans,not established,ASH_Jul2017_08,BNC101,Antineoplastic,1,2016,ongoing,in trial,-,
1290,GMA102,antibody,Peptide,antagonist,,primary,GLP1R,glp1r_human,P43220,Class A (Rhodopsin),GpCR;Rhodopsin,Glucagon receptor family,established,ASH_Jul2017_09,GMA102,Antidiabetic,1,2017,ongoing,in trial,-,
1291,namacizumab,antibody,Lipid,NAM,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GpCR;Rhodopsin,Cannabinoid receptors,established,ASH_Jul2017_10,Namacizumab,Fibrosis,1,2017,ongoing,in trial,-,
1292,naldemedine,small molecule,Peptide,antagonist,,primary,OPRM,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Mar2017_1,naldemedine,opioid-induced constipation,4,,-,approved,2017,
1293,HTL18318,small molecule,Aminergic ,agonist,,primary,OPRM,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Mar2017_2,HTL18318,dementia ; schizophrenia,1,2016,completed,in trial,-,
1294,suramin,small molecule,Nucleotide ,antagonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y,established,ASH_Oct2016_346,Suramin,African trypanosomiasis,4,,-,approved,1916,
1295,metiamide,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Oct2016_349,metiamide,acid reducer,4,,-,approved,-,
1296,pethidine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Oct2016_350,pethidine,Analgesics,4,,-,approved,1942,
1297,ketobemidone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Oct2016_351,ketobemidone,Analgesics,4,,-,approved,-,
1298,ketobemidone,small molecule,Aminergic ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_352,ketobemidone,Analgesics,4,,-,approved,-,
1299,ethylmorphine,small molecule,Aminergic ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_353,ethylmorphine,Analgesics,4,,-,approved,-,
1300,ketobemidone,small molecule,Aminergic ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_354,ketobemidone,Analgesics,4,,-,approved,-,
1301,phenindamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_355,phenindamine,Anti-Allergic,4,,-,approved,1949,
1302,chloropyramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_356,chloropyramine,Anti-Allergic,4,,-,approved,-,
1303,dimetindene,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_357,dimetindene,Anti-Allergic,4,,-,approved,-,
1304,chlorcyclizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_358,chlorcyclizine,Anti-Allergic,4,,-,approved,-,
1305,bilastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_359,bilastine,Anti-Allergic,4,,-,approved,2010,
1306,dimetindene,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_360,dimetindene,Anti-Allergic,4,,-,approved,-,
1307,isoetharine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_361,isoetharine,Anti-Asthmatic,4,,-,approved,1979,
1308,butriptyline,small molecule,Peptide,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Oct2016_363,butriptyline,Anti-depressant,4,,-,approved,1974,
1309,butriptyline,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_365,butriptyline,Anti-depressant,4,,-,approved,1974,
1310,bromopride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_366,bromopride,Antiemetics,4,,-,approved,-,
1311,ergonovine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_367,ergonovine,antihaemorrhagic,4,,-,approved,1946,
1312,sitaxentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Oct2016_368,sitaxentan,Antihypertensive,4,,-,approved,2006,copy and conflicting subfamily
1313,bupranolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_369,bupranolol,Antihypertensive,4,,-,approved,-,
1314,celiprolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_370,celiprolol,Antihypertensive,4,,-,approved,-,
1315,bopindolol,small molecule,Aminergic ,partial agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_371,bopindolol,Antihypertensive,4,,-,approved,-,
1316,celiprolol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_372,celiprolol,Antihypertensive,4,,-,approved,-,
1317,isothipendyl,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_373,isothipendyl,antipruritic,4,,-,approved,-,
1318,thioproperazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_374,thioproperazine,Antipsychotic,4,,-,approved,1962,
1319,benperidol,small molecule,Aminergic ,not available,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_375,benperidol,Antipsychotic,4,,-,approved,2006,
1320,thioproperazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_376,thioproperazine,Antipsychotic,4,,-,approved,1962,
1321,pipotiazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_378,pipotiazine,Antipsychotic,4,,-,approved,1980,
1322,acepromazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_379,acepromazine,Antipsychotic,4,,-,approved,-,
1323,thioproperazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_380,thioproperazine,Antipsychotic,4,,-,approved,1962,
1324,flupentixol,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_381,flupentixol,Antipsychotic,4,,-,approved,1965,
1325,pipotiazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_382,pipotiazine,Antipsychotic,4,,-,approved,1980,
1326,acepromazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_383,acepromazine,Antipsychotic,4,,-,approved,-,
1327,benperidol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_384,benperidol,Antipsychotic,4,,-,approved,2006,
1328,flupentixol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_385,flupentixol,Antipsychotic,4,,-,approved,1965,
1329,pipotiazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_386,pipotiazine,Antipsychotic,4,,-,approved,1980,
1330,acepromazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_387,acepromazine,Antipsychotic,4,,-,approved,-,
1331,thioproperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_388,thioproperazine,Antipsychotic,4,,-,approved,1962,
1332,flupentixol,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_389,flupentixol,Antipsychotic,4,,-,approved,1965,
1333,pipotiazine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_390,pipotiazine,Antipsychotic,4,,-,approved,1980,
1334,acepromazine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_391,acepromazine,Antipsychotic,4,,-,approved,-,
1335,thioproperazine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_392,thioproperazine,Antipsychotic,4,,-,approved,1962,
1336,flupentixol,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_393,flupentixol,Antipsychotic,4,,-,approved,1965,
1337,hyoscyamine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_394,hyoscyamine,Antispasmodics,4,,-,approved,-,
1338,alverine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_395,alverine,Antispasmodics,4,,-,approved,2014,
1339,hyoscyamine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_396,hyoscyamine,Antispasmodics,4,,-,approved,-,
1340,clofedanol,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_397,clofedanol,antitussive,4,,-,approved,1987,
1341,captodiame,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_399,captodiame,anxiolytic,4,,-,approved,-,
1342,captodiame,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_400,captodiame,anxiolytic,4,,-,approved,-,
1343,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_401,isoprenaline,cardiovascular ; Anti-Asthmatic ,4,,-,approved,1956,
1344,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,p08588,Class A (Rhodopsin),GPCR;Rhodopsin,Thyrotropin-releasing hormone receptors,established,ASH_Oct2016_402,isoprenaline,cardiovascular ; Anti-Asthmatic ,4,,-,approved,1956,
1345,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class B1 (Secretin),GPCR;Rhodopsin,Corticotropin-releasing factor receptors,established,ASH_Oct2016_403,isoprenaline,cardiovascular ; Anti-Asthmatic ,4,,-,approved,1956,
1346,xylometazoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_404,xylometazoline,decongestant,4,,-,approved,1959,
1347,levonordefrin,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_405,levonordefrin,decongestant,4,,-,approved,1960,
1348,xylometazoline,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Oct2016_406,xylometazoline,decongestant,4,,-,approved,1959,
1349,xylometazoline,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_407,xylometazoline,decongestant,4,,-,approved,1959,
1350,protirelin,small molecule,Aminergic ,agonist,,primary,TRHR,trfr_human,P34981,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_408,protirelin,Diagnostic,4,,-,approved,1976,
1351,corticorelin ovine triflutate,small molecule,Aminergic ,agonist,,primary,CRHR1,crfr1_human,P34998,Class A (Rhodopsin),GPCR;Secretin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_409,corticorelin ovine triflutate,Diagnostic,4,,-,approved,-,
1352,histamine,small molecule,Aminergic ,agonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_410,histamine ,for diagnosis of gastric acid secretory function,4,,-,approved,1939,
1353,tetryzoline,small molecule,Peptide,agonist,,primary,ADRA1A,ada1a_human,P35348,Class B1 (Secretin),GPCR;Rhodopsin,Calcitonin receptors,established,ASH_Oct2016_411,tetryzoline,"for eye irritation, decongestant",4,,-,approved,1982,
1354,ganirelix acetate,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_412,ganirelix,for prevention of premature ovulation in fertility treatment,4,,-,approved,1999,
1355,chenodeoxycholic acid,small molecule,Aminergic ,agonist,,primary,NR1H4,nr1h4_human,Q96RI1,Class A (Rhodopsin),Nuclear receptor,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_413,chenodeoxycholic acid,gall stones,4,,-,approved,1983,
1356,cinitapride,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Oct2016_414,cinitapride,gastrointestinal disorders,4,,-,approved,-,
1357,cinitapride,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Oct2016_415,cinitapride,gastrointestinal disorders,4,,-,approved,-,
1358,isometheptene,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_417,isometheptene,migraines,4,,-,approved,-,copy with conflicting subfamily
1359,calcitonin salmon recombinant,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class A (Rhodopsin),GPCR;Secretin,Adrenoceptors,established,ASH_Oct2016_418,calcitonin (salmon),Paget's disease,4,,-,approved,2005,
1360,methylscopolamine bromide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_421,methylscopolamine bromide,Anti-ulcer,4,,-,approved,1953,conflicting subfamily 
1361,methylscopolamine bromide,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_422,methylscopolamine bromide,Anti-ulcer,4,,-,approved,1953,conflicting subfamily 
1362,atosiban,small molecule,Protein,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,ASH_Oct2016_425,atosiban,labor repressant,4,,-,approved,2013,
1363,buserelin,peptide,Peptide,not available,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,ASH_Oct2016_426,buserelin,LHRH analogue,4,,-,approved,-,
1364,buserelin,peptide,Protein,not available,,secondary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,ASH_Oct2016_427,buserelin,LHRH analogue,4,,-,approved,-,
1365,acipimox,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,ASH_Oct2016_428,acipimox,lipid-lowering,4,,-,approved,2003,
1366,levonordefrin,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_429,alpha-methylnoradrenaline,nasal decongestant,4,,-,approved,1960,
1367,triptorelin,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Oct2016_430,triptorelin,palliiative treatment of advanced prostate cancer,4,,-,approved,2001,
1368,indoramin,small molecule,Aminergic ,not available,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_431,indoramin,Antihypertensive,4,,-,approved,1993,
1369,indoramin,small molecule,Aminergic ,not available,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_432,indoramin,Antihypertensive,4,,-,approved,1993,
1370,indoramin,small molecule,Aminergic ,not available,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_433,indoramin,Antihypertensive,4,,-,approved,1993,
1371,icatibant,small molecule,Peptide,antagonist,,secondary,BDKRB1,bkrb1_human,P46663,Class A (Rhodopsin),GPCR;Rhodopsin,Bradykinin receptors,established,ASH_Oct2016_434,"firazyr, icatibant, je049",hereditary angioedema,4,,-,approved,2008,
1372,iloprost,small molecule,Lipid ,agonist,,secondary,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,ASH_Oct2016_435,"iloprost,ventavis",Antihypertensive,4,,-,approved,2004,
1373,gamma hydroxybutyric acid,small molecule,Alicarboxylic acid ,agonist,,secondary,HCAR1,hcar1_human,Q9BXC0,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,ASH_Oct2016_437,sodium oxybate,Hypnotics and Sedatives,4,,-,approved,2002,
1374,ergoloid,small molecule,Aminergic ,agonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_0,ergoloid,cardiovascular disease,4,,-,approved,1953,
1375,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_1,"aripiprazole lauroxil, alks 9070",psychosis,4,,-,approved,2015,
1376,eletriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_10,eletriptan,Anti-migraine,4,,-,approved,2002,
1377,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_100,ergoloid,cardiovascular disease,4,,-,approved,1953,
1378,trimipramine,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_101,trimipramine,unipolar depression,4,,-,approved,1979,
1379,phentolamine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_102,phentolamine,cardiovascular disease,4,,-,approved,1952,
1380,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_103,dipivefrin,Antiglaucomic,4,,-,approved,1980,
1381,midodrine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_104,midodrine,cardiovascular disease,4,,-,approved,1996,
1382,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_105,mephentermine,cardiovascular disease,4,,-,approved,1951,
1383,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_106,dipivefrin,Antiglaucomic,4,,-,approved,1980,
1384,carvedilol,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_107,carvedilol,Antihypertensive,4,,-,approved,1995,
1385,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_108,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter
1386,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_109,ergoloid,cardiovascular disease,4,,-,approved,1953,
1387,metaraminol,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_110,metaraminol,cardiovascular disease,4,,-,approved,1954,
1388,naphazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_111,naphazoline,eye allergy,4,,-,approved,1971,
1389,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_112,ergotamine,Anti-migraine,4,,-,approved,1960,
1390,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_113,tolazoline,cardiovascular disease,4,,-,approved,1948,
1391,phenoxybenzamine,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_114,phenoxybenzamine,adrenal gland pheochromocytoma,4,,-,approved,1953,
1392,oxymetazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_115,oxymetazoline,allergic conjunctivitis,4,,-,approved,1986,
1393,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_116,labetalol,cardiovascular disease,4,,-,approved,1984,
1394,phentolamine,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_117,phentolamine,cardiovascular disease,4,,-,approved,1952,
1395,trimipramine,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_118,trimipramine,unipolar depression,4,,-,approved,1979,
1396,methoxamine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_119,methoxamine,cardiovascular disease,4,,-,approved,1982,
1397,molindone,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_12,molindone,schizophrenia,4,,-,approved,1974,
1398,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_120,tetrahydrozoline,nasal obstruction,4,,-,approved,1979,
1399,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_121,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter
1400,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_122,tetrahydrozoline,eye allergy,4,,-,approved,1979,
1401,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_123,mephentermine,cardiovascular disease,4,,-,approved,1951,
1402,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_124,ergotamine,Anti-migraine,4,,-,approved,1960,
1403,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_125,tolazoline,cardiovascular disease,4,,-,approved,1948,
1404,naphazoline,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_126,naphazoline,eye allergy,4,,-,approved,1971,
1405,phenoxybenzamine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_127,phenoxybenzamine,cardiovascular disease,4,,-,approved,1953,
1406,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_128,labetalol,cardiovascular disease,4,,-,approved,1984,
1407,naphazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_129,naphazoline,nasal obstruction,4,,-,approved,1971,
1408,haloperidol,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_13,haloperidol,conduct disorder,4,,-,approved,1967,
1409,dexmedetomidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_130,dexmedetomidine,Analgesics,4,,-,approved,1999,
1410,mirtazapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_131,mirtazapine,unipolar depression,4,,-,approved,1996,
1411,oxymetazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_132,oxymetazoline,dry eye,4,,-,approved,1986,
1412,guanfacine,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_133,guanfacine,attention deficit hyperactivity disorder,4,,-,approved,1986,
1413,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_134,tolazoline,arthralgia,4,,-,approved,1948,
1414,apraclonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_135,apraclonidine,Antiglaucomic,4,,-,approved,1987,
1415,phenoxybenzamine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_136,phenoxybenzamine,cardiovascular disease,4,,-,approved,1953,
1416,phentolamine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_137,phentolamine,cardiovascular disease,4,,-,approved,1952,
1417,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_138,labetalol,cardiovascular disease,4,,-,approved,1984,
1418,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_139,tetrahydrozoline,nasal obstruction,4,,-,approved,1979,
1419,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_14,"aripiprazole lauroxil, alks 9070",psychosis,4,,-,approved,2015,
1420,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_140,ergotamine,Anti-migraine,4,,-,approved,1960,
1421,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_141,ergoloid,cardiovascular disease,4,,-,approved,1953,
1422,methyldopa,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_142,methyldopa,Antihypertensive,4,,-,approved,1962,
1423,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_143,dipivefrin,Antiglaucomic,4,,-,approved,1980,
1424,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_144,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter
1425,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_145,mephentermine,cardiovascular disease,4,,-,approved,1951,
1426,esmirtazapine,small molecule,Aminergic ,antagonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_146,esmirtazapine,insomnia,3,2008,discontinued,in trial,-,
1427,guanabenz,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_147,guanabenz,Multiple Sclerosis,1,2015,recruiting,in trial,-,
1428,mirtazapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_148,mirtazapine,unipolar depression,4,,-,approved,1996,
1429,dexmedetomidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_149,dexmedetomidine,Antineoplastic,4,,-,approved,1999,
1430,trimipramine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_15,trimipramine,unipolar depression,4,,-,approved,1979,
1431,naphazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_150,naphazoline,nasal obstruction,4,,-,approved,1971,
1432,oxymetazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_151,oxymetazoline,dry eye,4,,-,approved,1986,
1433,guanfacine,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_152,guanfacine,obstructive sleep apnea,4,,-,approved,1986,
1434,phenoxybenzamine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_153,phenoxybenzamine,adrenal gland pheochromocytoma,4,,-,approved,1953,
1435,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_154,tolazoline,arthralgia,4,,-,approved,1948,
1436,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_155,ergoloid,cardiovascular disease,4,,-,approved,1953,
1437,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_156,labetalol,cardiovascular disease,4,,-,approved,1984,
1438,methyldopa,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_157,methyldopa,Antihypertensive,4,,-,approved,1962,
1439,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_158,ergotamine,Anti-migraine,4,,-,approved,1960,
1440,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_159,tetrahydrozoline,nasal obstruction,4,,-,approved,1979,
1441,chlorpromazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_16,chlorpromazine,psychosis,4,,-,approved,1957,
1442,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_160,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter
1443,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_161,mephentermine,cardiovascular disease,4,,-,approved,1951,
1444,apraclonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_162,apraclonidine,Antiglaucomic,4,,-,approved,1987,
1445,phentolamine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_163,phentolamine,cardiovascular disease,4,,-,approved,1952,
1446,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_164,dipivefrin,Antiglaucomic,4,,-,approved,1980,
1447,esmirtazapine,small molecule,Aminergic ,antagonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_165,esmirtazapine,insomnia,3,2008,discontinued,in trial,-,
1448,guanabenz,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_166,guanabenz,Antineoplastic,4,,-,approved,1982,
1449,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_167,dipivefrin,Antiglaucomic,4,,-,approved,1980,
1450,sotalol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_168,sotalol,atrial fibrillation,4,,-,approved,1992,
1451,dopamine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_169,dopamine,hypotension,4,,-,approved,1974,
1452,droperidol,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_17,droperidol,psychosis,4,,-,approved,1970,
1453,propafenone,small molecule,Aminergic ,antagonist,,secondary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_170,propafenone,cardiac arrhythmia,4,,-,approved,1989,
1454,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_171,mephentermine,cardiovascular disease,4,,-,approved,1951,
1455,nebivolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_172,nebivolol,Antihypertensive,4,,-,approved,2007,
1456,albuterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_173,albuterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,1981,
1457,levosalbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_174,levosalbutamol,Anti-Asthmatic,4,,-,approved,1999,
1458,metaproterenol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_175,metaproterenol,Anti-Asthmatic,4,,-,approved,1973,
1459,carteolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_176,carteolol,cardiovascular disease,4,,-,approved,1988,
1460,propafenone,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_177,propafenone,atrial fibrillation,4,,-,approved,1989,
1461,propranolol,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_178,propranolol,Antihypertensive,4,,-,approved,1967,
1462,dobutamine,small molecule,Aminergic ,agonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_179,dobutamine,heart failure,4,,-,approved,1978,
1463,trifluoperazine,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_18,trifluoperazine,psychosis,4,,-,approved,1959,
1464,sotalol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_180,sotalol,cardiovascular disease,4,,-,approved,1992,
1465,pirbuterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_181,pirbuterol,obstructive lung disease,4,,-,approved,1986,
1466,isoetharine,small molecule,Aminergic ,agonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_182,isoetharine,obstructive lung disease,4,,-,approved,1979,
1467,bitolterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_183,bitolterol,obstructive lung disease,4,,-,approved,1984,
1468,esmolol,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_184,esmolol,tinnitus,4,,-,approved,1986,
1469,dipivefrin,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_185,dipivefrin,Antiglaucomic,4,,-,approved,1980,
1470,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_186,mephentermine,cardiovascular disease,4,,-,approved,1951,
1471,carmoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_187,carmoterol,chronic obstructive pulmonary disease (COPD),2,2008,discontinued,in trial,-,
1472,batefenterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_188,batefenterol,chronic obstructive pulmonary disease (COPD),2,2016,completed,in trial,-,
1473,bedoradrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_189,bedoradrine,Anti-Asthmatic,2,2009,completed,in trial,-,No development reported
1474,thiothixene,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_19,thiothixene,psychosis,4,,-,approved,1967,
1475,abediterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_190,abediterol,Anti-Asthmatic,2,2016,completed,in trial,-,
1476,azd3199,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_191,azd3199,chronic obstructive pulmonary disease (COPD),2,2011,discontinued,in trial,-,Appears to be discontinued
1477,carvedilol,small molecule,Aminergic ,antagonist,,secondary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_192,carvedilol,Antihypertensive,4,,-,approved,1995,
1478,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_193,isoproterenol,Anti-Asthmatic,4,,-,approved,1956,
1479,carteolol,small molecule,Aminergic ,antagonist,,secondary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_194,carteolol,Antiglaucomic,4,,-,approved,1988,
1480,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_195,labetalol,cardiovascular disease,4,,-,approved,1984,
1481,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_196,mephentermine,cardiovascular disease,4,,-,approved,1951,
1482,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_197,dipivefrin,Antiglaucomic,4,,-,approved,1980,
1483,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_198,ergoloid,cardiovascular disease,4,,-,approved,1953,
1484,pimozide,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_199,pimozide,psychosis,4,,-,approved,1984,
1485,lecozotan,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_2,lecozotan,Alzheimer's disease,3,2006,discontinued,in trial,-,
1486,pimozide,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_20,pimozide,psychosis,4,,-,approved,1984,
1487,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_200,amoxapine,unipolar depression,4,,-,approved,1980,
1488,droperidol,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_201,droperidol,vomiting,4,,-,approved,1970,
1489,haloperidol,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_202,haloperidol,gastroparesis,4,,-,approved,1967,
1490,trifluoperazine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_203,trifluoperazine,psychosis,4,,-,approved,1959,
1491,chlorpromazine,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_204,chlorpromazine,psychosis,4,,-,approved,1957,
1492,thioridazine,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_205,thioridazine,psychosis,4,,-,approved,1962,
1493,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_206,ergoloid,cardiovascular disease,4,,-,approved,1953,
1494,loxapine,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_207,loxapine,psychosis,4,,-,approved,1975,
1495,promazine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_208,promazine,psychosis,4,,-,approved,1956,
1496,pergolide,small molecule,Aminergic ,agonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_209,pergolide,Antiparkinson,4,,-,approved,1988,
1497,haloperidol decanoate,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_21,haloperidol decanoate,psychosis,4,,-,approved,1986,
1498,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_210,amoxapine,unipolar depression,4,,-,approved,1980,
1499,pimozide,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_211,pimozide,psychosis,4,,-,approved,1984,
1500,haloperidol decanoate,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_212,haloperidol decanoate,psychosis,4,,-,approved,1986,
1501,levomepromazine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_213,levomepromazine,psychosis,4,,-,approved,1982,Approved prior to 1982 and then discontinued
1502,haloperidol,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_214,haloperidol,schizophrenia,4,,-,approved,1967,
1503,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_215,ergoloid,cardiovascular disease,4,,-,approved,1953,
1504,bromocriptine,small molecule,Aminergic ,agonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_216,bromocriptine,growth hormone excess,4,,-,approved,1978,
1505,trifluoperazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_217,trifluoperazine,psychosis,4,,-,approved,1959,
1506,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_218,ropinirole,Antiparkinson,4,,-,approved,1997,
1507,thioridazine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_219,thioridazine,psychosis,4,,-,approved,1962,
1508,vabicaserin,small molecule,Aminergic ,agonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_22,vabicaserin,schizophrenia,2,2008,discontinued,in trial,-,
1509,chlorpromazine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_220,chlorpromazine,psychosis,4,,-,approved,1957,
1510,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_221,amoxapine,unipolar depression,4,,-,approved,1980,
1511,pimozide,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_222,pimozide,psychosis,4,,-,approved,1984,
1512,loxapine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_223,loxapine,psychosis,4,,-,approved,1975,
1513,droperidol,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_224,droperidol,psychosis,4,,-,approved,1970,
1514,levomepromazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_225,levomepromazine,psychosis,4,,-,approved,1982,Approved prior to 1982 and then discontinued
1515,pergolide,small molecule,Aminergic ,agonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_226,pergolide,Antiparkinson,4,,-,approved,1988,
1516,haloperidol decanoate,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_227,haloperidol decanoate,psychosis,4,,-,approved,1986,
1517,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_228,amoxapine,unipolar depression,4,,-,approved,1980,
1518,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_229,ergoloid,cardiovascular disease,4,,-,approved,1953,
1519,pimozide,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_230,pimozide,psychosis,4,,-,approved,1984,
1520,pergolide,small molecule,Aminergic ,agonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_231,pergolide,Antiparkinson,4,,-,approved,1988,
1521,antazoline,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_232,antazoline,atrial fibrillation,4,,-,approved,1994,
1522,tolazoline,small molecule,Aminergic ,agonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_233,tolazoline,cardiovascular disease,4,,-,approved,1948,
1523,trimipramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_234,trimipramine,unipolar depression,4,,-,approved,1979,
1524,acrivastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_235,acrivastine,Anti-Allergic,4,,-,approved,1994,
1525,pyrilamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_236,pyrilamine,pruritus,4,,-,approved,1973,
1526,esmirtazapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_237,esmirtazapine,insomnia,3,2008,discontinued,in trial,-,
1527,dexchlorpheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_238,dexchlorpheniramine,sunburn,4,,-,approved,1981,
1528,histamine,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_239,histamine,Anti-migraine,4,,-,approved,1939,
1529,temanogrel,small molecule,Aminergic ,inverse agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_24,temanogrel,acute coronary syndrome,1,2015,unknown,in trial,-,
1530,methantheline,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_240,methantheline,digestive system disease,4,,-,approved,1951,
1531,tolazoline,small molecule,Aminergic ,agonist,,secondary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_241,tolazoline,arthralgia,4,,-,approved,1948,
1532,pitolisant,small molecule,Aminergic ,inverse agonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_242,pitolisant,Antiparkinson,3,2016,not open yet,in trial,-,
1533,bavisant,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_243,bavisant,attention deficit hyperactivity disorder,2,2011,withdrawn,in trial,-,No development reported
1534,pf-03654764,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_244,pf-03654764,allergic rhinitis,2,2009,discontinued,in trial,-,
1535,pf-03654746,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_245,pf-03654746,allergic rhinitis,2,2011,discontinued,in trial,-,
1536,irdabisant,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_246,irdabisant,cognitive impairment,1,2013,completed,in trial,-,
1537,toreforant,small molecule,Aminergic ,antagonist,,primary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_247,toreforant,Anti-Asthmatic,2,2014,completed,in trial,-,
1538,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_25,methysergide,Anti-migraine,4,,-,approved,1962,
1539,olmesartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,ASH_Sep2016_250,olmesartan medoxomil,cardiovascular disease,4,,-,approved,2002,
1540,tezosentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Sep2016_251,tezosentan,heart failure,3,2006,discontinued,in trial,-,
1541,tezosentan,small molecule,Peptide,antagonist,,primary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Sep2016_252,tezosentan,heart failure,3,2006,discontinued,in trial,-,
1542,darusentan,small molecule,Peptide,antagonist,,secondary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Sep2016_253,darusentan,Antihypertensive,3,2006,discontinued,in trial,-,
1543,goserelin,peptide,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Sep2016_255,goserelin,Antineoplastic,4,,-,approved,1989,
1544,ganirelix acetate,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Sep2016_256,ganirelix acetate,Fertility,4,,-,approved,1999,
1545,elagolix,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Sep2016_257,elagolix,endometriosis,3,2016,recruiting,in trial,-,
1546,relugolix,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Sep2016_258,relugolix,endometriosis,3,2017,recruiting,in trial,-,
1547,modimelanotide,protein,Peptide,agonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,ASH_Sep2016_259,modimelanotide,acute kidney injury,2,2013,discontinued,in trial,-,
1548,methylergonovine,small molecule,Aminergic ,partial agonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_26,methylergonovine,hemorrhage,4,,-,approved,1946,
1549,bremelanotide,protein,Peptide,agonist,,primary,MC3R,mc3r_human,P41968,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,ASH_Sep2016_260,bremelanotide,sexual dysfunction,3,2015,ongoing,in trial,-,
1550,modimelanotide,protein,Peptide,agonist,,primary,MC3R,mc3r_human,P41968,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,ASH_Sep2016_261,modimelanotide,acute kidney injury,2,2013,discontinued,in trial,-,
1551,camicinal,small molecule,Peptide,agonist,,primary,MLNR,mtlr_human,O43193,Class A (Rhodopsin),GPCR;Rhodopsin,Motilin receptors,not established,ASH_Sep2016_262,camicinal,gastroparesis,2,2014,completed,in trial,-,
1552,odelepran,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_263,odelepran,alcohol dependence,2,2008,discontinued,in trial,-,
1553,cebranopadol,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_264,cebranopadol,diabetic neuropathy,3,2016,recruiting,in trial,-,
1554,hydrocodone,small molecule,Peptide,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_265,hydrocodone,Analgesics,4,,-,approved,2013,
1555,oxymorphone,small molecule,Peptide,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_266,oxymorphone,opiate dependence,4,,-,approved,1959,
1556,cebranopadol,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_267,cebranopadol,diabetic neuropathy,3,2016,recruiting,in trial,-,
1557,odelepran,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_268,odelepran,alcohol dependence,2,2008,discontinued,in trial,-,
1558,dihydrocodeine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_269,dihydrocodeine,Analgesics,4,,-,approved,1958,
1559,vabicaserin,small molecule,Aminergic ,agonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_27,vabicaserin,schizophrenia,2,2008,discontinued,in trial,-,
1560,meperidine,small molecule,Peptide,agonist,,secondary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_270,meperidine,Analgesics,4,,-,approved,1942,
1561,difenoxin,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_271,difenoxin,recurrent infection of the gastrointestinal tract,4,,-,approved,1978,
1562,cebranopadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_273,cebranopadol,"osteoarthritis, knee",3,2016,recruiting,in trial,-,
1563,odelepran,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_275,odelepran,alcohol dependence,2,2008,discontinued,in trial,-,
1564,cebranopadol,small molecule,Peptide,agonist,,primary,OPRL1,oprx_human,P41146,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,not established,ASH_Sep2016_276,cebranopadol,Analgesics,3,2016,recruiting,in trial,-,
1565,sb-649868,small molecule,Peptide,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,ASH_Sep2016_277,sb-649868,insomnia,2,2007,completed,in trial,-,Suspected discontinued
1566,lemborexant,small molecule,Peptide,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,ASH_Sep2016_278,lemborexant,insomnia,2,2016,recruiting,in trial,-,
1567,sb-649868,small molecule,Peptide,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,ASH_Sep2016_279,sb-649868,insomnia,2,2007,completed,in trial,-,Suspected discontinued
1568,risperidone,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_28,risperidone,schizophrenia,4,,-,approved,1993,
1569,lemborexant,small molecule,Peptide,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,ASH_Sep2016_280,lemborexant,insomnia,2,2016,recruiting,in trial,-,
1570,atopaxar,small molecule,Peptide,antagonist,,primary,F2R,par1_human,P25116,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,ASH_Sep2016_282,atopaxar,acute coronary syndrome,2,2007,discontinued,in trial,-,
1571,lanreotide,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,ASH_Sep2016_283,lanreotide,Antineoplastic,4,,-,approved,2007,
1572,octreotide,peptide,Peptide,agonist,,primary,SSTR3,ssr3_human,P32745,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,ASH_Sep2016_284,octreotide,growth hormone excess,4,,-,approved,1988,
1573,octreotide,peptide,Peptide,agonist,,primary,SSTR4,ssr4_human,P31391,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,ASH_Sep2016_285,octreotide,growth hormone excess,4,,-,approved,1988,
1574,tradipitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,ASH_Sep2016_286,tradipitant,alcohol dependence,2,2016,recruiting,in trial,-,
1575,orvepitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,ASH_Sep2016_287,orvepitant,unipolar depression,2,2016,not open yet,in trial,-,Trials had been terminated in 2009 due to assessment of isolated events of seizure during program
1576,selepressin,protein,Peptide,agonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Sep2016_288,selepressin,septic shock,3,2015,recruiting,in trial,-,
1577,retosiban,small molecule,Peptide,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Sep2016_289,retosiban,premature birth,3,2015,recruiting,in trial,-,
1578,mirtazapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_29,mirtazapine,unipolar depression,4,,-,approved,1996,
1579,barusiban,protein,Peptide,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Sep2016_290,barusiban,Fertility,2,2012,completed,in trial,-,
1580,epelsiban,small molecule,Peptide,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Sep2016_291,epelsiban,premature ejaculation,2,2016,withdrawn,in trial,-,"Had no activity since 2009, then shows 2016 a phase 2 trial, but withdrawn due to change in portfolio prioritization"
1581,cenicriviroc,small molecule,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_292,cenicriviroc,antiviral ; HIV,3,2017,recruiting,in trial,-,
1582,cenicriviroc,small molecule,Protein,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,ASH_Sep2016_293,cenicriviroc,antiviral ; HIV,3,2017,recruiting,in trial,-,
1583,vercirnon,small molecule,Protein,antagonist,,primary,CCR9,ccr9_human,P51686,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_294,vercirnon,crohn's disease,3,2011,discontinued,in trial,-,
1584,ladarixin,small molecule,Protein,antagonist,,primary,CXCR1,cxcr1_human,P25024,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_296,ladarixin,bullous pemphigoid,2,2016,recruiting,in trial,-,
1585,danirixin,small molecule,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_297,"danirixin, GSK1325756",chronic obstructive pulmonary disease (COPD),2,2017,recruiting,in trial,-,
1586,ladarixin,small molecule,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_298,ladarixin,bullous pemphigoid,2,2016,recruiting,in trial,-,
1587,piclozotan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_3,piclozotan,stroke,2,2008,discontinued,in trial,-,
1588,ziprasidone,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_30,ziprasidone,schizophrenia,4,,-,approved,2001,
1589,elubrixin,small molecule,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_300,elubrixin,ulcerative colitis,2,2007,discontinued,in trial,-,
1590,amelubant,small molecule,Lipid ,antagonist,,primary,LTB4R,lt4r1_human,Q15722,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,not established,ASH_Sep2016_302,amelubant,chronic obstructive pulmonary disease (COPD),2,2014,discontinued,in trial,-,Disontinued due to significant increase in pulmonary related serious adverse events 
1591,asfotase alfa,enzyme,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,ASH_Sep2016_303,asfotase alfa,hypophosphatasia,4,,-,approved,2015,
1592,siponimod,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,ASH_Sep2016_304,siponimod,chronic progressive multiple sclerosis,3,2014,ongoing,in trial,-,
1593,ibipinabant,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,ASH_Sep2016_305,ibipinabant,Antidiabetic,3,2007,discontinued,in trial,-,
1594,drinabant,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,ASH_Sep2016_306,drinabant,schizophrenia,2,2007,discontinued,in trial,-,discontinued due to insufficient level of efficacy
1595,vidupiprant,small molecule,Lipid ,antagonist,,primary,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_307,"vidupiprant, AMG853",Anti-Asthmatic,2,2009,discontinued,in trial,-,
1596,fevipiprant,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_308,fevipiprant,Anti-Asthmatic,3,2017,recruiting,in trial,-,
1597,setipiprant,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_309,setipiprant,seasonal allergic rhinitis,3,2016,recruiting,in trial,-,
1598,loxapine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_31,loxapine,psychosis,4,,-,approved,1975,
1599,vidupiprant,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_310,"vidupiprant, AMG853",Anti-Asthmatic,2,2009,discontinued,in trial,-,
1600,azd1981,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_311,azd1981,Anti-Asthmatic,2,2014,discontinued,in trial,-,
1601,misoprostol,small molecule,Lipid ,agonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,ASH_Sep2016_312,misoprostol,hemorrhage,4,,-,approved,1988,
1602,ralinepag,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,ASH_Sep2016_314,"ralinepag, APD-811",Antihypertensive,2,2014,recruiting,in trial,-,
1603,apadenoson,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_315,apadenoson,atrial fibrillation,3,2011,discontinued,in trial,-,
1604,pentoxifylline,small molecule,Nucleotide ,antagonist,,secondary,ADORA2A,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_316,pentoxifylline,irritable bowel syndrome,4,,-,approved,1984,
1605,caffeine,small molecule,Nucleotide ,antagonist,,secondary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_317,caffeine,coronary artery disease,4,,-,approved,1999,
1606,theophylline,small molecule,Nucleotide ,antagonist,,secondary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_318,theophylline,Anti-Asthmatic,4,,-,approved,1976,
1607,caffeine,small molecule,Nucleotide ,antagonist,,secondary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_319,caffeine,atherosclerosis,4,,-,approved,1999,
1608,cyclobenzaprine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_32,cyclobenzaprine,spasticity,4,,-,approved,1977,
1609,cf101,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_320,"cf101, Piclidenoson",keratoconjunctivitis sicca,3,2015,not open yet,in trial,-,
1610,calcitonin salmon recombinant,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,ASH_Sep2016_321,calcitonin salmon recombinant,osteitis deformans,4,,-,approved,2005,
1611,calcitonin salmon recombinant,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,ASH_Sep2016_323,calcitonin salmon,postmenopausal osteoporosis,4,,-,approved,1978,
1612,calcitonin human,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,ASH_Sep2016_324,calcitonin human,parathyroid disease,4,,-,approved,1986,
1613,davalintide,protein,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,ASH_Sep2016_325,davalintide,Anti-obesity,2,2008,discontinued,in trial,-,
1614,telcagepant,small molecule,Peptide,antagonist,,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,ASH_Sep2016_326,telcagepant,Anti-migraine,3,2008,discontinued,in trial,-,
1615,ubrogepant,small molecule,Peptide,antagonist,,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,ASH_Sep2016_327,ubrogepant,Anti-migraine,3,2016,recruiting,in trial,-,
1616,davalintide,protein,Peptide,agonist,,secondary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,ASH_Sep2016_328,davalintide,Anti-obesity,2,2008,discontinued,in trial,-,
1617,rimegepant,small molecule,Peptide,antagonist,,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,ASH_Sep2016_329,rimegepant,Anti-migraine,2,2011,discontinued,in trial,-,
1618,nefazodone,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_33,nefazodone,unipolar depression,4,,-,approved,1994,
1619,emicerfont,small molecule,Peptide,antagonist,,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,ASH_Sep2016_330,emicerfont,irritable bowel syndrome,2,2007,discontinued,in trial,-,
1620,pexacerfont,small molecule,Peptide,antagonist,,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,ASH_Sep2016_331,pexacerfont,anxiety,3,2008,discontinued,in trial,-,
1621,dulaglutide,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,ASH_Sep2016_332,dulaglutide,Antidiabetic,4,,-,approved,2014,
1622,mk-0893,small molecule,Peptide,antagonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,ASH_Sep2016_333,mk-0893,Antidiabetic,2,2013,discontinued,in trial,-,
1623,glucagon,peptide,Peptide,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,ASH_Sep2016_334,glucagon hydrochloride recombinant,hypoglycemia,4,,-,approved,1998,
1624,decoglurant,small molecule,Amino acid ,NAM,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,ASH_Sep2016_336,decoglurant,unipolar depression,2,2011,discontinued,in trial,-,
1625,decoglurant,small molecule,Amino acid ,NAM,,primary,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,ASH_Sep2016_338,decoglurant,unipolar depression,2,2011,discontinued,in trial,-,
1626,dipraglurant,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,ASH_Sep2016_339,dipraglurant,Antiparkinson,2,2011,completed,in trial,-,
1627,thioridazine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_34,thioridazine,psychosis,4,,-,approved,1962,
1628,mavoglurant,small molecule,Amino acid ,antagonist,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,ASH_Sep2016_340,mavoglurant,obsessive-compulsive disorder,2,2016,recruiting,in trial,-,
1629,basimglurant,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,ASH_Sep2016_341,basimglurant,fragile x syndrome,2,2015,completed,in trial,-,
1630,glasdegib,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,ASH_Sep2016_343,glasdegib,Antineoplastic,2,2016,completed,in trial,-,
1631,tak-441,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,ASH_Sep2016_344,tak-441,basal cell carcinoma,1,2010,discontinued,in trial,-,
1632,abaloparatide,peptide,Peptide,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,ASH_Sep2016_345,"Abaloparatide, ITM-058, BA-058",Anti-osteoporotic,4,,-,approved,2017,
1633,methixene,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_35,methixene,Antiparkinson,4,,-,approved,1982,
1634,trifluoperazine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_36,trifluoperazine,psychosis,4,,-,approved,1959,
1635,trimipramine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_37,trimipramine,unipolar depression,4,,-,approved,1979,
1636,esmirtazapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_38,esmirtazapine,insomnia,3,2008,discontinued,in trial,-,
1637,vabicaserin,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_39,vabicaserin,schizophrenia,2,2008,discontinued,in trial,-,
1638,metoclopramide,small molecule,Aminergic ,antagonist,,secondary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_40,metoclopramide,pregnancy,4,,-,approved,1979,is this a completely different indication?
1639,naronapride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_41,naronapride,constipation,2,2009,completed,in trial,-,
1640,idalopirdine,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_42,idalopirdine,Alzheimer's disease,3,2014,recruiting,in trial,-,
1641,cerlapirdine,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_43,cerlapirdine,Alzheimer's disease,2,2009,discontinued,in trial,-,
1642,intepirdine,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_44,intepirdine,Alzheimer's disease,2,2016,recruiting,in trial,-,
1643,pf-05212377,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_45,pf-05212377,Alzheimer's disease,2,2012,terminated,in trial,-,Terminated not due to safety concerns - may still be viable drug to investigate
1644,ly2590443,small molecule,Aminergic ,antagonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_46,ly2590443,Anti-migraine,2,2008,discontinued,in trial,-,
1645,mepenzolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_47,mepenzolate,digestive system disease,4,,-,approved,1956,
1646,diphemanil,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_48,diphemanil,digestive system disease,4,,-,approved,1982,
1647,methixene,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_49,methixene,Antiparkinson,4,,-,approved,1982,
1648,gsk163090,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_5,gsk163090,unipolar depression,2,2009,discontinued,in trial,-,
1649,methscopolamine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_50,methscopolamine,cycloplegia,4,,-,approved,1953,
1650,isopropamide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_51,isopropamide,digestive system disease,4,,-,approved,1957,
1651,hexocyclium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_52,hexocyclium,digestive system disease,4,,-,approved,1982,
1652,fesoterodine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_53,fesoterodine,prostate adenocarcinoma,4,,-,approved,2007,
1653,darifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_54,darifenacin,overactive bladder,4,,-,approved,2004,
1654,propantheline,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_55,propantheline,digestive system disease,4,,-,approved,1953,
1655,batefenterol,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_56,batefenterol,chronic obstructive pulmonary disease (COPD),2,2015,completed,in trial,-,
1656,bethanechol,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_57,bethanechol,eosinophilic esophagitis,4,,-,approved,1948,
1657,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_58,"aripiprazole lauroxil, alks 9070",psychosis,4,,-,approved,2015,
1658,chlorpromazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_59,chlorpromazine,psychosis,4,,-,approved,1957,
1659,eletriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_6,eletriptan,Anti-migraine,4,,-,approved,2002,
1660,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_60,ergoloid,cardiovascular disease,4,,-,approved,1953,
1661,fluphenazine decanoate,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_61,fluphenazine decanoate,psychosis,4,,-,approved,1972,
1662,trimipramine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_62,trimipramine,unipolar depression,4,,-,approved,1979,
1663,levomepromazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_63,levomepromazine,psychosis,4,,-,approved,1982,Approved prior to 1982 and then discontinued
1664,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_64,amoxapine,unipolar depression,4,,-,approved,1980,
1665,haloperidol decanoate,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_65,haloperidol decanoate,psychosis,4,,-,approved,1986,
1666,fluphenazine enanthate,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_66,fluphenazine enanthate,psychosis,4,,-,approved,1967,
1667,thiothixene,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_67,thiothixene,psychosis,4,,-,approved,1967,
1668,acetylcholine,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_68,acetylcholine,Antiglaucomic,4,,-,approved,1973,
1669,propantheline,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_69,propantheline,digestive system disease,4,,-,approved,1953,
1670,ergoloid,small molecule,Aminergic ,agonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_7,ergoloid,cardiovascular disease,4,,-,approved,1953,
1671,tropicamide,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_70,tropicamide,myopia,4,,-,approved,1960,
1672,glycopyrrolate,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_71,glycopyrrolate,obstructive lung disease,4,,-,approved,1961,
1673,ipratropium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_72,ipratropium,chronic obstructive pulmonary disease (COPD),4,,-,approved,1986,
1674,cyclopentolate,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_73,cyclopentolate,cycloplegia,4,,-,approved,1974,
1675,isopropamide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_74,isopropamide,digestive system disease,4,,-,approved,1957,
1676,methscopolamine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_75,methscopolamine,digestive system disease,4,,-,approved,1953,
1677,oxyphenonium,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_76,oxyphenonium,digestive system disease,4,,-,approved,1982,
1678,dicyclomine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_77,dicyclomine,digestive system disease,4,,-,approved,1950,
1679,hexocyclium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_78,hexocyclium,digestive system disease,4,,-,approved,1982,
1680,mepenzolate,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_79,mepenzolate,digestive system disease,4,,-,approved,1956,
1681,gsk163090,small molecule,Aminergic ,antagonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_8,gsk163090,unipolar depression,2,2009,discontinued,in trial,-,
1682,carbachol,small molecule,Aminergic ,agonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_80,carbachol,Antiglaucomic,4,,-,approved,1972,
1683,methacholine,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_81,methacholine,Anti-Asthmatic,4,,-,approved,1986,
1684,batefenterol,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_82,batefenterol,chronic obstructive pulmonary disease (COPD),2,2016,completed,in trial,-,
1685,bethanechol,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_83,bethanechol,eosinophilic esophagitis,4,,-,approved,1948,
1686,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_84,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter
1687,tetrahydrozoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_85,tetrahydrozoline,eye allergy,4,,-,approved,1979,
1688,naphazoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_86,naphazoline,nasal obstruction,4,,-,approved,1971,
1689,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_87,ergotamine,Anti-migraine,4,,-,approved,1960,
1690,dipivefrin,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_88,dipivefrin,Antiglaucomic,4,,-,approved,1980,
1691,trimipramine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_89,trimipramine,unipolar depression,4,,-,approved,1979,
1692,gsk163090,small molecule,Aminergic ,antagonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_9,gsk163090,unipolar depression,2,2009,discontinued,in trial,-,
1693,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_90,mephentermine,cardiovascular disease,4,,-,approved,1951,
1694,carvedilol,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_91,carvedilol,Antihypertensive,4,,-,approved,1995,
1695,metaraminol,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_92,metaraminol,cardiovascular disease,4,,-,approved,1954,
1696,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_93,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter
1697,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_94,tetrahydrozoline,nasal obstruction,4,,-,approved,1979,
1698,phenoxybenzamine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_95,phenoxybenzamine,adrenal gland pheochromocytoma,4,,-,approved,1953,
1699,naphazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_96,naphazoline,nasal obstruction,4,,-,approved,1971,
1700,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_97,tolazoline,cardiovascular disease,4,,-,approved,1948,
1701,oxymetazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_98,oxymetazoline,Antiglaucomic,4,,-,approved,1986,
1702,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_99,ergotamine,Anti-migraine,4,,-,approved,1960,
1703,sb-269652,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMA_2017_002,sb-269652,antipsychotic,0,2000,unknown,preclinical,-,
1704,serelaxin,peptide,Peptide,agonist,,primary,RXFP1,rxfp1_human,Q9HBX9,Class A (Rhodopsin),GPCR;Rhodopsin,Relaxin receptors,not established,MMA_2017_003,"serelaxin, relaxin, RLX-030A, SUN-Y8002",Heart failure therapies,3,2014,completed,in trial,-,fda refused approval
1705,serelaxin,peptide,Peptide,agonist,,primary,RXFP2,rxfp2_human,Q8WXD0,Class A (Rhodopsin),GPCR;Rhodopsin,Relaxin receptors,not established,MMA_2017_005,"serelaxin, relaxin, RLX-030A, SUN-Y8002",Heart failure therapies,3,2014,completed,in trial,-,fda refused approval
1706,misoprostol,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMA_jun2017_001,misoprostol,hemorrhage,4,,-,approved,1988,
1707,cromolyn sodium,small molecule,Orphan ,agonist,,primary,GPR35,gpr35_human,Q9HC97,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,established,MMA_jun2017_010,cromolyn sodium,anti-allergenic,4,-,-,approved,2000,
1708,cer627,small molecule: combination,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,MMA2015_0071,cer627,Dyslipidemia with low HDL,1,2010,discontinued,in trial,-,
1709,cer627,small molecule: combination,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,MMA2015_0072,cer627,Dyslipidemia with low HDL,1,2010,discontinued,in trial,-,
1710,ljpc-501,peptide,Peptide,agonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMA2015_0090,athos-3,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),3,2015,completed,in trial,-,
1711,ljpc-501,peptide,Peptide,agonist,,primary,AGTR2,agtr2_human,P50052,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,not established,MMA2015_0091,athos-3,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),3,2015,completed,in trial,-,
1712,oxytocin,peptide,Peptide,agonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,MMA2016_0022,"opn-300, intranasal oxytocin",autism,4,,-,approved,1980,
1713,akp-11,small molecule,Lipid ,PAM,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMA2016_0028,akp-11,psoriasis,1,2016,completed,in trial,-,Australia
1714,min-202,small molecule,Peptide,antagonist,jnj-42847922,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,MMA2016_0029,"min-202, jnj-42847922",Anti-depressant and sleep disorder therapy,2,2015,completed,in trial,-,
1715,treprostinil,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMA2016_0038,"transcon treprostinil, subcutaneous injection",Antihypertensive,4,,-,approved,2002,
1716,treprostinil,small molecule,Nucleotide ,agonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,MMA2016_0040,"transcon treprostinil, subcutaneous injection",Antihypertensive,4,,-,approved,2002,
1717,verucerfont,small molecule,Peptide,antagonist,nbi-77860,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,MMA2016_0047,"verucerfont, nbi-77860, 561679",Congenital Adrenal Hyperplasia,2,2013,completed,in trial,-,
1718,pbf-999,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAapril2016_0022,pbf-999,Huntington's disease,1,2016,terminated,in trial,-,Terminated due to change in therapeutic indication
1719,obe001,small molecule,Peptide,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,MMAapril2016_0035,obe001,labor and delivery,3,2017,recruiting,in trial,-,
1720,re-021,small molecule,Peptide,antagonist,sparsentan,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMAapril2016_0044,"re-021, sparsentan",kidney disease; nephropathy,2,2012,completed,in trial,-,
1721,re-021,small molecule,Peptide,antagonist,sparsentan,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,MMAapril2016_0045,"re-021, sparsentan",kidney disease; nephropathy,2,2012,completed,in trial,-,
1722,etelcalcetide,peptide,Ion ,agonist,"amg 416,  velcalcetide,  kai-4169,  ono-5163",primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,MMAapril2016_0047,"etelcalcetide, amg 416, velcalcetide, kai-4169, ono-5163",parathyroid disorders,4,,-,approved,2017,new fda approval in Feb 2017
1723,pbf-509,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAapril2016_0077,pbf-509,Antineoplastic,2,2015,recruiting,in trial,-,
1724,srx-1177,peptide,Peptide,not available,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,MMAapril2016_0099,srx-1177,Antineoplastic,0,2015,not open yet,preclinical,-,
1725,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0100,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,completed,in trial,-,
1726,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0101,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,completed,in trial,-,
1727,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0102,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,completed,in trial,-,
1728,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0103,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,completed,in trial,-,
1729,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0104,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,completed,in trial,-,
1730,promethazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAapril2016_0105,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,completed,in trial,-,
1731,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0106,"cl-h1t, promethazine + sumatriptan",Anti-migraine,3,2013,completed,in trial,-,
1732,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0107,"cl-h1t, promethazine + sumatriptan",Anti-migraine,3,2013,completed,in trial,-,
1733,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0108,"cl-h1t, promethazine + sumatriptan",Anti-migraine,3,2013,completed,in trial,-,
1734,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0109,"cl-h1t, promethazine + sumatriptan",Anti-migraine,3,2013,completed,in trial,-,
1735,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0110,zp-triptan,Anti-migraine,3,2016,completed,in trial,-,
1736,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0111,zp-triptan,Anti-migraine,3,2016,completed,in trial,-,
1737,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0112,zp-triptan,Anti-migraine,3,2016,completed,in trial,-,
1738,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0113,zp-triptan,Anti-migraine,3,2016,completed,in trial,-,
1739,erenumab,antibody,Peptide,antagonist,amg 334,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,MMAapril2016_0116,"amg 334, Erenumab",Anti-migraine,3,2017,completed,in trial,-,
1740,trv734,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0140,trv734,Analgesics,1,2015,completed,in trial,-,
1741,dexmedetomidin,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAapril2016_0144,"dex-in, intranasal dexmedetomidin",Analgesics,4,,-,approved,1999,
1742,ccx872,small molecule,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAapril2016_0147,ccx872,Antineoplastic ; pancreatic cancer,1,2015,ongoing,in trial,-,
1743,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAapril2016_0157,"rayva, alprostadil + ddaip.hcl",Raynaud's Disease,2,2014,completed,in trial,-,
1744,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAapril2016_0158,"rayva, alprostadil + ddaip.hcl",Raynaud's Disease,2,2014,completed,in trial,-,
1745,hydrocodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0192,hydrocodone,Analgesics,4,,-,approved,1943,
1746,hydrocodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0193,hydrocodone,Analgesics,4,,-,approved,1943,
1747,int-767,small molecule,Steroid ,agonist,,primary,GPBAR1,gpbar_human,Q8TDU6,Class A (Rhodopsin),GPCR;Rhodopsin,Bile acid receptors,not established,MMAapril2016_0196,int-767,Treatment of liver fibrosis,1,2015,ongoing,in trial,-,Appears to be heading to phase 2 trials as of 2015
1748,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0197,jnp-010,overactive bladder,4,,-,approved,1975,
1749,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0198,jnp-010,overactive bladder,4,,-,approved,1975,
1750,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0199,jnp-010,overactive bladder,4,,-,approved,1975,
1751,min-001,small molecule,Aminergic ,agonist,cyr-101,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0202,"min-001,  cyr-101",schizophrenia,2,2009,completed,in trial,-,Can't find information if discontinued or not
1752,min-117,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0204,min-117,Anti-depressant,2,2016,completed,in trial,-,
1753,min-117,small molecule,Aminergic ,not available,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAapril2016_0206,min-117,Anti-depressant,2,2016,completed,in trial,-,
1754,min-117,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0206,min-117,Anti-depressant,2,2016,completed,in trial,-,
1755,min-117,small molecule,Aminergic ,not available,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAapril2016_0207,min-117,Anti-depressant,2,2016,completed,in trial,-,
1756,remd-477,antibody,Peptide,antagonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAapril2016_0214,remd-477,Antidiabetic,2,2017,recruiting,in trial,-,
1757,x4p-001,small molecule,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAapril2016_0220,x4p-001,Antineoplastic ; renal cell carcinoma,3,2016,recruiting,in trial,-,
1758,cf602,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAapril2016_0230,cf602,sexual dysfunction,1,2017,not open yet,in trial,-,
1759,lurasidone,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0233,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,
1760,lurasidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAapril2016_0234,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,
1761,lurasidone,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAapril2016_0235,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,
1762,lurasidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0236,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,
1763,lurasidone,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0237,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,
1764,hydromorphone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0260,"ltx-04,  hydromorphone hcl",Analgesics,1,2015,completed,in trial,-,
1765,hydromorphone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0261,"ltx-04,  hydromorphone hcl",Analgesics,1,2015,completed,in trial,-,
1766,hydromorphone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0262,"ltx-04,  hydromorphone hcl",Analgesics,1,2015,completed,in trial,-,
1767,mle4901,small molecule,Peptide,antagonist,azd4901,primary,TACR3,nk3r_human,P29371,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,not established,MMAapril2016_0263,"mle4901,  azd4901",for Polycystic Ovarian Syndrome,2,2016,ongoing,in trial,-,
1768,ryi-018,antibody,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0280,ryi-018,liver disease; nonalcoholic steatohepatitis,1,2017,not open yet,in trial,-,
1769,sens-111,small molecule,Aminergic ,antagonist,,primary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAapril2016_0282,sens-111,for vertigo and tinnitus,3,2017,recruiting,in trial,-,
1770,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAapril2016_0296,"zyn002, Topical cannabidiol gel",Anticonvulsants; Antiepileptics,0,2017,not open yet,preclinical,-,
1771,cannabidiol,small molecule,Lipid ,agonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0296,"zyn002, Topical cannabidiol gel",Anticonvulsants; Antiepileptics,0,2017,not open yet,preclinical,-,
1772,cannabidiol,small molecule,Lipid ,agonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0297,"zyn002, Topical cannabidiol gel",Anticonvulsants; Antiepileptics,0,2017,not open yet,preclinical,-,
1773,syn120,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0309,"syn120, Landipirdine",cognitive disorders,2,2014,completed,in trial,-,
1774,syn120,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0310,"syn120, Landipirdine",cognitive disorders,2,2014,completed,in trial,-,
1775,arry-502,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,MMAapril2016_0314,arry-502,Anti-Allergic,2,2012,completed,in trial,-,
1776,azp-531,peptide,Peptide,agonist,unacylated ghrelin,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,MMAapril2016_0315,"azp-531, unacylated ghrelin",Antidiabetic,1,2014,ongoing,in trial,-,
1777,cal-1,cell therapy,Protein,not available,autologous t cell and blood stem cell therapy,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAapril2016_0320,"cal-1, autologous t cell and blood stem cell therapy",antiviral ; HIV,2,2012,ongoing,in trial,-,
1778,glpg1205,small molecule,Orphan ,antagonist,,primary,GPR84,gpr84_human,Q9NQS5,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,MMAapril2016_0323,glpg1205,for ulcerative colitis; IBS,2,2015,completed,in trial,-,
1779,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAapril2016_0328,"epidiolex, oral liquid cannabidiol, gwp42003",schizophrenia,2,2013,completed,in trial,-,
1780,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0328,"epidiolex, oral liquid cannabidiol, gwp42003",schizophrenia,2,2013,completed,in trial,-,
1781,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0328,"epidiolex, oral liquid cannabidiol, gwp42003",schizophrenia,2,2013,completed,in trial,-,
1782,tetrahydrocannabivarin (thcv),small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0329,"gwp42004, Tetrahydrocannabivarin-9",Antidiabetic,2,2014,completed,in trial,-,
1783,tetrahydrocannabinol prodrug,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_001,"THC prodrug transdermal patch,ZYN001",neuropathic pain; fibromyalgia,0,2016,not open yet,preclinical,-,
1784,tetrahydrocannabinol prodrug,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_001,"THC prodrug transdermal patch,ZYN001",neuropathic pain; fibromyalgia,0,2016,not open yet,preclinical,-,
1785,tetrahydrocannabinol prodrug,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAaug2017_001,"THC prodrug transdermal patch,ZYN001",neuropathic pain; fibromyalgia,0,2016,not open yet,preclinical,-,
1786,vibegron,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAaug2017_002,"MK-4618, RVT-901",Urinary incontinence,2,2017,completed,in trial,,
1787,SEP-363856,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,MMAaug2017_003,SEP-363856,Antiparkinson; Schizophrenia; Psychosis,2,2016,completed,in trial,-,
1788,cannabidiol,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_004,"PTL101 capsules, purified CBD",epilepsy,2,2017,ongoing,in trial,-,
1789,SEP-363856,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAaug2017_004,SEP-363857,Antiparkinson; Schizophrenia; Psychosis,2,2016,completed,in trial,-,
1790,cannabidiol,small molecule,Lipid ,antagonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_005,"PTL101 capsules, purified CBD",epilepsy,2,2017,ongoing,in trial,-,
1791,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAaug2017_006,"PTL101 capsules, purified CBD",epilepsy,2,2017,ongoing,in trial,-,
1792,THC:CBD,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_007,"PTL 201, Cannabidiol/tetrahydrocannabinol",Multiple Sclerosis,2,2016,ongoing,in trial,-,
1793,THC:CBD,small molecule,Lipid ,antagonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_008,"PTL 201, Cannabidiol/tetrahydrocannabinol",Multiple Sclerosis,2,2016,ongoing,in trial,-,
1794,PTR-36,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,MMAaug2017_009,ADC3680B; PTR-36,Anti-Asthmatic,2,2017,ongoing,in trial,-,
1795,OBE2109,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,MMAaug2017_010,"OBE2109, KLH-2109",Endometriosis; Uterine fibroids,2,2017,ongoing,in trial,-,
1796,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAaug2017_011,apomorphine liquid formulation,Antiparkinson,1,2017,completed,in trial,-,
1797,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAaug2017_012,apomorphine liquid formulation,Antiparkinson,1,2017,completed,in trial,-,
1798,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAaug2017_013,apomorphine liquid formulation,Antiparkinson,1,2017,completed,in trial,-,
1799,MOR107,peptide,Peptide,agonist,,primary,AGTR2,agtr2_human,P50052,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,not established,MMAaug2017_015,"LP2, MOR107",Diabetic Kidney Disease,1,2017,ongoing,in trial,-,
1800,xanomeline + trospium chloride,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_016,"LY 246708, Trospium chloride/xanomeline tartrate",Schizophrenia; Alzheimer's disease,2,2017,ongoing,in trial,-,
1801,xanomeline + trospium chloride,small molecule,Aminergic ,agonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_017,"LY 246708, Trospium chloride/xanomeline tartrate",Schizophrenia; Alzheimer's disease,2,2017,ongoing,in trial,-,
1802,xanomeline + trospium chloride,small molecule,Aminergic ,agonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_018,"LY 246708, Trospium chloride/xanomeline tartrate",Schizophrenia; Alzheimer's disease,2,2017,ongoing,in trial,-,
1803,xanomeline + trospium chloride,small molecule,Aminergic ,agonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_019,"LY 246708, Trospium chloride/xanomeline tartrate",Schizophrenia; Alzheimer's disease,2,2017,ongoing,in trial,-,
1804,xanomeline + trospium chloride,small molecule,Aminergic ,agonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_020,"LY 246708, Trospium chloride/xanomeline tartrate",Schizophrenia; Alzheimer's disease,2,2017,ongoing,in trial,-,
1805,ACT-774312,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,MMAaug2017_022,ACT-774312,Anti-Allergic,1,2017,ongoing,in trial,-,
1806,ACT-541468,small molecule,Peptide,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,MMAaug2017_023,ACT-541468,insomnia,2,2017,ongoing,in trial,-,
1807,ACT-541468,small molecule,Peptide,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,MMAaug2017_024,ACT-541468,insomnia,2,2017,ongoing,in trial,-,
1808,ACT-539313,small molecule,Peptide,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,MMAaug2017_025,ACT-539313,Anti-anxiety,1,2017,ongoing,in trial,-,
1809,ACT-246475,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,MMAaug2017_026,ACT-246475,cardiovascular diseases; myocardial infarction,1,2017,completed,in trial,-,
1810,aprocitentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,MMAaug2017_027,aprocitentan,Hypertension,2,2017,completed,in trial,-,
1811,aprocitentan,small molecule,Peptide,antagonist,,primary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,MMAaug2017_028,aprocitentan,Hypertension,2,2017,completed,in trial,-,
1812,betahistine,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAaug2017_029,"betahistine dihydrochloride spray, AM-125",Dizzy/Fainting Spells,1,2017,ongoing,in trial,-,
1813,betahistine,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAaug2017_030,"betahistine dihydrochloride spray, AM-125",Dizzy/Fainting Spells,1,2017,ongoing,in trial,-,
1814,ATX2417,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,MMAaug2017_031,OC2417,Anti-Asthmatic,1,2017,completed,in trial,-,
1815,AZD8871,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAaug2017_032,AZD8871,Anti-Asthmatic,1,2017,completed,in trial,-,
1816,AZD8871,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_033,AZD8871,Anti-Asthmatic,1,2017,completed,in trial,-,
1817,AZD8871,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_034,AZD8871,Anti-Asthmatic,1,2017,completed,in trial,-,
1818,AZD8871,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_035,AZD8871,Anti-Asthmatic,1,2017,completed,in trial,-,
1819,AZD8871,small molecule,Aminergic ,agonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_036,AZD8871,Anti-Asthmatic,1,2017,completed,in trial,-,
1820,AZD8871,small molecule,Aminergic ,agonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_037,AZD8871,Anti-Asthmatic,1,2017,completed,in trial,-,
1821,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAaug2017_038,CBD,Graft Versus Host Disease,2,2017,completed,in trial,-,
1822,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_039,CBD,Graft Versus Host Disease,2,2017,completed,in trial,-,
1823,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_040,CBD,Graft Versus Host Disease,2,2017,completed,in trial,-,
1824,BTX-1503,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_041,BTX 1204; BTX 1308; BTX 1503; BTX1204,Skin disorder therapies,1,2017,ongoing,in trial,-,
1825,BTX-1503,small molecule,Lipid ,antagonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_042,BTX 1204; BTX 1308; BTX 1503; BTX1204,Skin disorder therapies,1,2017,ongoing,in trial,-,
1826,cenerimod,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMAaug2017_043,Cenerimod,Systemic Lupus Erythematosus,2,2017,ongoing,in trial,-,
1827,CNTX-6970,small molecule,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAaug2017_044,CNTX-6970,Analgesics,1,2017,completed,in trial,-,
1828,CNTX-6016,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_045,CNTX-6016,Analgesics,0,2017,not open yet,preclinical,-,
1829,CNTX-0290,small molecule,Peptide,agonist,,primary,SSTR4,ssr4_human,P31391,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAaug2017_046,CNTX-0290,Analgesics,1,2017,completed,in trial,-,
1830,DP1038,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAaug2017_047,"DP1038, intranasal octreotide acetate",growth hormone deficiency,1,2017,completed,in trial,-,
1831,DP1039,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAaug2017_048,"DP1038, intranasal octreotide acetate",growth hormone deficiency,1,2017,completed,in trial,-,
1832,DP1040,peptide,Peptide,agonist,,primary,SSTR3,ssr3_human,P32745,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAaug2017_049,"DP1038, intranasal octreotide acetate",growth hormone deficiency,1,2017,completed,in trial,-,
1833,DP1041,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAaug2017_050,"DP1038, intranasal octreotide acetate",growth hormone deficiency,1,2017,completed,in trial,-,
1834,gc021109,small molecule,Nucleotide ,agonist,,primary,P2RY6,p2ry6_human,Q15077,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,MMAfeb2016_0055,gc021109,Alzheimer's disease,1,2015,completed,in trial,-,
1835,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAfeb2016_0059,"roclatan, rhopressa + latanoprost",Antiglaucomic,3,2017,completed,in trial,-,
1836,cerc-501,small molecule,Peptide,antagonist,ly2456302,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0074,"cerc-501, ly2456302",Substance use disorders,2,2016,recruiting,in trial,-,
1837,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0084,eli-200,addiction,4,,-,approved,2016,
1838,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0085,eli-200,addiction,4,,-,approved,2016,
1839,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0086,eli-200,addiction,4,,-,approved,2016,
1840,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0087,eli-200,Analgesics,4,,-,approved,2016,
1841,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0088,eli-200,Analgesics,4,,-,approved,2016,
1842,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0089,eli-200,Analgesics,4,,-,approved,2016,
1843,drm04,small molecule,Aminergic ,antagonist,anticholinergic,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAfeb2016_0095,"drm04, anticholinergic",hyperhidrosis,3,2015,completed,in trial,-,
1844,mogamulizumab,antibody,Protein,antagonist,,primary,CCR4,ccr4_human,P51679,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAjun2016_0001,mogamulizumab,Antineoplastic,3,2012,ongoing,in trial,-,
1845,mogamulizumab,antibody,Protein,antagonist,,primary,CCR4,ccr4_human,P51679,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAjun2016_0001,mogamulizumab,Antineoplastic,3,2012,ongoing,in trial,-,
1846,ridogrelum,small molecule,Lipid ,antagonist,,primary,TBXA2R,ta2r_human,P21731,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAjun2016_0002,ridogrel,for the prevention of systemic thrombo-embolism; adjunctive  to thrombolytic therapy,4,,-,approved,-,
1847,api246,small molecule,Peptide,antagonist,srx246,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,MMAjun2016_0005,"api246,  srx246",Treatment of affective and anger disorders,2,2016,completed,in trial,-,
1848,boxaban,small molecule,Lipid ,antagonist,"hepatoren,  vasculan,  ifetroban",primary,TBXA2R,ta2r_human,P21731,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAjun2016_0011,"boxaban, hepatoren, vasculan, ifetroban",Treatment of asystemic scleroderma; hepatorenal syndrome; asthma,2,2017,not open yet,in trial,-,
1849,exendin (9-39) ,peptide,Peptide,antagonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAjun2016_0019,exendin (9-39) ,hypoglycemia,2,2016,recruiting,in trial,-,Appears pause in research from 2009-2016
1850,apelin,peptide,Peptide,not available,,primary,APLNR,apj_human,P35414,Class A (Rhodopsin),GPCR;Rhodopsin,Apelin receptors,not established,MMAjun2016_0045,apelin,Cardiovascular disorders; Insulin sensitivity,1,2013,completed,in trial,-,ligand
1851,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmar2016_0004,p2b001,Antiparkinson,3,2016,ongoing,in trial,-,
1852,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmar2016_0005,p2b001,Antiparkinson,3,2016,ongoing,in trial,-,
1853,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmar2016_0006,p2b001,Antiparkinson,3,2016,ongoing,in trial,-,
1854,hydrocodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0009,"hysingla er, hydrocodone bitartrate extended release",Analgesics,4,,-,approved,1943,
1855,hydrocodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0010,"hysingla er, hydrocodone bitartrate extended release",Analgesics,4,,-,approved,1943,
1856,isometheptene,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmar2016_0022,"tnx-201, single isomer isometheptene, imh",Anti-migraine,4,,-,approved,1962,
1857,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0045,"butab, rel-1028, oral, enteric-coated buprenorphine",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
1858,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0047,"butab, rel-1028, oral, enteric-coated buprenorphine",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
1859,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0055,"egalet-001, reformulated morphine",Analgesics; opioid addiction,4,,-,approved,1984,
1860,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0056,"egalet-001, reformulated morphine",Analgesics; opioid addiction,4,,-,approved,1984,
1861,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0057,"egalet-001, reformulated morphine",Analgesics; opioid addiction,4,,-,approved,1984,
1862,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0078,"rexista, oxycodone xr",Analgesics,3,2016,completed,in trial,-,waiting for new FDA approval
1863,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0079,"rexista, oxycodone xr",Analgesics,3,2016,completed,in trial,-,waiting for new FDA approval
1864,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0080,"rexista, oxycodone xr",Analgesics,3,2016,completed,in trial,-,waiting for new FDA approval
1865,hydrocodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0081,"s-718632, extended release hydrocodone",Analgesics,4,,-,approved,1943,
1866,hydrocodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0082,"s-718632, extended release hydrocodone",Analgesics,4,,-,approved,1943,
1867,eltoprazine,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0086,eltoprazine,dyskinesias,2,2015,ongoing,in trial,-,
1868,eltoprazine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0087,eltoprazine,dyskinesias,2,2015,ongoing,in trial,-,
1869,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0088,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",Analgesics,4,,-,approved,1971,
1870,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0089,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",Analgesics,4,,-,approved,1971,
1871,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0090,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",Analgesics,4,,-,approved,1971,
1872,suvn-g3031,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmar2016_0093,suvn-g3031,Alzheimer's disease,1,2016,recruiting,in trial,-,
1873,suvn-d4010,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0094,suvn-d4010,Alzheimer's disease,1,2017,recruiting,in trial,-,
1874,rvt-101,small molecule,Aminergic ,antagonist,"sb-742457,  gsk 742457",primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0106,"rvt-101, sb-742457, gsk 742457",Alzheimer's disease,3,2015,ongoing,in trial,-,
1875,pbf-680,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAmar2016_0115,pbf-680,Anti-Asthmatic,2,2015,recruiting,in trial,-,
1876,am1030,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0116,am1030,Anti-inflammatory ; atopic dermatitis,2,2015,completed,in trial,-,
1877,zpl-389,small molecule,Aminergic ,antagonist,zpl-3893787,primary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmar2016_0120,"zpl-389, zpl-3893787",Anti-inflammatory ; atopic dermatitis,2,2015,completed,in trial,-,
1878,fasoracetam monohydrate,small molecule,Amino acid ,not available,,secondary,GRM1,grm1_human,Q13255,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0121,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,
1879,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,MMAmar2016_0122,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,
1880,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0123,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,
1881,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM7,grm7_human,Q14831,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0124,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,
1882,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0125,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,
1883,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM4,grm4_human,Q14833,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0125,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,
1884,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM6,grm6_human,O15303,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0125,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,
1885,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM8,grm8_human,O00222,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0125,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,
1886,cpb-307,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMAmar2016_0127,cpb-307,autoimmune diseases,1,2014,completed,in trial,-,
1887,cromolyn sodium,small molecule,Orphan ,agonist,,primary,GPR35,gpr35_human,Q9HC97,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,established,MMAmar2016_0133,pa101b,autoimmune diseases,2,2016,completed,in trial,-,
1888,itraconazole,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,MMAmar2016_0140,suba-itraconazole,Antineoplastic,4,,-,approved,1992,
1889,q-122,small molecule,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAmar2016_0157,q-122,Anti-inflammatory ; hot flashes,1,2014,completed,in trial,-,
1890,taladegib,small molecule,Protein,antagonist,ly2940680,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,MMAmar2016_0177,"taladegib, ly2940680",Antineoplastic,2,2015,recruiting,in trial,-,
1891,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmar2016_0193,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",chronic obstructive pulmonary disease (COPD),3,2016,ongoing,in trial,-,
1892,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmar2016_0194,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",chronic obstructive pulmonary disease (COPD),3,2016,ongoing,in trial,-,
1893,vilanterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmar2016_0195,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",chronic obstructive pulmonary disease (COPD),3,2016,ongoing,in trial,-,
1894,npsp795,small molecule,Ion ,antagonist,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,MMAmar2016_0202,npsp795,hypocalcaemia,2,2014,completed,in trial,-,
1895,mt-1303,small molecule,Lipid ,antagonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMAmar2016_0211,mt-1303,autoimmune diseases; Multiple Sclerosis; Crohn's disease,2,2015,ongoing,in trial,-,
1896,nelotanserin,small molecule,Aminergic ,inverse agonist,apd-125,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0233,"nelotanserin, apd-125",dementia; Parkinson's disease,2,2016,recruiting,in trial,-,
1897,glucagon,peptide,Peptide,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmar2016_0239,zp-glucagon,Antidiabetic,4,,-,approved,1960,
1898,efpeglenatide,peptide,Peptide,agonist,hm11260c,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmar2016_0245,"efpeglenatide, hm11260c",Antidiabetic,2,2014,completed,in trial,-,
1899,ttp273,small molecule,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmar2016_0255,ttp273,Antidiabetic,2,2016,completed,in trial,-,
1900,lixisenatide,small molecule,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmar2016_0257,"lixilan, lantus (basal insulin) + lyxumia (lixisenatide)",Antidiabetic,4,,-,approved,2016,
1901,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAmar2016_0268,cannabidiol,epilepsy,3,2016,not open yet,in trial,-,
1902,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmar2016_0268,cannabidiol,epilepsy,3,2016,not open yet,in trial,-,
1903,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmar2016_0269,cannabidiol,epilepsy,3,2016,not open yet,in trial,-,
1904,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmar2016_0270,"epidiolex, oral liquid cannabidiol, gwp42003",epilepsy,3,2016,recruiting,in trial,-,
1905,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAmar2016_0271,"epidiolex, oral liquid cannabidiol, gwp42003",epilepsy,3,2016,recruiting,in trial,-,
1906,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmar2016_0271,"epidiolex, oral liquid cannabidiol, gwp42003",epilepsy,3,2016,recruiting,in trial,-,
1907,fenfluramine,small molecule,Aminergic ,agonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0273,"zx008, brabafen, low-dose fenfluramine",epilepsy; Dravet's syndrome,3,2016,recruiting,in trial,-,
1908,fenfluramine,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0274,"zx008, brabafen, low-dose fenfluramine",epilepsy; Dravet's syndrome,3,2016,recruiting,in trial,-,
1909,cosyntropin,peptide,Peptide,agonist,,primary,MC2R,acthr_human,Q01718,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,established,MMAmar2016_0275,"re-034, cosyntropin, tetracosactid",epilepsy,0,2016,ongoing,preclinical,-,
1910,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmar2016_0296,"helios insert, bimatoprost ocular insert",Antiglaucomic,2,2016,completed,in trial,-,
1911,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmar2016_0297,"helios insert, bimatoprost ocular insert",Antiglaucomic,2,2016,completed,in trial,-,
1912,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmar2016_0298,"helios insert, bimatoprost ocular insert",Antiglaucomic,2,2016,completed,in trial,-,
1913,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0039,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,
1914,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0040,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,
1915,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0041,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,
1916,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0042,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,
1917,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0043,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,
1918,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0044,aclidinium,Anti-Asthmatic ; COPD,4,,-,approved,2001,
1919,am-831,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0047,am-831,Antipsychotic ; schizophrenia,1,2011,discontinued,in trial,-,
1920,am-831,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0048,am-831,Antipsychotic ; schizophrenia,1,2011,discontinued,in trial,-,
1921,am-831,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0049,am-831,Antipsychotic ; schizophrenia,1,2011,discontinued,in trial,-,
1922,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0071,"pxt3003, baclofen + naltrexone + sorbitol",for type 1A Charcot-Marie-Tooth disease,3,2016,recruiting,in trial,-,
1923,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0072,"pxt3003, baclofen + naltrexone + sorbitol",for type 1A Charcot-Marie-Tooth disease,3,2016,recruiting,in trial,-,
1924,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0073,"pxt3003, baclofen + naltrexone + sorbitol",Analgesics; for type 1A Charcot-Marie-Tooth disease,4,,-,approved,1998,
1925,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0074,"pxt3003, baclofen + naltrexone + sorbitol",Analgesics; for type 1A Charcot-Marie-Tooth disease,4,,-,approved,1998,
1926,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0075,"pxt3003, baclofen + naltrexone + sorbitol",Analgesics; for type 1A Charcot-Marie-Tooth disease,4,,-,approved,1998,
1927,macimorelin,peptide,Peptide,agonist,aezs-130,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,MMAmay2016_0080,"macimorelin,  aezs-130","growth hormone deficiency, cancer cachexia",3,2015,completed,in trial,-,Applied for fda approval in 2013 and rejected in 2014
1928,td-4208,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0081,"td-4208, Revefenacin",chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,
1929,cyclobenzaprine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0082,tnx-102,"fibromyalgia, PTSD",3,2017,recruiting,in trial,-,
1930,levodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0101,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,
1931,levodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0102,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,
1932,levodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0103,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,
1933,levodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0104,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,
1934,levodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0105,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,
1935,alfentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0108,"ox51,  sublingual alfentanil",Analgesics,4,,-,approved,1986,
1936,ttp054,small molecule,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0113,ttp054,Antidiabetic,2,2012,discontinued,in trial,-,
1937,glpg0974,small molecule,Lipid ,antagonist,,primary,FFAR2,ffar2_human,O15552,Class A (Rhodopsin),GPCR;Rhodopsin,Free fatty acid receptors,not established,MMAmay2016_0156,glpg0974,Anti-inflammatory ; neutrophil driven inflammation; ulcerative colitis,2,2013,completed,in trial,-,
1938,ro4917523,small molecule,Amino acid ,antagonist,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,MMAmay2016_0177,ro4917523,"Major depressive disorder, Fragile X syndrome",2,2012,discontinued,in trial,-,discontinued due to negative results
1939,alks 33,small molecule,Peptide,antagonist,samidorphan,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0184,"alks 3831,  olanzapine + alks 33,samidorphan",Anti-obesity,3,2016,recruiting,in trial,-,
1940,alks 33,small molecule,Peptide,antagonist,samidorphan,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0184,"alks 3831,  olanzapine + alks 33,samidorphan",Anti-obesity,3,2016,recruiting,in trial,-,
1941,alks 33,small molecule,Peptide,antagonist,samidorphan,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0184,"alks 3831,  olanzapine + alks 33,samidorphan",Anti-obesity,3,2016,recruiting,in trial,-,
1942,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0185,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1943,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0186,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1944,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0187,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1945,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0188,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1946,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0189,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1947,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0190,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1948,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0191,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1949,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0192,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1950,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0193,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1951,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0194,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1952,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0195,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1953,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0196,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1954,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0197,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1955,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0198,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1956,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0199,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1957,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0200,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1958,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0201,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1959,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0202,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1960,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0203,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1961,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0204,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1962,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0205,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1963,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0206,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1964,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0207,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1965,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0209,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1966,ccx507,small molecule,Protein,antagonist,,primary,CCR9,ccr9_human,P51686,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAmay2016_0216,ccx507,ulcerative colitis; inflammatory bowel disease,1,2014,completed,in trial,-,
1967,inv102,small molecule,Aminergic ,inverse agonist,nadolol,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0225,"inv102, nadolol",for inflammatory lung disease,2,2013,ongoing,in trial,-,
1968,rm-493,peptide,Peptide,agonist,setmelanotide,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,MMAmay2016_0229,"rm-493, setmelanotide",Anti-obesity,3,2017,recruiting,in trial,-,
1969,amantadine hcl,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0242,"ads-5102, amantadine hcl extended release",dyskinesias,4,,-,approved,1968,
1970,adx71441,small molecule,Amino acid ,PAM,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0243,adx71441,neurologic disorders,0,2017,not open yet,preclinical,-,
1971,adx71441,small molecule,Amino acid ,PAM,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0244,adx71441,neurologic disorders,0,2017,not open yet,preclinical,-,
1972,alx- 0651,antibody,Protein,antagonist,biparatopic nanobody,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAmay2016_0267,"alx- 0651, biparatopic nanobody",Antineoplastic,1,2011,terminated,in trial,-,
1973,apd334,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMAmay2016_0282,apd334,for autoimmune disorders,2,2015,recruiting,in trial,-,
1974,apd811,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0283,apd811,Antihypertensive,2,2014,ongoing,in trial,-,
1975,azd2820,small molecule,Peptide,agonist,,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,MMAmay2016_0297,azd2820,Anti-obesity,1,2011,discontinued,in trial,-,
1976,bci-838,small molecule,Amino acid ,antagonist,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmay2016_0306,bci-838,Anti-depressant,1,2012,completed,in trial,-,No development reported
1977,bci-838,small molecule,Amino acid ,antagonist,,primary,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmay2016_0307,bci-838,Anti-depressant,1,2012,completed,in trial,-,No development reported
1978,cis-uca eye drops,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0333,cis-uca eye drops,for ocular surface inflammation,2,2014,completed,in trial,-,
1979,amphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,MMAmay2016_0357,d-amphetamine transdermal system (d-ats),cognitive dysfunction; ADHD,2,2012,completed,in trial,-,
1980,azilsartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMAmay2016_0371,"edarbyclor, azilsartan medoxomil + chlorthalidone",Antihypertensive,4,,-,approved,2011,
1981,ema401,small molecule,Peptide,antagonist,,primary,AGTR2,agtr2_human,P50052,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,not established,MMAmay2016_0377,ema401,peripheral neuropathic pain; post herpetic neuralgia,2,2017,not open yet,in trial,-,
1982,glycopyrrolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0378,ep-101,chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,
1983,cannabidivarin,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmay2016_0402,"gwp42006, Cannabidivarin",epilepsy,2,2015,recruiting,in trial,-,
1984,cannabidivarin,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAmay2016_0403,"gwp42006, Cannabidivarin",epilepsy,2,2015,recruiting,in trial,-,
1985,cannabidivarin,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmay2016_0403,"gwp42006, Cannabidivarin",epilepsy,2,2015,recruiting,in trial,-,
1986,iferanserin,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0414,"iferanserin ointment, ven 309",Antihemorrhoidal,3,2011,discontinued,in trial,-,
1987,losartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMAmay2016_0431,inv-144,Antihypertensive ; for Diabetic neuropathy,4,,-,approved,1995,
1988,lgd-6972,small molecule,Peptide,antagonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0453,lgd-6972,Antidiabetic,2,2016,recruiting,in trial,-,
1989,bupropion/trazodone,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0460,"lorexys, sip-104, bupropion/trazodone",Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,2,2014,completed,in trial,-,
1990,bupropion/trazodone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0461,"lorexys, sip-104, bupropion/trazodone",Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,2,2014,completed,in trial,-,
1991,bupropion/trazodone,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0462,"lorexys, sip-104, bupropion/trazodone",Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,2,2014,completed,in trial,-,
1992,mg01ci,small molecule,Aminergic ,antagonist,extended-release metadoxine,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0480,"mg01ci, extended-release metadoxine,",neurologic disorders; ADHD,3,2015,terminated,in trial,-,FDA clinical hold
1993,netupitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,MMAmay2016_0499,netupitant + palonosetron,Antiemetics,4,,-,approved,2014,
1994,opa-6566,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAmay2016_0512,opa-6566,Antiglaucomic,2,2011,completed,in trial,-,
1995,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0514,"ox219, buprenorphine + naloxone sublingual tablet",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
1996,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0516,"ox219, buprenorphine + naloxone sublingual tablet",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
1997,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0517,"ox219, buprenorphine + naloxone sublingual tablet",Analgesics; opioid addiction,4,,-,approved,1971,
1998,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0518,"ox219, buprenorphine + naloxone sublingual tablet",Analgesics; opioid addiction,4,,-,approved,1971,
1999,pdc31,peptide,Lipid ,antagonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0526,pdc31,pre-term labor; dysmenorrhea,1,2010,completed,in trial,-,
2000,reparixin,small molecule,Protein,antagonist,,primary,CXCR1,cxcr1_human,P25024,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAmay2016_0551,reparixin,Antidiabetic; type I diabetes,3,2013,ongoing,in trial,-,
2001,reparixin,small molecule,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAmay2016_0552,reparixin,Antidiabetic; type I diabetes,3,2013,ongoing,in trial,-,
2002,semaglutide,peptide,Peptide,agonist,nn9535,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0563,"semaglutide, nn9535 ",Antidiabetic,3,2017,recruiting,in trial,-,
2003,t111,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAmay2016_0579,"t111, Nalbuphine extended release",pruritus,3,2014,ongoing,in trial,-,
2004,tak-875,small molecule,Lipid ,agonist,fasiglifam,primary,FFAR1,ffar1_human,O14842,Class A (Rhodopsin),GPCR;Rhodopsin,Free fatty acid receptors,not established,MMAmay2016_0580,"tak-875, fasiglifam",Antidiabetic,3,2013,discontinued,in trial,-,discontinued due to concerns about liver safety
2005,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0589,tiotropium + olodaterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2004,
2006,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0590,tiotropium + olodaterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2004,
2007,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0591,tiotropium + olodaterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2004,
2008,olodaterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0592,tiotropium + olodaterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2014,
2009,cimetidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0601,"tl-118, hamsa-1, cyclophosphamide + diclofenac + sulfasalazine + cimetidine",Antihistamines,4,,-,approved,1977,
2010,trv130,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0607,"trv130, Oliceridine",Analgesics; post-operative pain,3,2016,recruiting,in trial,-,
2011,tt-401,peptide,Peptide,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0612,"tt-401, Pegapamodutide, LY2944876",Antidiabetic,2,2014,completed,in trial,-,
2012,tt-401,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0613,"tt-401, Pegapamodutide, LY2944876",Antidiabetic,2,2014,completed,in trial,-,
2013,txa127,peptide,Orphan ,agonist,angiotensin(1-7),primary,MAS1,mas_human,P04201,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,MMAmay2016_0617,"txa127, angiotensin (1-7)",for stem cell engraftment and thrombocytopenia,2,2012,discontinued,in trial,-,
2014,txa127,peptide,Orphan ,agonist,angiotensin(1-7),primary,MAS1,mas_human,P04201,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,MMAmay2016_0617,"txa127, angiotensin (1-7)","Non-HodgkinHodgkin Disease, Multiple Myeloma",2,2016,ongoing,in trial,-,
2015,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0618,umeclidinium + vilanterol,Bronchodilator ; COPD,4,,-,approved,2013,
2016,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0618,umeclidinium + vilanterol,Bronchodilator ; COPD,4,,-,approved,2013,
2017,vilanterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0619,umeclidinium bromide (gsk573719) + vilanterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2013,
2018,vasomera,peptide,Peptide,antagonist,pb1046,primary,VIPR2,vipr2_human,P41587,Class B1 (Secretin),GPCR;Rhodopsin,VIP and PACAP receptors,not established,MMAmay2016_0630,"vasomera, pb1046",Antihypertensive,2,2016,recruiting,in trial,-,
2019,vpd-737,small molecule,Peptide,antagonist,serlopitant,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,MMAmay2016_0635,"vpd-737, serlopitant",pruritus,2,2016,recruiting,in trial,-,
2020,ykp10811,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0641,ykp10811,for chronic or functional constipation,2,2014,completed,in trial,-,
2021,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0645,"naloxone nasal spray, indivior",Analgesics; overdose/drug toxicity,4,,-,approved,1971,
2022,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0646,"naloxone nasal spray, indivior",Analgesics; overdose/drug toxicity,4,,-,approved,1971,
2023,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0647,"naloxone nasal spray, indivior",Analgesics; overdose/drug toxicity,4,,-,approved,1971,
2024,amphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,MMAmay2016_0658,"hld-100, reformulated amphetamine",cognitive dysfunction; ADHD,2,2017,ongoing,in trial,-,
2025,doxylamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0669,diclectin + diclegis; doxylamine succinate + pyridoxine hydrochloride dr tablets,Antihistamine; for nausea and vomiting of pregnancy,4,,-,approved,1948,
2026,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0676,e-58425,Analgesics,3,2017,recruiting,in trial,-,
2027,tramadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0678,e-58425,Analgesics,3,2017,recruiting,in trial,-,
2028,tramadol,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0679,e-58425,Analgesics,3,2017,recruiting,in trial,-,
2029,oc459,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,MMAmay2016_0684,oc459,for allergic rhinitis,2,2016,recruiting,in trial,-,
2030,asm-024,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0687,asm-024,Anti-Asthmatic ; COPD,2,2015,completed,in trial,-,
2031,amisulpride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0704,"apd403, apd421",Antiemetics,3,2013,completed,in trial,-,
2032,amisulpride,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0705,"apd403, apd421",Antiemetics,3,2013,completed,in trial,-,
2033,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0706,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,
2034,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0707,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,
2035,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0708,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,
2036,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0709,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,
2037,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0710,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,
2038,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0711,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,
2039,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0713,"incruse ellipta,  umeclidinium bromide",chronic obstructive pulmonary disease (COPD),4,,-,approved,2013,
2040,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0714,"incruse ellipta,  umeclidinium bromide",chronic obstructive pulmonary disease (COPD),4,,-,approved,2013,
2041,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0719,"eye-d, controlled-release latanoprost insert",Antiglaucomic,1,2014,completed,in trial,-,
2042,ser100,small molecule,Peptide,agonist,,primary,OPRL1,oprx_human,P41146,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,not established,MMAmay2016_0735,ser100,Antihypertensive,2,2013,completed,in trial,-,
2043,follitropin,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,MMAmay2016_0738,"bemfola, afolia recombinant follicle stimulating hormone",Fertility,4,,-,approved,1997,
2044,valsartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMAmay2016_0742,sacubitril + valsartan,Antihypertensive,4,,-,approved,2012,
2045,parathyroid hormone,protein,Peptide,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,MMAmay2016_0745,"natpara, npsp558, parathyroid horomone",Control hypocalcemia,4,,-,approved,2015,
2046,p2045,peptide,Peptide,agonist,188re-p2045,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAmay2016_0746,"p2045, 188re-p2045",Antineoplastic,1,2014,withdrawn,in trial,-,Withdrawn due to PI left study institution; had 10 year break in research
2047,selexipag,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0747,selixipag,Antihypertensive,4,,-,approved,2015,
2048,hydrocodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0753,hydrocodone bitartrate with acetaminophen,Analgesics,4,,-,approved,1943,
2049,rolapitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,MMAmay2016_0753,"sch 619734, rolapitant",Antiemetics,4,,-,approved,2015,
2050,hydrocodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0754,hydrocodone bitartrate with acetaminophen,Analgesics,4,,-,approved,1943,
2051,teriparatide,peptide,Peptide,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,MMAmay2016_0763,"cp046, intranasal teriparatide",Anti-osteoporotic,4,,-,approved,1987,
2052,v81444,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAmay2016_0766,"v81444, CPI 444",Antiparkinson,2,2014,completed,in trial,-,
2053,deuterium containing analog of sodium oxybate,small molecule,Amino acid ,agonist,gamma hydroxybutyric acid,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0771,jzp-386,sleep disorders; narcolepsy,1,2014,completed,in trial,-,
2054,deuterium containing analog of sodium oxybate,small molecule,Amino acid ,agonist,gamma hydroxybutyric acid,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0773,jzp-386,sleep disorders; narcolepsy,1,2014,completed,in trial,-,
2055,vilanterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0779,fluticasone furoate and vilanterol inhalation powder,chronic obstructive pulmonary disease (COPD),4,,-,approved,2013,
2056,mirabegron,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0790,"ym178, mirabegron",incontinence,4,,-,approved,2012,
2057,tafluprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0794,"taflotan, tapros, zioptan, tafluprost, saflutan, de-085, mk-2452",Reduce intraocular pressure,4,,-,approved,2012,
2058,vsn16r,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAmay2016_0803,vsn16r,Antispasmodics;  for spatisity related to multiple sclerosis,2,2015,recruiting,in trial,-,
2059,sofpironium bromide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0805,bbi-4000,Anticholinergics; for thetopical treatment of primary axillary hyperhidrosis,2,2017,recruiting,in trial,-,
2060,liraglutide,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0808,"ideglira,  insulin degludec + liraglutide,  nn-9068",Antidiabetic,4,,-,approved,2009,
2061,mod-6031,peptide,Peptide,agonist,long-acting oxyntomodulin,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0898,"mod-6031, long-acting oxyntomodulin",Antidiabetic ; Anti-obesity,1,2016,recruiting,in trial,-,
2062,mod-6031,peptide,Peptide,agonist,long-acting oxyntomodulin,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0899,"mod-6031, long-acting oxyntomodulin",Antidiabetic ; Anti-obesity,1,2016,recruiting,in trial,-,
2063,pxt002331,small molecule,Amino acid ,PAM,,primary,GRM4,grm4_human,Q14833,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmay2016_0906,pxt002331,Antiparkinson,1,2015,completed,in trial,-,
2064,betahistine,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0919,betahistine,vertigo,4,,-,approved,1970,
2065,betahistine,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0920,betahistine,vertigo,4,,-,approved,1970,
2066,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0921,"ox219, buprenorphine + naloxone sublingual tablet",Analgesics; opioid addiction,4,,-,approved,1971,
2067,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2017_001,baclofen,anti-spastic,4,,-,approved,1977,
2068,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2017_001,baclofen,anti-spastic,4,,-,approved,1977,
2069,acebutolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD001,-,Antihypertensive,4,,-,approved,1984,
2070,aceprometazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD003,-,Hypnotics and Sedatives,4,,-,approved,-,Withdrawn in EU - not sure if ever in trials in US
2071,acetophenazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD006,-,schizophrenia,4,,-,approved,1961,
2072,acetophenazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD006,-,schizophrenia,4,,-,approved,1961,
2073,alcaftadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD011,-,Anti-Allergic,4,,-,approved,2010,
2074,alfentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD015,-,Analgesics,4,,-,approved,1986,
2075,alprenolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD019,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1966,"No longer marketed, but may still be available"
2076,alprenolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD019,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1966,"No longer marketed, but may still be available"
2077,alvimopan,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD021,-,Opiate Antagonists,4,,-,approved,2008,
2078,anileridine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD027,-,Analgesics; Narcotics,4,,-,approved,1982,
2079,anisotropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD029,-,Antispasmodics; Anti-ulcer,4,,-,approved,1982,
2080,anisotropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD029,-,Antispasmodics; Anti-ulcer,4,,-,approved,1982,
2081,anisotropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD029,-,Antispasmodics; Anti-ulcer,4,,-,approved,1982,
2082,apraclonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD032,-,Antiglaucomic,4,,-,approved,1987,
2083,arbutamine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD034,-,Cardiotonic,4,,-,approved,1997,
2084,arformoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD036,-,Bronchodilator,4,,-,approved,2006,
2085,astemizole,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD037,-,Anti-Allergic,4,,-,approved,1988,
2086,atenolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD038,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1981,
2087,azatadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD041,-,Anti-Allergic,4,,-,approved,1977,
2088,benzphetamine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD046,-,Central Nervous System Stimulants,4,,-,approved,1960,
2089,benzphetamine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD046,-,Central Nervous System Stimulants,4,,-,approved,1960,
2090,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,
2091,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,
2092,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,
2093,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,
2094,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,
2095,benzquinamide,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,
2096,benztropine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD049,-,Antiparkinson,4,,-,approved,1954,
2097,betaxolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD052,-,Antihypertensive,4,,-,approved,1985,
2098,betazole,small molecule,Aminergic ,agonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD053,-,Diagnostic,4,,-,approved,1982,
2099,bethanechol,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD054,-,Parasympathomimetics,4,,-,approved,1948,
2100,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,
2101,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,
2102,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,
2103,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,
2104,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,
2105,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,
2106,bevantolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD056,-,Antihypertensive,2,1989,discontinued,in trial,-,Decided 1989 not to market it in US and elsewhere
2107,biperiden,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD057,-,Antidyskinetics,4,,-,approved,1959,
2108,bisoprolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD058,-,Antihypertensive,4,,-,approved,1992,
2109,bromodiphenhydramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD062,-,Anti-Allergic,4,,-,approved,1954,
2110,brompheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD063,-,Anti-Allergic,4,,-,approved,1957,
2111,buclizine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD064,-,Antiemetics,4,,-,approved,1982,
2112,buclizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD064,-,Antiemetics,4,,-,approved,1982,
2113,buspirone,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD066,-,Anti-anxiety,4,,-,approved,1986,
2114,buspirone,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD066,-,Anti-anxiety,4,,-,approved,1986,
2115,butorphanol,small molecule,Peptide,partial agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD070,-,Analgesics,4,,-,approved,1978,
2116,butorphanol,small molecule,Peptide,partial agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD070,-,Analgesics,4,,-,approved,1978,
2117,butorphanol,small molecule,Peptide,partial agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD070,-,Analgesics,4,,-,approved,1978,
2118,cabergoline,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD071,-,Antiparkinson,4,,-,approved,1996,
2119,caffeine,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,NRDD072,-,Central Nervous System Stimulants,4,,-,approved,1999,
2120,caffeine,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,NRDD072,-,Central Nervous System Stimulants,4,,-,approved,1999,
2121,carbachol,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD077,-,Antiglaucomic,4,,-,approved,1972,
2122,carbachol,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD077,-,Antiglaucomic,4,,-,approved,1972,
2123,carbetocin,small molecule,Peptide,agonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD078,-,Labor Inducing,3,2016,completed,in trial,-,Approved in Europe but not FDA
2124,carbinoxamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD080,-,Anti-Allergic,4,,-,approved,2003,
2125,carbinoxamine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD080,-,Anti-Allergic,4,,-,approved,2003,
2126,carboprost tromethamine,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD081,-,Abortifacient,4,,-,approved,1965,
2127,carphenazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD082,-,schizophrenia,4,,-,approved,1982,
2128,carphenazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD082,-,schizophrenia,4,,-,approved,1982,
2129,carphenazine,small molecule,Aminergic ,antagonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD082,-,schizophrenia,4,,-,approved,1982,
2130,carteolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD084,-,Antiglaucomic,4,,-,approved,1988,
2131,ceruletide,small molecule,Peptide,agonist,,primary,CCKAR,cckar_human,P32238,Class A (Rhodopsin),GPCR;Rhodopsin,Cholecystokinin receptors,established,NRDD085,-,Diagnostic,4,,-,approved,1982,
2132,cevimeline,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD086,-,Parasympathomimetics,4,,-,approved,2000,
2133,cevimeline,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD086,-,Parasympathomimetics,4,,-,approved,2000,
2134,chlophedianol,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD087,-,Antitussive,4,,-,approved,1987,Not available in US- discontinued
2135,chlorpheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD094,-,Anti-Allergic,4,,-,approved,1950,
2136,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
2137,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
2138,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
2139,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
2140,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
2141,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
2142,chlorprothixene,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
2143,chorionic gonadotropin,protein,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD099,-,Fertility,4,,-,approved,1973,
2144,chorionic gonadotropin,protein,Protein,agonist,,secondary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD099,-,Fertility,4,,-,approved,1973,
2145,cimetidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD104,-,GI Anti-Ulcer ; antihistamines,4,,-,approved,1977,
2146,cinacalcet,small molecule,Ion ,PAM,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,NRDD105,-,Calcimimetics,4,,-,approved,2004,
2147,cinalukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,NRDD106,-,Anti-Asthmatic,1,2005,discontinued,in trial,-,
2148,cinnarizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD107,-,Anti-Allergic,4,,-,approved,1989,
2149,cisapride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD109,-,Parasympathomimetics,4,,-,approved,1993,
2150,clemastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD112,-,Anti-Allergic,4,,-,approved,1977,
2151,clenbuterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD113,-,Bronchodilator,4,,-,approved,-,Not approved in US
2152,clidinium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD114,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,2013,
2153,clozapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
2154,clozapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
2155,clozapine,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
2156,clozapine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
2157,clozapine,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
2158,clozapine,small molecule,Aminergic ,antagonist,,secondary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
2159,clozapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
2160,clozapine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
2161,cocaine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD123,-,local anesthetic,4,,-,approved,1982,
2162,cocaine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD123,-,local anesthetic,4,,-,approved,1982,
2163,codeine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD124,-,Analgesics,4,,-,approved,2009,
2164,codeine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD124,-,Analgesics,4,,-,approved,2009,
2165,codeine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD124,-,Analgesics,4,,-,approved,2009,
2166,cosyntropin,peptide,Peptide,agonist,,primary,MC2R,acthr_human,Q01718,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,established,NRDD128,-,Diagnostic,4,,-,approved,1970,
2167,cyclizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD130,-,Antiemetics,4,,-,approved,1982,
2168,cyclobenzaprine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD131,-,Anti-depressant,4,,-,approved,1977,
2169,cyclopentolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD132,-,Mydriatics,4,,-,approved,1974,
2170,cycrimine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD134,-,Antiparkinson,4,,-,approved,1982,
2171,cyproheptadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD135,-,Anti-Allergic ; Appetite Stimulant,4,,-,approved,1961,
2172,cyproheptadine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD135,-,Anti-Allergic ; Appetite Stimulant,4,,-,approved,1961,
2173,danazol,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD139,-,Antiendometriosis ; Antineoplastic,4,,-,approved,1976,
2174,danazol,small molecule,Peptide,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD139,-,Antiendometriosis ; Antineoplastic,4,,-,approved,1976,
2175,dapiprazole,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD141,-,opthalmological,4,,-,approved,1990,
2176,dapiprazole,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD141,-,opthalmological,4,,-,approved,1990,
2177,dapiprazole,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD141,-,opthalmological,4,,-,approved,1990,
2178,debrisoquin,small molecule,Aminergic ,not available,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD143,-,Antihypertensive,4,,-,approved,1970,Approved from before 1970
2179,debrisoquin,small molecule,Aminergic ,not available,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD143,-,Antihypertensive,4,,-,approved,1970,Approved from before 1970
2180,debrisoquin,small molecule,Aminergic ,not available,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD143,-,Antihypertensive,4,,-,approved,1970,Approved from before 1970
2181,debrisoquin,small molecule,Aminergic ,not available,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD143,-,Antihypertensive,4,,-,approved,1970,Approved from before 1970
2182,debrisoquin,small molecule,Aminergic ,not available,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD143,-,Antihypertensive,4,,-,approved,1970,Approved from before 1970
2183,debrisoquin,small molecule,Aminergic ,not available,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD143,-,Antihypertensive,4,,-,approved,1970,Approved from before 1970
2184,desipramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD148,-,Anti-depressant,4,,-,approved,1964,
2185,desipramine,small molecule,Aminergic ,unknown,,secondary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD148,-,Anti-depressant,4,,-,approved,1964,
2186,desipramine,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD148,-,Anti-depressant,4,,-,approved,1964,
2187,desipramine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD148,-,Anti-depressant,4,,-,approved,1964,
2188,desipramine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD148,-,Anti-depressant,4,,-,approved,1964,
2189,dexbrompheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD153,-,Anti-Allergic,4,,-,approved,1963,
2190,dexmedetomidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD155,-,Analgesics; Hypnotics and Sedatives,4,,-,approved,1999,
2191,dezocine,small molecule,Peptide,partial agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD157,-,Analgesics,4,,-,approved,1989,
2192,dezocine,small molecule,Peptide,partial agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD157,-,Analgesics,4,,-,approved,1989,
2193,dicyclomine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD162,-,Antispasmodics,4,,-,approved,1950,
2194,dimenhydrinate,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD170,-,Antiemetics,4,,-,approved,1972,
2195,dinoprost tromethamine,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD171,-,Abortifacient,4,,-,approved,1981,
2196,dinoprostone,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD172,-,Abortifacient,4,,-,approved,1977,
2197,dinoprostone,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD172,-,Abortifacient,4,,-,approved,1977,
2198,dinoprostone,small molecule,Lipid ,agonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD172,-,Abortifacient,4,,-,approved,1977,
2199,dinoprostone,small molecule,Lipid ,agonist,,primary,PTGER4,pe2r4_human,P35408,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD172,-,Abortifacient,4,,-,approved,1977,
2200,diphemanil,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD173,-,Bronchodilator,4,,-,approved,1976,
2201,diphenhydramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD174,-,Anti-Allergic ; Hypnotics and sedatives; Antiemetics; Antipruritics; Antitussives,4,,-,approved,1946,
2202,diphenidol,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD175,-,Antiemetics,4,,-,approved,1967,
2203,diphenidol,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD175,-,Antiemetics,4,,-,approved,1967,
2204,diphenidol,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD175,-,Antiemetics,4,,-,approved,1967,
2205,diphenoxylate,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD176,-,Antidiuretic,4,,-,approved,1960,
2206,diphenylpyraline,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD177,-,Anti-Allergic,4,,-,approved,1982,
2207,dipivefrin,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD178,-,opthalmological,4,,-,approved,1980,
2208,dobutamine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD182,-,Cardiotonic,4,,-,approved,1978,
2209,domperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD184,-,Antiemetics,2,2015,recruiting,in trial,-,
2210,doxacurium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD185,-,Muscle Relaxants,4,,-,approved,1991,
2211,doxacurium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD186,-,Muscle Relaxants,4,,-,approved,1991,
2212,doxazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD187,-,Anticholesteremic ; Antihypertensive ; Vasodilator,4,,-,approved,1990,
2213,doxazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD187,-,Anticholesteremic ; Antihypertensive ; Vasodilator,4,,-,approved,1990,
2214,doxazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD187,-,Anticholesteremic ; Antihypertensive ; Vasodilator,4,,-,approved,1990,
2215,doxylamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD188,-,Anti-Allergic ; Antiemetics; Antitussive ; Hypnotics and Sedatives,4,,-,approved,1948,
2216,dronedarone,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD190,-,Anti-Arrhythmia,4,,-,approved,2009,
2217,dronedarone,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD190,-,Anti-Arrhythmia,4,,-,approved,2009,
2218,droperidol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD191,-,Adjuvants; Anesthesia,4,,-,approved,1970,
2219,emedastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD199,-,Anti-Allergic,4,,-,approved,1997,
2220,ephedrine,small molecule,Aminergic ,not available,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD204,-,Central Nervous System Stimulants,4,,-,approved,1963,
2221,epoprostenol,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD206,-,Antihypertensive ; Platelet Aggregation Inhibitors,4,,-,approved,1995,
2222,eprosartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD207,-,Antihypertensive,4,,-,approved,1997,
2223,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD209,-,Nootropic ; Vasodilator,4,,-,approved,1953,
2224,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD209,-,Nootropic ; Vasodilator,4,,-,approved,1953,
2225,ergotamine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD210,-,Anti-migraine,4,,-,approved,1960,
2226,ergotamine,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD210,-,Anti-migraine,4,,-,approved,1960,
2227,esmolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD212,-,Anti-Arrhythmia,4,,-,approved,1986,
2228,ethopropazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD217,-,Antidyskinetics,4,,-,approved,1982,
2229,etomidate,small molecule,Aminergic ,PAM,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD222,-,Anesthetics; Intravenous,4,,-,approved,1982,
2230,felypressin,peptide,Peptide,agonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD226,-,Hemostatic s; Vasoconstricting,1,2010,completed,in trial,-,"Not approved in US, but used here and elsewhere"
2231,fenoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD229,-,Bronchodilator ; Tocolytic,4,,withdrawn,approved,-,
2232,flavoxate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD230,-,Antispasmodics,4,,-,approved,1970,
2233,flavoxate,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD230,-,Antispasmodics,4,,-,approved,1970,
2234,flunarizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD236,-,Anticonvulsants; Vasodilator,4,,-,approved,1968,
2235,flupenthixol,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD240,-,schizophrenia,3,2015,recruiting,in trial,-,"Never approved by fda, clinical trials in Europe in 2005"
2236,flupenthixol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD240,-,schizophrenia,3,2015,recruiting,in trial,-,"Never approved by fda, clinical trials in 1989"
2237,fluphenazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD241,-,schizophrenia,4,,-,approved,1959,
2238,fluphenazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD241,-,schizophrenia,4,,-,approved,1959,
2239,fluspirilene,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD244,-,schizophrenia,4,,-,approved,1977,
2240,follitropin,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD246,-,Fertility,4,,-,approved,1997,
2241,forasartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD248,-,Antihypertensive,4,,-,approved,-,"Never approved by fda, used from long time ago"
2242,glucagon,peptide,Peptide,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,NRDD256,-,Antihypoglycemic,4,,-,approved,1960,
2243,gonadorelin,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD259,-,Fertility,4,,-,approved,1982,
2244,gonadorelin,small molecule,Peptide,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD259,-,Fertility,4,,-,approved,1982,
2245,goserelin,peptide,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD260,-,Antineoplastic s; Hormonal,4,,-,approved,1989,
2246,guanabenz,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD261,-,Antihypertensive,4,,-,approved,1982,
2247,haloperidol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD266,-,schizophrenia,4,,-,approved,1967,
2248,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,
2249,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,
2250,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,
2251,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,
2252,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,
2253,hydroxyzine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD275,-,Antipruritics; Anxiolytics sedatives and hypnotics,4,,-,approved,1956,
2254,isoetharine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD290,-,Bronchodilator,4,,-,approved,1979,
2255,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD293,-,Bronchodilator ; Cardiotonic,4,,-,approved,1956,
2256,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD293,-,Bronchodilator ; Cardiotonic,4,,-,approved,1956,
2257,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD296,-,Antihypertensive,4,,-,approved,1984,
2258,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD296,-,Antihypertensive,4,,-,approved,1984,
2259,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD296,-,Antihypertensive,4,,-,approved,1984,
2260,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD296,-,Antihypertensive,4,,-,approved,1984,
2261,levallorphan,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD298,-,Opiate Antagonists,4,,-,approved,1982,
2262,levobunolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD299,-,Antiglaucomic,4,,-,approved,1985,
2263,levobunolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD299,-,Antiglaucomic,4,,-,approved,1985,
2264,levocabastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD301,-,Anti-Allergic,4,,-,approved,1993,
2265,levomethadyl acetate,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD302,-,Analgesics,4,,-,approved,1993,
2266,levorphanol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD303,-,Analgesics,4,,-,approved,1953,
2267,liraglutide,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,NRDD305,-,Antidiabetic,4,,-,approved,2010,
2268,lisdexamfetamine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD306,-,Central Nervous System Stimulants,4,,-,approved,2007,FDA approval 2007 for ADHD; pro-drug of dextroamphetamine so not NME
2269,lisdexamfetamine,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD306,-,Central Nervous System Stimulants,4,,-,approved,2007,FDA approval 2007 for ADHD; pro-drug of dextroamphetamine so not NME
2270,lisuride,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD307,-,Antiparkinson,4,,-,approved,2011,
2271,lisuride,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD307,-,Antiparkinson,4,,-,approved,2011,
2272,lisuride,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD307,-,Antiparkinson,4,,-,approved,2011,
2273,loperamide,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD308,-,Antidiuretic,4,,-,approved,1976,
2274,losartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD310,-,Antihypertensive,4,,-,approved,1995,
2275,lutropin alfa,peptide,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD311,-,Fertility,4,,-,approved,2004,
2276,marinol,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,NRDD314,-,Antiemetics,4,,-,approved,1985,
2277,meclizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD315,-,Antiemetics,4,,-,approved,1957,
2278,melatonin,small molecule,Melatonin ,agonist,,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,NRDD320,-,Hypnotics and Sedatives,4,,-,approved,2005,
2279,melatonin,small molecule,Melatonin ,agonist,,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,NRDD320,-,Hypnotics and Sedatives,4,,-,approved,2005,
2280,menotropins,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD322,-,Fertility,4,,-,approved,1975,
2281,menotropins,protein,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD322,-,Fertility,4,,-,approved,1975,
2282,mepenzolate,small molecule,Alicarboxylic acid ,antagonist,,secondary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,NRDD324,-,Antispasmodics,4,,-,approved,1956,
2283,mepenzolate,small molecule,Alicarboxylic acid ,antagonist,,secondary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,NRDD324,-,Antispasmodics,4,,-,approved,1956,
2284,meperidine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD325,-,Analgesics,4,,-,approved,1942,
2285,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD326,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1951,
2286,mequitazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD329,-,Anti-Allergic,4,,-,approved,-,"Marketed but I don't think fda approved, if so then long ago"
2287,mesoridazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD331,-,schizophrenia,4,,-,approved,1970,
2288,mesoridazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD331,-,schizophrenia,4,,-,approved,1970,
2289,metaraminol,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD333,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1954,
2290,methadone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD334,-,Analgesics,4,,-,approved,1947,
2291,methadyl acetate,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD335,-,Analgesics,4,,-,approved,1993,
2292,methantheline,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD336,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1951,
2293,methdilazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD339,-,Anti-Allergic,4,,-,approved,1982,
2294,levomepromazine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
2295,levomepromazine,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
2296,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
2297,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
2298,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
2299,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
2300,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
2301,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
2302,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
2303,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
2304,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
2305,methoxamine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD343,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1982,
2306,methoxamine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD343,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1982,
2307,methyldopa,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD346,-,Antihypertensive,4,,-,approved,1962,
2308,methylergonovine,small molecule,Aminergic ,partial agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD347,-,Abortifacient,4,,-,approved,1946,
2309,methylnaltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD348,-,OIC treatment,4,,-,approved,2008,
2310,methylscopolamine bromide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD351,-,Antispasmodics,4,,-,approved,1953,
2311,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD353,-,Anti-migraine s; Vasoconstrictor,4,,-,approved,1962,
2312,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD353,-,Anti-migraine s; Vasoconstrictor,4,,-,approved,1962,
2313,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD353,-,Anti-migraine s; Vasoconstrictor,4,,-,approved,1962,
2314,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD353,-,Anti-migraine s; Vasoconstrictor,4,,-,approved,1962,
2315,metipranolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD354,-,Anti-Arrhythmia ; Antihypertensive ; Anti-glaucoma,4,,-,approved,1989,
2316,metipranolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD354,-,Anti-Arrhythmia ; Antihypertensive ; Anti-glaucoma,4,,-,approved,1989,
2317,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,
2318,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,
2319,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,
2320,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,
2321,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,
2322,metoprolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD359,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1978,
2323,mianserin,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD363,-,Anti-depressant,4,,-,approved,1996,"Doesn't appear to be FDA approved, but analogue mirtazapine is "
2324,mianserin,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD363,-,Anti-depressant,4,,-,approved,1996,"Doesn't appear to be FDA approved, but analogue mirtazapine is "
2325,mianserin,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD363,-,Anti-depressant,4,,-,approved,1996,"Doesn't appear to be FDA approved, but analogue mirtazapine is "
2326,mianserin,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD363,-,Anti-depressant,4,,-,approved,1996,"Doesn't appear to be FDA approved, but analogue mirtazapine is "
2327,midodrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD365,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1996,
2328,midodrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD365,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1996,
2329,minaprine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used
2330,minaprine,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used
2331,minaprine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used
2332,minaprine,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used
2333,minaprine,small molecule,Aminergic ,antagonist,,secondary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used
2334,mivacurium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD370,-,Muscle Relaxants,4,,-,approved,1992,
2335,molindone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD372,-,schizophrenia,4,,-,approved,1974,
2336,nadolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD376,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1979,
2337,nadolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD376,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1979,
2338,nafarelin,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD377,-,Antiendometriosis,4,,-,approved,1990,
2339,nafarelin,small molecule,Peptide,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD377,-,Antiendometriosis,4,,-,approved,1990,
2340,nedocromil,small molecule,Lipid ,not available,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,NRDD379,-,Anti-Allergic ; Anti-Asthmatic,4,,-,approved,1992,
2341,nefazodone,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD380,-,Anti-depressant,4,,-,approved,1994,
2342,nefazodone,small molecule,Aminergic ,unknown,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD380,-,Anti-depressant,4,,-,approved,1994,
2343,nefazodone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD380,-,Anti-depressant,4,,-,approved,1994,
2344,nicergoline,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD384,-,Nootropic ; Vasodilator,4,,-,approved,-,"Marketed but I don't think fda approved, if so then long ago"
2345,nizatidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD394,-,GI Anti-Ulcer ; antihistamines,4,,-,approved,1988,
2346,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
2347,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
2348,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
2349,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
2350,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
2351,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
2352,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
2353,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
2354,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
2355,orciprenaline,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD399,-,Bronchodilator,4,,-,approved,1973,
2356,orphenadrine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD400,-,Antiparkinson s; Muscle Relaxants; Central,4,,-,approved,1957,
2357,oxprenolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD405,-,Antihypertensive ; Anti-Arrhythmia,4,,-,approved,1983,
2358,oxprenolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD405,-,Antihypertensive ; Anti-Arrhythmia,4,,-,approved,1983,
2359,oxyphencyclimine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD407,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1982,
2360,oxyphencyclimine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD407,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1982,
2361,oxyphencyclimine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD407,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1982,
2362,oxyphenonium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD408,-,Mydriatics,4,,-,approved,1982,
2363,pemirolast,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD416,-,Anti-Allergic,4,,-,approved,1999,
2364,penbutolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD417,-,Antihypertensive,4,,-,approved,1987,
2365,penbutolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD417,-,Antihypertensive,4,,-,approved,1987,
2366,pentagastrin,small molecule,Peptide,agonist,,primary,CCKBR,gasr_human,P32239,Class A (Rhodopsin),GPCR;Rhodopsin,Cholecystokinin receptors,established,NRDD418,-,Diagnostic,4,,-,approved,1974,
2367,pentazocine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD419,-,Analgesics,4,,-,approved,1967,
2368,pentazocine,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD419,-,Analgesics,4,,-,approved,1967,
2369,pergolide,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD422,-,Antiparkinson,4,,-,approved,1988,
2370,pergolide,small molecule,Aminergic ,agonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD422,-,Antiparkinson,4,,-,approved,1988,
2371,perphenazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD425,-,schizophrenia,4,,-,approved,1957,
2372,perphenazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD425,-,schizophrenia,4,,-,approved,1957,
2373,phendimetrazine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD427,-,Appetite suppressant,4,,-,approved,1976,
2374,phendimetrazine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD427,-,Appetite suppressant,4,,-,approved,1976,
2375,pheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD431,-,Anti-Allergic,4,,-,approved,1994,
2376,phenoxybenzamine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD434,-,Anticonvulsants; Hypnotics and Sedatives,4,,-,approved,1953,
2377,phentolamine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD437,-,Antihypertensive,4,,-,approved,1952,
2378,phenylpropanolamine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD439,-,Appetite Depressants; Nasal Decongestants,4,,-,approved,1958,
2379,phenylpropanolamine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD439,-,Appetite Depressants; Nasal Decongestants,4,,-,approved,1958,
2380,pimozide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD443,-,Antidyskinetics; Antipsychotic,4,,-,approved,1984,
2381,pindolol,small molecule,Aminergic ,partial agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD444,-,Antihypertensive,4,,-,approved,1982,
2382,pindolol,small molecule,Aminergic ,partial agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD444,-,Antihypertensive,4,,-,approved,1982,
2383,pirenzepine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD446,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,-,
2384,practolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD449,-,Anti-Arrhythmia,4,,-,approved,-,
2385,pranlukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,NRDD451,-,Anti-Asthmatic,4,,-,approved,-,
2386,prazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD453,-,Antihypertensive ; antispasmodics,4,,-,approved,1976,
2387,prazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD453,-,Antihypertensive ; antispasmodics,4,,-,approved,1976,
2388,prazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD453,-,Antihypertensive ; antispasmodics,4,,-,approved,1976,
2389,procaterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD459,-,Bronchodilator,3,2015,recruiting,in trial,-,
2390,procyclidine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD460,-,Antidyskinetics; Antiparkinson s,4,,-,approved,1955,
2391,procyclidine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD460,-,Antidyskinetics; Antiparkinson s,4,,-,approved,1955,
2392,procyclidine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD460,-,Antidyskinetics; Antiparkinson s,4,,-,approved,1955,
2393,progabide,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,NRDD461,-,Anticonvulsants,4,,-,approved,-,Not FDA approved but used in other countries
2394,promazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2395,promazine,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2396,promazine,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2397,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2398,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2399,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2400,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2401,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2402,promazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2403,promazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2404,promazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2405,promazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2406,promazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2407,promazine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
2408,promethazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,
2409,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,
2410,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,
2411,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,
2412,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,
2413,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,
2414,propantheline,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD464,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1953,
2415,propericiazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD466,-,schizophrenia,4,,-,approved,-,Not FDA approved but used in other countries
2416,propericiazine,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD466,-,schizophrenia,4,,-,approved,-,Not FDA approved but used in other countries
2417,propericiazine,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD466,-,schizophrenia,4,,-,approved,-,Not FDA approved but used in other countries
2418,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2419,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2420,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2421,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2422,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2423,propiomazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2424,propiomazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2425,propiomazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2426,propiomazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2427,propiomazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2428,propiomazine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2429,propiomazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2430,propiomazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2431,propiomazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
2432,propoxyphene,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD468,-,Analgesics,4,,-,approved,1957,
2433,propoxyphene,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD468,-,Analgesics,4,,-,approved,1957,
2434,propoxyphene,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD468,-,Analgesics,4,,-,approved,1957,
2435,remoxipride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD479,-,schizophrenia,4,,-,approved,1990,Withdrawn 
2436,risperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD484,-,schizophrenia,4,,-,approved,1993,
2437,risperidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD484,-,schizophrenia,4,,-,approved,1993,
2438,ritodrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD485,-,Tocolytic,4,,-,approved,1987,
2439,rizatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD486,-,Anti-migraine,4,,-,approved,1998,
2440,rizatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD486,-,Anti-migraine,4,,-,approved,1998,
2441,saprisartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD489,-,Antihypertensive,2,1997,discontinued,in trial,-,
2442,scopolamine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD491,-,Adjuvants; Anesthesia; Antispasmodics; Mydriatics,4,,-,approved,1953,
2443,secretin,peptide,Peptide,agonist,,primary,SCTR,sctr_human,P47872,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,NRDD493,-,Diagnostic,4,,-,approved,2002,
2444,sermorelin,peptide,Peptide,agonist,,primary,GHRHR,ghrhr_human,Q02643,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,NRDD494,-,Hormone Replacement,4,,-,approved,1990,
2445,succinylcholine,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD501,-,Muscle Relaxants; Skeletal,4,,-,approved,1952,
2446,sulpiride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD504,-,Antidepressive ; Second-Generation; Antipsychotic,3,2016,recruiting,in trial,-,Not FDA approved but used in other countries
2447,tasosartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD509,-,Antihypertensive,3,2000,discontinued,in trial,-,Disontinued due to safety profile
2448,terazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD514,-,Antineoplastic s; Antihypertensive,4,,-,approved,1987,
2449,terazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD514,-,Antineoplastic s; Antihypertensive,4,,-,approved,1987,
2450,terazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD514,-,Antineoplastic s; Antihypertensive,4,,-,approved,1987,
2451,terbutaline,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD515,-,Bronchodilator ; Tocolytic,4,,-,approved,1974,
2452,terfenadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD516,-,Anti-Allergic,4,,-,approved,1985,
2453,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,
2454,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,
2455,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,
2456,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,
2457,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,
2458,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,
2459,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,
2460,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,
2461,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,
2462,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,
2463,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,
2464,thioridazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD521,-,schizophrenia,4,,-,approved,1962,
2465,thioridazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD521,-,schizophrenia,4,,-,approved,1962,
2466,thioridazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD521,-,schizophrenia,4,,-,approved,1962,
2467,thioridazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD521,-,schizophrenia,4,,-,approved,1962,
2468,thyrotropin alfa,protein,Protein,agonist,,primary,TSHR,tshr_human,P16473,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD522,-,Diagnostic,4,,-,approved,1998,
2469,ticlopidine,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,NRDD525,-,Platelet Aggregation Inhibitors,4,,-,approved,1991,
2470,tolazoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD530,-,Antihypertensive,4,,-,approved,1948,
2471,treprostinil,small molecule,Nucleotide ,agonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,NRDD537,-,Antihypertensive ; Antithrombotic,4,,-,approved,2002,
2472,tridihexethyl,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD540,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1954,
2473,tridihexethyl,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD540,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1954,
2474,tridihexethyl,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD540,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1954,
2475,trifluoperazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD541,-,Antiemetics; Antipsychotic,4,,-,approved,1959,
2476,trifluoperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD541,-,Antiemetics; Antipsychotic,4,,-,approved,1959,
2477,triflupromazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,
2478,triflupromazine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,
2479,triflupromazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,
2480,triflupromazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,
2481,triflupromazine,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,
2482,trihexyphenidyl,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD543,-,Antiparkinson,4,,-,approved,1949,
2483,trimeprazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD545,-,Antipruritics,4,,-,approved,1982,
2484,tripelennamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD550,-,Anti-Allergic,4,,-,approved,1948,
2485,triprolidine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD551,-,Anti-Allergic,4,,-,approved,1982,
2486,tropicamide,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD552,-,Diagnostic,4,,-,approved,1960,
2487,urofollitropin,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD554,-,Fertility,4,,-,approved,1986,
2488,vasopressin,peptide,Peptide,agonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD560,-,Antidiuretic,4,,-,approved,1982,
2489,vasopressin,peptide,Peptide,agonist,,primary,AVPR1B,v1br_human,P47901,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD560,-,Antidiuretic,4,,-,approved,1982,
2490,vasopressin,peptide,Peptide,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD560,-,Antidiuretic,4,,-,approved,1982,
2491,yohimbine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD564,-,Mydriatics; Anti-impotence,0,2000,discontinued,preclinical,-,Inferred dates
2492,yohimbine,small molecule,Aminergic ,antagonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD564,-,Mydriatics; Anti-impotence,0,2000,discontinued,preclinical,-,Inferred dates
2493,yohimbine,small molecule,Aminergic ,antagonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD564,-,Mydriatics; Anti-impotence,0,2000,discontinued,preclinical,-,Inferred dates
2494,zuclopenthixol,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD567,-,schizophrenia,4,,-,approved,1962,
2495,zuclopenthixol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD567,-,schizophrenia,4,,-,approved,1962,
2496,zuclopenthixol,small molecule,Aminergic ,antagonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD567,-,schizophrenia,4,,-,approved,1962,
2497,trabodenoson,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMA_CLDATES_0363,trabodenoson and latanoprost,Antiglaucomic,2,2016,completed,in trial,-,
